e10vk
 
    SECURITIES AND EXCHANGE
    COMMISSION
    Washington, D.C.
    20549
 
 
 
 
    Form 10-K
 
    |   | 	
      | 	
      | 	
| 
    (Mark One)
    
 | 
 
 | 
 
 | 
|  
 | 
| 
 
    þ
 
 | 
 
 | 
    ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
    SECURITIES EXCHANGE ACT OF 1934
 | 
| 
 
 | 
 
 | 
    For the fiscal year ended
    December 31, 2007
 | 
| 
 
    or
 
 | 
| 
 
    o
    
 
 | 
 
 | 
    TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
    SECURITIES EXCHANGE ACT OF 1934
 | 
| 
 
 | 
 
 | 
    For the transition period
    from          to          
 | 
 
    Commission file number 0-26946
 
    INTEVAC, INC.
    (Exact name of registrant as
    specified in its charter)
 
    |   | 	
      | 	
      | 	
| 
 
    Delaware
 
 | 
 
 | 
    94-3125814
 | 
    (State or other jurisdiction
    of 
    incorporation or organization)
 | 
 
 | 
    (I.R.S. Employer 
    Identification No.)
    
 | 
 
    3560 Bassett Street
    Santa Clara, California 95054
    (Address of principal executive
    office, including Zip Code)
    Registrants telephone number, including area code:
    (408) 986-9888
    Securities registered pursuant to Section 12(b) of the
    Act:
 
    |   | 	
      | 	
      | 	
| 
 
    Title of Each Class
 
 | 
 
 | 
 
    Name of Each Exchange on Which Registered
 
 | 
|  
 | 
| 
 
    Common Stock ($0.001 par value)
 
 | 
 
 | 
    The Nasdaq Stock Market LLC (NASDAQ Global Select)
 | 
 
    Securities registered pursuant to Section 12(g) of the
    Act:
 
    None.
 
 
 
 
    Indicate by check mark if the registrant is a well-known
    seasoned issuer, as defined in Rule 405 of the Securities
    Act.  o Yes     þ No
 
    Indicate by check mark if the registrant is not required to file
    reports pursuant to Section 13 or Section 15(d) of the
    Act.  o Yes     þ No
 
    Indicate by check mark whether the registrant (1) has filed
    all reports required to be filed by Section 13 or 15(d) of
    the Securities Exchange Act of 1934 during the preceding
    12 months (or for such shorter period that the registrant
    was required to file such reports), and (2) has been
    subject to such filing requirements for the past
    90 days.  þ Yes     o No
 
    Indicate by a check mark if disclosure of delinquent filers
    pursuant to Item 405 of
    Regulation S-K
    is not contained herein, and will not be contained, to the best
    of registrants knowledge, in definitive proxy or
    information statements incorporated by reference in
    Part III of this
    Form 10-K
    or any amendment to this
    Form 10-K.  o
    
 
    Indicate by check mark whether the registrant is a large
    accelerated filer, an accelerated filer, a non-accelerated
    filer, or a smaller reporting company. See the definitions of
    large accelerated filer, accelerated
    filer and smaller reporting company in
    Rule 12b-2
    of the Exchange Act. (Check one):
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
    Large accelerated
    filer o
    
 
 | 
 
 | 
    Accelerated
    filer þ
    
 | 
 
 | 
    Non-accelerated
    filer o 
    (Do not check if a smaller reporting company)
 | 
 
 | 
    Smaller reporting
    company o
 | 
 
    Indicate by check mark whether the registrant is a shell company
    (as defined in
    Rule 12b-2
    of the
    Act).  o Yes     þ No
 
    The aggregate market value of voting stock held by
    non-affiliates of the Registrant, as of June 30, 2007 was
    approximately $356,923,914 (based on the closing price for
    shares of the Registrants Common Stock as reported by the
    Nasdaq Stock Market for the last trading day prior to that
    date). Shares of Common Stock held by each executive officer,
    director, and holder of 5% or more of the outstanding Common
    Stock have been excluded in that such persons may be deemed to
    be affiliates. This determination of affiliate status is not
    necessarily a conclusive determination for other purposes.
 
    On March 7, 2008, 21,676,698 shares of the
    Registrants Common Stock, $0.001 par value, were
    outstanding.
 
    DOCUMENTS INCORPORATED BY REFERENCE.
 
    Portions of the Registrants Proxy Statement for the 2008
    Annual Meeting of Stockholders are incorporated by reference
    into Part III. Such proxy statement will be filed within
    120 days after the end of the fiscal year covered by this
    Annual Report on
    Form 10-K.
 
 
 
    Except for historical information contained in this
    Form 10-K,
    certain statements set forth herein, including statements
    regarding growth in industry shipments of hard disk drives;
    trends in semiconductor manufacturing equipment including line
    width dimensions, wafer size and market size; timing of shipment
    and revenue recognition for our new semiconductor equipment
    products; projected growth in Imaging Instrumentation product
    sales as a percentage of Imaging Instrumentation revenues;
    timing of volume production for our night-vision sensor modules
    for rifle sights and our
    LIVAR®
    cameras; the expectation that a significant portion of our
    revenue will continue to be concentrated with a small number of
    international customers; continued government and internal
    funding for development of Digital Enhanced Night Vision
    Goggles; the estimated cost of compliance with environmental
    regulations; projected reduction in new 200
    Lean®
    shipments in 2008 relative to 2007; expected fluctuations in our
    quarterly and annual revenues and operating margins; and our
    expectation that we will continue to retain our earnings, rather
    then paying dividends are forward- looking statements that are
    dependant on certain risks and uncertainties including such
    factors, among others, as hard disk drive industry conditions;
    our ability to forecast and meet the equipment needs of
    semiconductor manufacturers and deliver our Lean Etch systems as
    planned; our ability to design and market new Imaging
    Instrumentation products and sell increasing levels of those
    products to military and commercial customers; our ability to
    continue to raise external funding and provide internal funding
    for development of our Imaging Instrumentation products; our
    ability to maintain compliance with environmental regulations on
    a cost-effective basis; our ability to cost-effectively manage
    significant fluctuations in our business levels from quarter to
    quarter and other factors described below. Therefore, actual
    outcomes and result may differ materially from what is expressed
    or forecast in such forward-looking statements. Words such as
    expect, anticipate, intend,
    plan, believe, seek,
    estimate and variations of such words and similar
    expressions are intended to identify such forward looking
    statements. See Risk Factors in the
    Business section of this Annual Report on
    Form 10-K
    for a more thorough list of potential risks and
    uncertainties.
TABLE OF CONTENTS
 
    PART I
 
 
    Overview
 
    Intevacs business consists of two reportable segments:
 
    Equipment:  Intevac is a leader in the design,
    manufacture and marketing of high-productivity lean
    manufacturing systems and has been producing Lean
    Thinking platforms since 1994. We are the leading supplier
    of magnetic media sputtering equipment to the hard disk drive
    industry and offer leading-edge, high-productivity etch systems
    to the semiconductor industry.
 
    Imaging Instrumentation:  Intevac is a leader
    in the development of compact, cost-effective, high-sensitivity
    digital-optical products for the capture and display of
    low-light images and the optical analysis of materials. We
    provide sensors, cameras and systems for commercial applications
    in the inspection, medical, scientific and security industries
    and for government applications such as night vision and
    long-range target identification.
 
    Intevac was incorporated in October 1990 in California and
    completed a leveraged buyout of a number of divisions of Varian
    Associates in February 1991. Intevac was reincorporated in
    Delaware in 2007. Our principal executive offices are located at
    3560 Bassett Street, Santa Clara, California 95054, and our
    phone number is
    (408) 986-9888.
 
    Equipment
    Segment
 
    Hard
    Disk Drive Equipment Market
 
    We design, manufacture, market and service complex capital
    equipment used to deposit, or sputter, thin films of material
    onto magnetic disks that are used in hard disk drives, and also
    equipment to lubricate these disks. Disk and disk drive
    manufacturers produce magnetic disks in a sophisticated
    manufacturing process involving many steps, including plating,
    annealing, polishing, texturing, sputtering and lubrication. We
    believe our systems represent approximately 60% of the installed
    capacity of disk sputtering systems worldwide. Our systems are
    used by manufacturers such as Fuji Electric, Hitachi Global
    Storage Technologies, Seagate Technology and Western Digital.
    
    1
 
    Hard disk drives are a primary storage medium for digital data
    and are used in products and applications such as personal
    computers, enterprise data storage, streaming video, personal
    audio and video players and video game platforms. We believe
    that hard disk drive shipments will continue to grow, driven by
    these products, by other new and emerging applications, by the
    proliferation of personal computers into emerging markets in
    Asia and Eastern Europe and by technology advances in the
    industry. As a result of these and other factors, TrendFocus has
    projected that hard disk drive unit shipments will increase from
    435 million units in 2006 to 785 million units in
    2011, equivalent to a 12.5% cumulative annual growth rate.
    Continued growth in hard disk drive shipments is a key factor in
    determining demand for magnetic disks used in hard disk drives.
    TrendFocus also has projected that unit shipments of magnetic
    disks for hard disk drives will increase from 786 million
    units in 2006 to 1.2 billion units in 2011, equivalent to a
    9.3% cumulative annual growth rate.
 
    Demand for our disk manufacturing products is driven by a number
    of factors, including demand for hard disk drives, market share,
    the average number of magnetic disks used in each hard drive,
    utilization and productivity of disk manufacturers
    installed base of magnetic disk manufacturing equipment, and
    obsolescence of the installed base as new recording technologies
    are introduced. The introduction of perpendicular recording
    technology by disk manufacturers in recent years had a
    significant impact on the equipment market, and has increased
    demand both for new equipment, such as our 200
    Lean®
    disk sputtering system, and for technology upgrades to the
    installed base of our legacy MDP-250 systems. However, in 2007,
    relative to 2006, shipments of new systems declined, while
    technology upgrades became a larger percentage of our Equipment
    revenues.
 
    Hard
    Disk Drive Equipment Products
 
    Disk
    Sputtering Systems
 
    The 200 Lean is our latest generation disk sputtering system.
    The first 200 Lean shipped in late 2003, and the installed base
    totaled 110 systems as of the end of 2007. We believe
    approximately 90% of these systems are used in production, and
    the balance are used in research and development. The 200 Lean
    was designed to provide enhanced capabilities relative to our
    MDP-250 system and to lower overall cost of ownership for disk
    manufacturers. The 200 Lean provides higher disk throughput
    from a smaller footprint, which enables more disks to be
    manufactured per square-foot of factory floor space. The 200
    Leans modular architecture enables our customers to
    incorporate any number of disk manufacturing process steps
    required by their evolving technology roadmaps. Most 200 Leans
    have been delivered with the capability to perform up to 20
    process steps versus the 12 process step maximum on the MDP-250.
    The 200 Lean also allows rapid reconfiguration to accommodate
    varying process recipes, disk sizes and disk materials.
 
    We shipped approximately 110 of our previous generation MDP-250
    disk sputtering systems from 1994 through 2005. We believe
    approximately 65% of these systems were still being used for
    production as of the end of 2007 and that the balance were in
    storage, in use in research and development or permanently
    retired from service.
 
    Disk
    Lubrication Systems
 
    Disk lubrication is the manufacturing step that immediately
    follows deposition of magnetic films. During lubrication, a
    microscopic layer of lubricant is applied to the disks
    surface to improve durability and reduce surface friction
    between the disk and the read/write head assembly.
 
    The Intevac
    AccuLubertm
    disk lubrication system lubricates disks by depositing a thin
    film of lubricant on the disk while it is under vacuum. This
    eliminates the use of large amounts of solvents during the
    lubrication process, which are environmentally hazardous and are
    expensive to procure, store and dispose of. The AccuLubers
    vapor process capability creates a uniform lubricant coating,
    and two lubricating process chambers provide high throughput and
    redundancy. The first AccuLuber was shipped and accepted by the
    customer during 2007, and production units are expected to begin
    shipping in 2008.
 
    The Intevac DLS-100 disk lubrication system provides our
    customers with an alternate lubrication process by dipping disks
    into a lubricant/solvent mixture. Intevac has been manufacturing
    dip lubrication systems similar to the DLS-100 since 1996.
    
    2
 
    Non-Systems
    Business
 
    We also provide installation, maintenance and repair services,
    technology upgrades, spare parts and consumables to our system
    customers. An increased level of technology upgrades caused
    non-systems business to increase significantly from 2006 to
    2007, both in absolute terms and as a percentage of Equipment
    revenues.
 
    Semiconductor
    Equipment Market
 
    A wide range of manufacturing equipment is used to fabricate
    semiconductor chips including: atomic layer deposition
    (ALD), chemical vapor deposition (CVD),
    physical vapor deposition (PVD), electrochemical
    plating (ECP), etch, ion implantation, rapid thermal
    processing (RTP), chemical mechanical planarization
    (CMP), wafer wet cleaning, wafer metrology and inspection, and
    systems that etch, measure and inspect circuit patterns on masks
    used in the photolithography process.
 
    Most chips are built on a silicon wafer base and include a
    variety of circuit components, such as transistors and other
    devices, that are connected by multiple layers of wiring
    (interconnects). To build a chip, the transistors, capacitors
    and other circuit components are first created on the surface of
    the wafer by performing a series of processes to deposit and
    selectively remove successive film layers. Similar processes are
    then used to build the layers of wiring structures on the wafer.
 
    Most chips are currently fabricated using 65 nanometer (nm) and
    larger linewidth dimensions. Over time, we believe the 45 nm,
    and then 32 nm, are likely to be the next line width
    nodes to be implemented as manufacturers work to
    squeeze more and more components onto each chip. As the density
    of the circuit components increases to enable greater computing
    power in the same or smaller area, the complexity of building
    the chip also increases, necessitating more process steps to
    form smaller structures and more intricate wiring schemes.
 
    Over time, the semiconductor industry has also migrated to
    increasingly larger wafers to build chips. The predominant wafer
    size used for volume production today is 200 millimeter (mm), or
    eight-inch, wafers, but a substantial number of advanced
    fabrications now use 300mm, or
    12-inch,
    wafers to gain the economic advantages of a larger surface area.
    The majority of new fabrication capacity is 300mm.
 
    We are utilizing our expertise in the design, manufacturing,
    marketing and support of complex manufacturing equipment and the
    prior experience of our management team in the semiconductor
    manufacturing equipment business to develop products for the
    semiconductor manufacturing market, which we believe is
    substantially larger than the hard disk drive equipment market
    that we currently serve.
 
    Semiconductor
    Manufacturing Products
 
    We announced our new etch semiconductor manufacturing system,
    the Lean
    Etchtm,
    during 2007. The Lean Etch is a 300 mm system designed to
    address the need for significant productivity improvement and
    provide enabling etch technology at 45 nanometer nodes and
    below. We plan to deliver evaluation systems to customers during
    2008 and begin production shipments during 2009. We do not
    expect to recognize any revenue from Lean Etch shipments until
    2009.
 
    Imaging
    Instrumentation Segment
 
    Imaging
    Instrumentation Market
 
    We develop, manufacture and sell compact, cost-effective,
    high-sensitivity digital-optical products for the capture and
    display of low-light images and the optical analysis of
    materials. We provide sensors, cameras and systems for
    commercial applications in the inspection, medical, scientific
    and security industries and for government applications such as
    night vision and long-range target identification. The majority
    of our imaging revenue has historically been derived from
    contracts related to the development of electro-optical sensors,
    cameras and systems and funded by the U.S. Government, its
    agencies and contractors. However, the percentage of Imaging
    Instrumentation revenue derived from product sales grew from 15%
    in 2006 to 27% in 2007 and is expected to continue to increase
    in 2008.
    
    3
 
    Imaging
    Instrumentation Products
 
    Raman Spectrometers  On January 31, 2007,
    we completed an acquisition of the assets and certain
    liabilities of DeltaNu, LLC, a Laramie, Wyoming company that
    pioneered development of miniature Raman spectrometer systems.
    Raman spectrometer systems are used to identify materials by
    illuminating the material with a laser and measuring the
    characteristic spectrum of light scattered from the material.
    The process enables real-time, non-destructive identification of
    liquids and solids outside of the laboratory, and is well suited
    to applications such as hazmat, forensics, homeland security,
    geology, gemology, medical, pharmaceutical and industrial
    quality assurance. DeltaNus products include the Advantage
    Series of low-cost, high-performance bench-top spectrometers,
    the Inspector series of hand-held field analysis spectrometers,
    the
    ExamineRtm
    high-performance Raman microscope, and a new series of
    near-infrared Raman instruments which incorporate our core
    technology in near-infrared sensors into the Advantage and
    ExamineR product lines.
 
    Near Infrared Cameras  Our
    MOSIR®
    line of cameras provide previously unavailable high sensitivity
    in the near infrared portion of the spectrum and are well suited
    for low-light spectroscopy, physical science, life science and
    industrial applications within the commercial imaging market.
 
    Near-Eye Display Systems  On November 9,
    2007, we completed an acquisition of the assets and certain
    liabilities of Creative Display Systems, LLC, (CDS)
    a Carlsbad, California company that specializes in
    high-performance, micro-display products for near-eye and
    portable viewing of video in defense and commercial markets.
    CDSs portfolio of intellectual property includes key
    patent applications relating to CDSs innovative
    eyeglass-mounted display systems, which provide high definition
    and a wide
    field-of-view
    in miniaturized light-weight and portable designs.
 
    Low-Light Cameras  Our CMOS-based cameras
    include our
    NightVista®
    line of day/night digital video cameras for low light level
    surveillance applications and our
    MicroVista®
    line of cameras for microscopy, medical imaging, and inspection
    applications between wavelengths of 200 and 1100 nanometers.
 
    Night Vision Rifle Sights  In 2007, we
    completed development and began pilot production of night vision
    sensor modules for use in a digital rifle-sight system by the
    military of a NATO country. We expect to begin volume production
    deliveries during 2008.
 
    Head Mounted Night Vision Systems  The
    U.S. military has funded development of various night
    vision technologies at multiple companies, which has evolved to
    todays widely deployed Generation-III night
    vision tubes. The U.S. military is now funding development
    of a compact head mounted digital imaging system, or Digital
    Enhanced Night Vision Goggle (DENVG). DENVG
    integrates a visible imager, an infrared imager and a video
    display. This approach allows low light and infrared imagery to
    be viewed individually, or to be overlaid (digitally
    fused), and also enables connectivity to a wireless
    network for distribution of the imagery and other information.
    The U.S. Army plans to begin production of this type of
    system in 2011. During 2007, we completed joint development,
    with DRS Technologies, Inc. (DRS), of a prototype
    DENVG night vision goggle for the U.S. Army. The prototype used
    our low-light night vision sensors in combination with a DRS
    thermal imaging sensor. We have delivered multiple prototype
    units and have completed extensive field testing with the Army.
    We expect to continue funded development of DENVG technology
    during 2008, and we expect to deliver enhanced-performance
    prototypes for field testing within the year.
 
    Long-Range Target Identification  Current
    long-range military nighttime surveillance systems are based on
    expensive thermal imaging camera systems. These systems are
    relatively large, which is a disadvantage for airborne and
    portable applications. Accordingly, there is a need for a
    cost-effective, compact, long-range imaging solution that
    identifies targets at a distance greater than an
    adversarys detection range capability. Our Laser
    Illuminated Viewing and Ranging
    (LIVAR®)
    system can be used to identify targets at distances of up to
    twenty kilometers and has been incorporated into
    U.S. weapons development programs, such as the Airborne
    Laser, the Cost Effective Targeting System, and the Long-Range
    Identification System programs. We expect to deliver
    pre-production LIVAR cameras for both land-based and airborne
    applications during 2008, and we expect initial production
    deliveries to commence in late 2008.
 
    Intensified Photodiodes  We have developed,
    under a number of research and development contracts,
    intensified photodiode technology that enables single photon
    detection at extremely high data rates, which is designed for
    use in target identification and other military applications.
    
    4
 
    Backlog
 
    Our backlog of orders at December 31, 2007 was
    $34.2 million, as compared to a December 31, 2006
    backlog of $125.0 million. The $34.2 million of
    backlog at December 31, 2007 consisted of
    $28.4 million of Equipment backlog and $5.8 million of
    Imaging Instrumentation backlog. The $125.0 million of
    backlog at December 31, 2006 consisted of
    $119.4 million of Equipment backlog and $5.6 million
    of Imaging Instrumentation backlog. The decrease in Equipment
    backlog was primarily the result of reduced orders for 200 Lean
    disk sputtering systems. Backlog at December 31, 2007
    includes two 200 Lean systems, as compared to twenty-four 200
    Lean systems in backlog at December 31, 2006. Backlog
    includes only customer orders with scheduled delivery dates that
    are not subject to any customer contingencies.
 
    Customer
    Concentration
 
    Historically, a significant portion of our revenue in any
    particular period has been attributable to sales to a small
    number of customers. In 2007, Seagate; Matsubo, our Japanese
    equipment distributor; Fuji Electric and Hitachi Global Storage
    Technology each accounted for more than 10% of our revenues, and
    in aggregate accounted for 90% of revenues. In 2006, Seagate,
    Matsubo, and Hitachi Global Storage Technology each accounted
    for more than 10% of our revenues, and in aggregate accounted
    for 93% of revenues. In 2005, Seagate, Matsubo, Hitachi Global
    Storage Technology and Maxtor each accounted for more than 10%
    of our revenues, and in aggregate accounted for 90% of revenues.
    We expect that sales of our products to relatively few customers
    will continue to account for a high percentage of our revenues
    in the foreseeable future.
 
    Foreign sales accounted for 82% of revenue in 2007, 90% of
    revenue in 2006 and 71% of revenues in 2005. The majority of our
    foreign sales are to companies in Asia or to U.S. companies
    for use in their Asian manufacturing or development operations.
    We anticipate that sales to these international customers will
    continue to be a significant portion of our Equipment revenues.
    Our disk sputtering equipment customers include magnetic disk
    manufacturers, such as Fuji Electric, and vertically integrated
    hard disk drive manufacturers, such as Hitachi Global Storage
    Technology and Seagate. Our customers manufacturing
    facilities are primarily located in California, China, Japan,
    Malaysia and Singapore.
 
    Our Equipment customers businesses tend to be cyclical,
    with their peak sales occurring during the second half of the
    year. As a result, our customers have a tendency to order
    equipment for delivery and installation by midyear, so that they
    have new capacity in place for their peak production period.
    However, while this pattern applied during 2007, during both
    2005 and 2006 our customers were capacity constrained, demand
    did not follow normal seasonal patterns, and we realized our
    highest revenues during the fourth fiscal quarter.
 
    Competition
 
    The principal competitive factors affecting the markets for our
    equipment products include price, product performance and
    functionality, ease of integration, customer support and
    service, reputation and reliability. We have historically
    experienced intense competition worldwide for magnetic disk
    sputtering equipment from competitors including Anelva
    Corporation, Ulvac and Oerlikon, (formerly Unaxis Holdings,
    Ltd.), each of which has sold substantial numbers of systems
    worldwide. In addition, as we enter the semiconductor equipment
    market, we anticipate that we will experience competition from
    competitors such as Applied Materials, LAM Research and Tokyo
    Electron, Ltd. Our Equipment competitors all have substantially
    greater financial, technical, marketing, manufacturing and other
    resources than we do. There can be no assurance that any of our
    competitors will not develop enhancements to, or future
    generations of, competitive products that offer superior price
    or performance features, or that new competitors will not enter
    our markets and develop such enhanced products.
 
    The principal competitive factors affecting our Imaging
    Instrumentation products include price, extreme low light level
    sensitivity, power consumption, resolution, size, ease of
    integration, reliability, reputation and customer support and
    service. We face substantial competition for our Imaging
    Instrumentation products, and many of our competitors have
    greater resources than we do. In the military market, ITT
    Industries, Inc. and Northrop Grumman Corporation, who are large
    and well-established defense contractors, are the primary
    U.S. manufacturers of image intensifier tubes used in
    Generation-III night vision devices and their derivative
    products. Our low-light digital cameras are intended to displace
    Generation-III night vision based products. We expect that ITT,
    Northrop
    
    5
 
    Grumman, BAE and other companies will develop digital night
    vision products and aggressively promote their sales.
    Furthermore, CMC Electronics, DRS, FLIR Systems and Raytheon
    manufacture cooled infrared sensors and cameras which are
    presently used in long-range target identification systems, and
    with which our LIVAR target identification sensors and cameras
    compete. In the commercial markets, companies such as Andor,
    E2V, Goodrich, Hamamatsu, Texas Instruments and Roper Scientific
    offer competitive sensor and camera products, and companies such
    as Ahura, B&W Tek, Horiba  Jobin Yvon,
    InPhotonics, Ocean Optics, Renishaw and Smiths Detection offer
    competitive portable Raman spectrometer products.
 
    Marketing
    and Sales
 
    Equipment sales are made through our direct sales force, with
    the exception of in Japan and Malaysia, where we sell our
    products through our distributor, Matsubo. The selling process
    for our Equipment products is multi-level and long-term,
    involving individuals from marketing, engineering, operations,
    customer service and senior management. The process involves
    making sample disks or wafers for the prospective customer and
    responding to their needs for moderate levels of machine
    customization. Customers often require a significant number of
    product presentations and demonstrations before making a
    purchasing decision.
 
    Installing and integrating new equipment requires a substantial
    investment by a customer. Sales of our systems depend, in
    significant part, upon the decision of a prospective customer to
    replace obsolete equipment or to increase manufacturing capacity
    by upgrading or expanding existing manufacturing facilities or
    by constructing new manufacturing facilities, all of which
    typically involve a significant capital commitment. After making
    a decision to select our equipment, our customers typically
    purchase one or more engineering systems to develop and qualify
    their production process prior to ordering and taking delivery
    of multiple production systems. Accordingly, our systems have a
    lengthy sales cycle, during which we may expend substantial
    funds and management time and effort with no assurance that a
    sale will result.
 
    The production of large complex systems requires us to make
    significant investments in inventory both to fulfill customer
    orders and to maintain adequate supplies of spare parts to
    service previously shipped systems. In some cases we manufacture
    subsystems
    and/or
    complete systems prior to receipt of a customer order to smooth
    our production flow
    and/or
    reduce our lead time. We maintain inventories of spare parts in
    California, Singapore and Shenzhen, China to support our
    customers. We often require our customers to pay for systems in
    three installments, with a portion of the system price billed
    upon receipt of an order, a portion of the price billed upon
    shipment, and the balance of the price and any sales tax due
    upon completing installation and acceptance of the system at the
    customers factory. All customer product payments are
    recorded as customer advances, which are released into revenue
    in accordance with our revenue recognition policy.
 
    We provide process and applications support, customer training,
    installation,
    start-up
    assistance and emergency service support to our equipment
    customers. We conduct training classes for our customers
    process engineers, machine operators and machine service
    personnel. Additional training is also given to our customers
    during equipment installation. We have field offices in
    Singapore, China, Korea, Malaysia and Japan to support our
    customers in Asia. We generally add additional support centers
    as necessary to maintain close proximity to our customers
    factories as they deploy our systems.
 
    Warranty for our equipment typically ranges between 12 and
    24 months from customer acceptance. During this warranty
    period any necessary non-consumable parts are supplied and
    installed without charge. Our employees provide field service
    support in the United States, Singapore, Malaysia, China and
    Japan. In Japan, field service support is also supplemented by
    our distributor, Matsubo.
 
    Sales of our Imaging Instrumentation products for military
    applications are primarily made to the end user through our
    direct sales force. In cases where our products are enabling
    technology for more complex systems, we also sell to leading
    defense contractors such as Boeing, Lockheed Martin Corporation,
    Northrop Grumman Corporation, Raytheon, DRS Technologies and
    Sagem.
 
    We are subject to long sales cycles in our Imaging
    Instrumentation segment because many of our products, such as
    our night vision systems, typically must be designed into our
    customers products, which are often complex and
    state-of-the-art.
    These development cycles are often multi-year, and our sales are
    contingent on our customer successfully integrating our product
    into its product, completing development of its product and then
    obtaining
    
    6
 
    production orders for its product. Sales of these products are
    also often dependent on ongoing funding of defense programs by
    the U.S. government and its allies. Additionally, sales to
    international customers are subject to issuance of export
    licenses by the United States government, which cannot always be
    obtained.
 
    Sales of our commercial Imaging Instrumentation products are
    made through a combination of direct sales, system integrators,
    distributors and value added resellers and can also be subject
    to long sales cycles.
 
    Imaging Instrumentation generally invoices its research and
    development customers either as costs are incurred, or as
    program milestones are achieved, depending upon the particular
    contract terms. As a government contractor, we invoice customers
    using estimated annual rates approved by the Defense Contracts
    Audit Agency (DCAA). A majority of our contracts are
    Cost Plus Fixed Fee (CPFF) contracts. On any CPFF
    contract, 15% of the fee is withheld pending completion of the
    program and DCAAs annual audit of our actual rates. The
    withheld portion of the fee is included in revenue and in
    unbilled accounts receivable until paid.
 
    Research
    and Development and Intellectual Property
 
    Our long-term growth strategy requires continued development of
    new products. We work closely with our global customers to
    design products that meet their planned technical and production
    requirements. Product development and engineering organizations
    are located primarily in the United States and Singapore.
 
    We invested $40.1 million (18.6% of net sales) for fiscal
    2007, $30.0 million (11.6% of net sales) for fiscal 2006,
    and $14.4 million (10.5% of net sales) for fiscal 2005 for
    product development and engineering programs to create new
    products and to improve existing technologies and products. We
    have spent an average of 15.0% of net sales on product
    development and engineering over the last five years.
 
    We believe our competitive position significantly depends on our
    research, development, engineering, manufacturing and marketing
    capabilities, and not just on our patent position. However,
    protection of Intevacs technological assets by obtaining
    and enforcing intellectual property rights, including patents,
    is important. Therefore, our practice is to file patent
    applications in the United States and other countries for
    inventions that we consider important. We have a substantial
    number of patents in the United States and other countries, and
    additional applications are pending for new inventions. Although
    we do not consider our business materially dependent upon any
    one patent, the rights of Intevac and the products made and sold
    under our patents along with other intellectual property,
    including trademarks, know-how, trade secrets and copyrights,
    taken as a whole, are a significant element of our business.
 
    We enter into patent and technology licensing agreements with
    other companies when management determines that it is in our
    best interest to do so. We pay royalties under existing patent
    license agreements for use, in several of our products, of
    certain patented technologies. We also receive, from time to
    time, royalties from licenses granted to third parties.
    Royalties received from or paid to third parties have not been,
    and are not expected to be, material to our consolidated results
    of operations.
 
    In the normal course of business, we periodically receive and
    make inquiries regarding possible patent infringement. In
    dealing with such inquiries, it may be necessary or useful for
    us to obtain or grant licenses or other rights. However, there
    can be no assurance that such licenses or rights will be
    available to us on commercially reasonable terms, or at all. If
    we are not able to resolve or settle claims, obtain necessary
    licenses
    and/or
    successfully prosecute or defend our position, our business,
    financial condition and results of operations could be
    materially and adversely effected.
 
    Manufacturing
 
    We manufacture our Equipment products at our facilities in
    California and Singapore. Our Equipment manufacturing operations
    include electromechanical assembly, mechanical and vacuum
    assembly, fabrication of sputter sources, and system assembly,
    alignment and testing. We make extensive use of the local
    supplier infrastructure serving the semiconductor equipment
    business. We purchase vacuum pumps, valves, instrumentation and
    fittings, power supplies, printed wiring board assemblies,
    computers and control circuitry, and custom mechanical parts
    made by forging, machining and welding. We also have our own
    small fabrication center that supports our engineering
    departments and makes some of the machined parts used in our
    products.
    
    7
 
    We manufacture our Imaging Instrumentation products at our
    facilities in California and Wyoming. Imaging Instrumentation
    manufacturing includes production of advanced photo-cathodes and
    sensors, lasers, cameras, integrated camera systems, compact
    Raman spectrometry instruments and micro-displays. We make
    extensive use of advanced manufacturing techniques and
    equipment, and our operations include vacuum, electromechanical
    and optical system assembly. We make use of the supplier
    infrastructure serving the semiconductor, camera and optics
    manufacturing industries. In manufacturing our sensors, we
    purchase wafers, components, processing supplies and chemicals.
    In manufacturing our camera systems, we purchase printed circuit
    boards, electromechanical components and assemblies, mechanical
    components and enclosures, optical components and computers.
 
    Employees
 
    At December 31, 2007, we had 480 employees, including
    38 contract employees. Of these 480 employees, 141 were in
    research and development, 228 in operations, and 111 in
    administration, customer support and marketing. Of the
    480 employees, 338 were in the Equipment segment, 101 were
    in the Imaging Instrumentation segment, and 41 were in Corporate.
 
    Compliance
    with Environmental Regulations
 
    We are subject to a variety of governmental regulations relating
    to the use, storage, discharge, handling, emission, generation,
    manufacture, treatment and disposal of toxic or otherwise
    hazardous substances, chemicals, materials or waste. We treat
    the cost of complying with government regulations and operating
    a safe workplace as a normal cost of business and allocate the
    cost of these activities to all functions, except where the cost
    can be isolated and charged to a specific function. The
    environmental standards and regulations promulgated by
    government agencies in Santa Clara, California, Fremont,
    California and Singapore are rigorous and set a high standard of
    compliance. We believe our costs of compliance with these
    regulations and standards are comparable to other companies
    operating similar facilities in Santa Clara, California,
    Fremont, California and Singapore.
 
    Executive
    Officers of the Registrant
 
    Certain information about our executive officers as of
    March 14, 2008 is listed below:
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
    Name
 
 | 
 
 | 
 
    Age
 
 | 
 
 | 
 
    Position
 
 | 
|  
 | 
| 
 
    Executive Officers:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Norman H. Pond
 
 | 
 
 | 
 
 | 
    69
 | 
 
 | 
 
 | 
    Chairman of the Board
 | 
| 
 
    Kevin Fairbairn
 
 | 
 
 | 
 
 | 
    54
 | 
 
 | 
 
 | 
    President and Chief Executive Officer
 | 
| 
 
    Jeffrey Andreson
 
 | 
 
 | 
 
 | 
    46
 | 
 
 | 
 
 | 
    Vice President, Finance and Administration, Chief Financial
    Officer, Treasurer and Secretary
 | 
| 
 
    Michael Barnes
 
 | 
 
 | 
 
 | 
    49
 | 
 
 | 
 
 | 
    Vice President and Chief Technical Officer
 | 
| 
 
    Kimberly Burk
 
 | 
 
 | 
 
 | 
    42
 | 
 
 | 
 
 | 
    Sr. Director, Human Resources
 | 
| 
 
    Ralph Kerns
 
 | 
 
 | 
 
 | 
    61
 | 
 
 | 
 
 | 
    Vice President, Business Development, Equipment Products
 | 
| 
 
    Luke Marusiak
 
 | 
 
 | 
 
 | 
    45
 | 
 
 | 
 
 | 
    Chief Operating Officer
 | 
| 
 
    Joseph Pietras
 
 | 
 
 | 
 
 | 
    53
 | 
 
 | 
 
 | 
    Vice President and General Manager, Imaging Instrumentation
 | 
| 
 
    Other Key Officers:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Verle Aebi
 
 | 
 
 | 
 
 | 
    53
 | 
 
 | 
 
 | 
    Chief Technology Officer, Imaging Instrumentation
 | 
| 
 
    James Birt
 
 | 
 
 | 
 
 | 
    43
 | 
 
 | 
 
 | 
    Vice President, Customer Support, Equipment Products
 | 
| 
 
    Terry Bluck
 
 | 
 
 | 
 
 | 
    48
 | 
 
 | 
 
 | 
    Vice President, Technology, Equipment Products
 | 
| 
 
    Jerry Carollo
 
 | 
 
 | 
 
 | 
    55
 | 
 
 | 
 
 | 
    Vice President and General Manager, Creative Display Systems
 | 
| 
 
    Keith Carron
 
 | 
 
 | 
 
 | 
    49
 | 
 
 | 
 
 | 
    Managing Director and General Manager, DeltaNu
 | 
| 
 
    Timothy Justyn
 
 | 
 
 | 
 
 | 
    45
 | 
 
 | 
 
 | 
    Vice President, Manufacturing, Equipment Products
 | 
| 
 
    Dave Kelly
 
 | 
 
 | 
 
 | 
    45
 | 
 
 | 
 
 | 
    Vice President, Engineering, Imaging Instrumentation
 | 
    
    8
 
    Mr. Pond is a founder of Intevac and has served as
    Chairman of the Board since February 1991. Mr. Pond served
    as President and Chief Executive Officer from February 1991
    until July 2000 and again from September 2001 through January
    2002. Mr. Pond holds a BS in physics from the University of
    Missouri at Rolla and an MS in physics from the University of
    California at Los Angeles.
 
    Mr. Fairbairn joined Intevac as President and Chief
    Executive Officer in January 2002 and was appointed a director
    in February 2002. Before joining Intevac, Mr. Fairbairn was
    employed by Applied Materials from July 1985 to January 2002,
    most recently as Vice-President and General Manager of the
    Conductor Etch Organization with responsibility for the Silicon
    and Metal Etch Divisions. From 1996 to 1999, Mr. Fairbairn
    was General Manager of Applied Materials Plasma Enhanced
    Chemical Vapor Deposition Business Unit and from 1993 to 1996,
    he was General Manager of Applied Materials Plasma Silane
    CVD Product Business Unit. Mr. Fairbairn holds an MA in
    engineering sciences from Cambridge University.
 
    Mr. Andreson joined Intevac in June 2007 and has
    served as Vice President, Finance and Administration, Chief
    Financial Officer, Treasurer and Secretary since August 2007.
    Before joining Intevac Mr. Andreson served as managing
    director and controller of Applied Materials, Inc.s Global
    Services product group. Since joining Applied Materials in 1995,
    Mr. Andreson held a number of senior financial positions,
    including managing director, Global Financial Planning and
    Analysis; Controller, Metron subsidiary; controller, North
    American Sales and Service; and Controller, Volume
    Manufacturing. From 1989 through 1995, Mr. Andreson held
    various roles at Measurex Corporation. Mr. Andreson holds
    an M.B.A. from Santa Clara University and a B.S. in Finance
    from San Jose State University.
 
    Dr. Barnes joined Intevac as Vice President and
    Chief Technical Officer in February 2006. Before joining
    Intevac, Dr. Barnes was General Manager of the High Density
    Plasma Chemical Vapor Deposition Business Unit at Novellus
    Systems from March 2004 to February 2006. From January 2004 to
    March 2004, he was Vice President, Technology at Nanosys, and
    from August 2003 to January 2004, he was Vice President,
    Engineering at OnWafer Technologies. Dr. Barnes was
    employed by Applied Materials from April 1998 to August 2003,
    first as a Managing Director and subsequently as Vice President,
    Etch Engineering and Technology. Dr. Barnes holds a BS, MS
    and PhD in electrical engineering from the University of
    Michigan.
 
    Ms. Burk has served as Human Resources Director
    since May 2000. Prior to joining Intevac, Ms. Burk served
    as Human Resources Manager of Moen, Inc. from 1999 to 2000 and
    as Human Resources Manager of Lawson Mardon from 1994 to 1999.
    Ms. Burk holds a BS in sociology from Northern Illinois
    University.
 
    Mr. Kerns joined Intevac as Vice President, Business
    Development of the Equipment Products Division in August 2003.
    Before joining Intevac, Mr. Kerns was employed by Applied
    Materials from April 1997 to November 2002, most recently as
    Managing Director for Business Development for the Process
    Modules Group. Previously, Mr. Kerns was General Manager of
    Applied Materials Metal Etch Division from 2000 to 2002.
    From 1998 to 2000, Mr. Kerns was Senior Director for
    Applied Materials North America Multinational Accounts,
    and from 1997 to 1998, he was General Manager of Applied
    Materials Dielectric Etch Division. Mr. Kerns holds a
    BS in chemistry from the University of Idaho and a PhD in
    theoretical chemistry from Princeton University.
 
    Mr. Marusiak joined Intevac as Chief Operating
    Officer in April 2004. Before joining Intevac, Mr. Marusiak
    was employed by Applied Materials from July 1991 to April 2004,
    most recently as Senior Director of North American Operations.
    Previously, Mr. Marusiak managed Applied Materials
    Field Operations in North America. Mr. Marusiak holds a BS
    in electrical engineering from Gannon University and an MS in
    teleprocessing science from the University of Southern
    Mississippi.
 
    Mr. Pietras joined Intevac as Vice President and
    General Manager of the Imaging Instrumentation Business in
    August 2006. Before joining Intevac, Mr. Pietras was
    employed by the Sarnoff Corporation from March 2005 to July 2006
    as General Manager of Sarnoff Imaging Systems. From September
    1998 to March 2005, he was employed by Roper Scientific as Vice
    President, Operations. Mr. Pietras holds a BS in Physics
    from the Stevens Institute of Technology and a MA and PhD in
    Physics from Columbia University.
 
    Mr. Aebi has served as Chief Technology Officer of
    our Imaging Instrumentation business since August 2006.
    Previously, Mr. Aebi served as President of the Photonics
    Division from July 2000 to July 2006 and as General Manager of
    the Photonics Division since May 1995. Mr. Aebi was elected
    as a Vice President of the Company in
    
    9
 
    September 1995. From 1988 through 1994, Mr. Aebi was the
    Engineering Manager of the night vision business we acquired
    from Varian Associates in 1991, where he was responsible for new
    product development in the areas of advanced photocathodes and
    image intensifiers. Mr. Aebi holds a BS in physics and an
    MS in electrical engineering from Stanford University.
 
    Mr. Birt joined Intevac as Vice President, Customer
    Support of the Equipment Products Division in September 2004.
    Before joining Intevac, Mr. Birt was employed by Applied
    Materials from July 1992 to September 2004, most recently as
    Director, Field Operations/Quality North America. Mr. Birt
    holds a BS in electrical engineering from Texas A&M
    University.
 
    Mr. Bluck rejoined Intevac as Vice President,
    Technology of the Equipment Products Division in August 2004.
    Mr. Bluck had previously worked at Intevac from December
    1996 to November 2002 in various engineering positions. The
    business unit Mr. Bluck worked for was sold to Photon
    Dynamics in November 2002, and he was employed there as Vice
    President, Rapid Thermal Process Product Engineering until
    August 2004. Mr. Bluck holds a BS in physics from
    San Jose State University.
 
    Mr. Carollo joined Intevac in November 2007 as Vice
    President and General Manager of Intevacs Creative Display
    Systems subsidiary. Prior to joining Intevac, Mr. Carollo
    was founder, president and CEO of Creative Display Systems.
    Prior to founding Creative Display Systems Mr. Carollo
    worked for Rockwell-Collins Optronics Electro-Optics from 1993
    to 2006 where his most recent position was General Manager.
    Mr. Corollo holds numerous patents in the area of optics,
    display systems and optical communications, a MS in Optics from
    the University of Rochester and a BS in Physics from the State
    University of New York.
 
    Dr. Carron joined Intevac in January 2007 as
    Managing Director and General Manager of Intevacs DeltaNu,
    Inc. subsidiary. Prior to joining Intevac, Dr. Carron was
    the CEO of DeltaNu, LLC from March 2002 until January 2007.
    Dr. Carron was also a professor of Chemistry at the
    University of Wyoming from 1988 to 2006. Dr. Carron holds a
    BA in Chemistry from Washington University and a PhD in
    Chemistry from Northwestern University.
 
    Mr. Justyn has served as Vice President, Equipment
    Manufacturing since April 1997. Mr. Justyn joined Intevac
    in February 1991 and has served in various roles in our
    Equipment Products Division and our former night vision
    business. Mr. Justyn holds a BS in chemical engineering
    from the University of California, Santa Barbara.
 
    Mr. Kelly joined Intevac in December 2006 as Vice
    President, Engineering of the Imaging Instrumentation business.
    Before joining Intevac, Mr. Kelly was employed by Redlake
    MASD LLC, a division of Roper Industries from January 2004 to
    December 2006, most recently as Vice President, Engineering and
    Custom Service. From November 2000 to December 2003, he was
    employed by Fast Technology AG as Vice President, Engineering.
    Mr. Kelly holds a BS and a MS in mechanical engineering
    from the University of Michigan.
 
    Available
    Information
 
    Our annual report on
    Form 10-K,
    quarterly reports on
    Form 10-Q,
    current reports on
    Form 8-K,
    and amendments to such reports are available, free of charge, on
    or through our Internet home page as soon as reasonably
    practicable after we electronically file such material with, or
    furnish it to, the Securities and Exchange Commission. The
    public may also read and copy any materials we file with the SEC
    at the SECs Public Reference Room at
    100 F Street, N.E., Washington D.C. 20549. The public
    may obtain information on the operation of the Public Reference
    Room by calling the SEC at
    1-800-SEC-0330.
    The SEC also maintains an Internet website (www.sec.gov)
    that contains reports, proxy and information statements and
    other information regarding us that we file electronically with
    the SEC. Our Internet home page is located at
    www.intevac.com; however, the information in, or that can
    be accessed through, our home page is not part of this report.
 
    Trade
    Marks
 
    200 Lean®,
    AccuLuberTM,
    
    ExaminerRTM,
    Lean
    Etchtm,
    LIVAR®,
    MicroVista®
    ,
    NightVista®
    and
    MOSIR®,
    among others, are our trademarks.
    
    10
 
 
 
    Demand
    for capital equipment is cyclical, which subjects our business
    to long periods of depressed revenues interspersed with periods
    of unusually high revenues.
 
    Our Equipment business sells equipment to capital-intensive
    industries, which sell commodity products such as disk drives
    and semiconductors. When demand for these commodity products
    exceeds capacity, demand for new capital equipment such as ours
    tends to be amplified. Conversely, when supply of these
    commodity products exceeds demand, the demand for new capital
    equipment such as ours tends to be depressed. For example, the
    hard disk drive industry has been historically subject to
    multi-year cycles because of the long lead times and high costs
    involved in adding capacity, and to seasonal cycles driven by
    consumer purchasing patterns, which tend to be heaviest in the
    third and fourth quarters of each year.
 
    The cyclical nature of the capital equipment industry means that
    in some years we will have unusually high sales of new systems,
    and that in other years our sales of new systems will be
    severely depressed. The timing, length and volatility of these
    cycles are difficult to predict. These cycles have affected the
    timing and amounts of our customers capital equipment
    purchases and investments in new technology. For example, sales
    of systems for magnetic disk production were severely depressed
    from mid-1998 until mid-2003 and grew rapidly from 2004 through
    2006. The number of new systems delivered or scheduled for
    delivery in the second half of 2007 was significantly lower than
    the number of systems delivered in the first half of the year,
    and we are projecting that new system shipments will be
    significantly lower in 2008 than 2007. We cannot predict with
    any certainty when these cycles will begin or end.
 
    If
    demand for hard disk drives does not continue to grow and our
    customers do not replace or upgrade their installed base of disk
    sputtering systems, then future sales of our disk sputtering
    systems will suffer.
 
    From mid-1998 until mid-2003, there was very little demand for
    new disk sputtering systems, as magnetic disk manufacturers were
    burdened with over-capacity and were not investing in new disk
    sputtering equipment. By 2003, however, over-capacity had
    diminished, and orders for our 200 Lean began to increase. From
    2004 through the end of 2006, there was strong demand for new
    disk sputtering systems.
 
    Sales of our equipment for capacity expansions are dependent on
    the capacity expansion plans of our customers and upon whether
    our customers select our equipment for their capacity
    expansions. We have no control over our customers
    expansion plans, and we cannot be sure that they will select our
    equipment if they do expand their capacity. Our customers may
    not implement capacity expansion plans, or we may fail to win
    orders for equipment for those capacity expansions, which could
    have a material adverse effect on our business and our operating
    results. In addition, some manufacturers may choose to purchase
    used systems from other manufacturers or customers rather than
    purchasing new systems from us.
 
    Sales of our 200 Lean disk sputtering systems are also dependent
    on obsolescence and replacement of the installed base of disk
    sputtering equipment. If technological advancements are
    developed that extend the useful life of the installed base of
    systems, then sales of our 200 Lean will be limited to the
    capacity expansion needs of our customers, which would
    significantly decrease our revenue. For example, during 2007
    some of our customers decided to use legacy systems for the
    production of first generation perpendicular media, which
    delayed the replacement of such legacy systems with new 200 Lean
    systems.
 
    Our customers have experienced competition from companies that
    produce alternative storage technologies like flash memory,
    where increased capacity, improving cost, lower power
    consumption and performance ruggedness have resulted in
    competition with lower capacity, smaller form factor disk drives
    in handheld applications. While this competition has
    traditionally been in the markets for handheld consumer
    electronics applications like personal media players, these
    competitors have recently announced products for notebook and
    enterprise computer applications. If alternative technologies,
    such as flash memory, replace hard disk drives as a primary
    method of digital storage, then demand for our products would
    likely decrease.
 
    We are
    exposed to risks associated with a highly concentrated customer
    base.
 
    Historically, a significant portion of our revenue in any
    particular period has been attributable to sales of our disk
    sputtering systems to a limited number of customers. In 2007,
    one of our customers accounted for 31% of our
    
    11
 
    revenues, and four customers in the aggregate accounted for 90%
    of our revenues. The same four customers, in the aggregate,
    accounted for 31% of our net accounts receivable at
    December 31, 2007. During 2006, Seagate acquired Maxtor,
    and in June 2007, Western Digital announced the acquisition of
    Komag. This consolidation in the industry limits the number of
    potential customers for our products. Orders from a relatively
    limited number of magnetic disk manufacturers have accounted
    for, and likely will continue to account for, a substantial
    portion of our revenues. The loss of, or delays in purchasing
    by, any one of our large customers would significantly reduce
    potential future revenues. In addition, the concentration of our
    customer base may enable customers to demand pricing and other
    terms unfavorable to us, and makes us more vulnerable to any
    changes in demand by a given customer. Furthermore, the
    concentration of customers can lead to extreme variability in
    revenue and financial results from period to period. For
    example, during 2007 revenues ranged between $76.4 million
    in the first quarter and $16.8 million in the fourth
    quarter.
 
    Our
    operating results fluctuate significantly from quarter to
    quarter, which may cause the price of our stock to
    decline.
 
    Over the last eight quarters, our revenues per quarter have
    fluctuated between $16.8 million and $95.9 million.
    Over the same period our operating income (loss) as a percentage
    of revenues has fluctuated between approximately 23% and (42%)
    of revenues. We anticipate that our revenues and operating
    margins will continue to fluctuate. We expect this fluctuation
    to continue for a variety of reasons, including:
 
     | 
     | 
     | 
    |   | 
         
 | 
    
    changes in the demand, due to seasonality, cyclicality and other
    factors in the markets, for computer systems, storage subsystems
    and consumer electronics containing disks our customers produce
    with our systems;
 | 
|   | 
    |   | 
         
 | 
    
    delays or problems in the introduction and acceptance of our new
    products, or delivery of existing products;
 | 
|   | 
    |   | 
         
 | 
    
    timing of orders, acceptance of new systems by our customers or
    cancellation of those orders; and
 | 
|   | 
    |   | 
         
 | 
    
    new products, services or technological innovations by our
    competitors or us.
 | 
 
    Additionally, because our systems are priced in the millions of
    dollars and we sell a relatively small number of systems, we
    believe that
    quarter-to-quarter
    comparisons of our revenues and operating results may not be an
    accurate indicator of our future performance. Our operating
    results in one or more future quarters may fail to meet the
    expectations of investment research analysts or investors, which
    could cause an immediate and significant decline in the trading
    price of our common shares.
 
    Our
    long-term revenue growth is dependent on new products. If these
    new products are not successful, then our results of operations
    will be adversely affected.
 
    We have invested heavily, and continue to invest, in the
    development of new products, especially our new Lean Etch
    system. Our success in developing and selling new products
    depends upon a variety of factors, including our ability to
    predict future customer requirements accurately, technological
    advances, total cost of ownership of our systems, our
    introduction of new products on schedule, our ability to
    manufacture our products cost-effectively and the performance of
    our products in the field. Our new product decisions and
    development commitments must anticipate continuously evolving
    industry requirements significantly in advance of sales.
 
    The majority of our revenues in both fiscal 2007 and fiscal 2006
    were from sales of our 200 Lean disk sputtering system and
    related parts and services. The 200 Lean was first delivered in
    December 2003. When first introduced, advanced vacuum
    manufacturing equipment, such as the 200 Lean, is subject to
    extensive customer acceptance tests after installation at the
    customers factory. These acceptance tests are designed to
    validate reliable operation to specifications in areas such as
    throughput, vacuum level, robotics, process performance and
    software features and functionality. These tests are generally
    more comprehensive for new systems than for mature systems, and
    are designed to highlight problems encountered with early
    versions of the equipment. For example, initial builds of the
    200 Lean experienced high production and warranty costs in
    comparison to our more established product lines. Failure to
    promptly address any of the problems uncovered in these tests
    could have adverse effects on our business, including
    rescheduling of backlog, failure to achieve customer acceptance
    and therefore revenue recognition as anticipated, unanticipated
    product rework and warranty costs, penalties for
    non-performance, cancellation of orders, or return of products
    for credit.
    
    12
 
    We are making a substantial investment to develop our new Lean
    Etch system for semiconductor manufacturing. We spent a
    substantial portion of our research and development costs on
    this new product in 2006 and increased our level of spending on
    this project in 2007. We may experience problems with the Lean
    Etch similar to the startup problems encountered with the 200
    Lean. Moreover, we have not developed or sold products for this
    market previously. Failure to correctly assess the size of the
    market, to successfully develop a cost effective product to
    address the market, or to establish effective sales and support
    of the new product would have a material adverse effect on our
    future revenues and profits, and could include loss of our
    entire investment in the project.
 
    We are jointly developing a next generation head mounted
    night-vision system with another defense contractor. This system
    is planned for sale to the U.S. military and will compete
    with head-mounted systems developed by our competitors. The
    U.S. military does not intend to initiate production of
    this system until 2011. We plan to make a significant investment
    in this type of product and cannot be assured when, or if, we
    will be awarded any production contracts for these night vision
    systems.
 
    We have developed a night-vision sensor and camera module for
    use in a NATO customers digital rifle-sight system. We
    cannot guarantee that we will achieve the yield improvements and
    cost reductions necessary for this program to be successful.
    Shipments under this program are subject to export approval by
    the U.S. government.
 
    Products based on our LIVAR target identification and low light
    level camera technologies are designed to offer significantly
    improved capability to military customers. We are also
    developing commercial products in our Imaging Instrumentation
    business. None of our Imaging Instrumentation products are
    currently being manufactured in high volume, and we may
    encounter unforeseen difficulties when we commence volume
    production of these products. Our Imaging Instrumentation
    business will require substantial further investment in sales
    and marketing, in product development and in additional
    production facilities in order to expand our operations. We may
    not succeed in these activities or generate significant sales of
    these new products. In 2007, sales of our Imaging
    Instrumentation products were $5.2 million out of a total
    of $19.1 million of Imaging Instrumentation revenues.
 
    Failure of any of these new products to perform as intended, to
    penetrate their markets and develop into profitable product
    lines or to achieve their production cost objectives would have
    a material adverse effect on our business.
 
    Our
    sales cycle is long and unpredictable, which requires us to
    incur high sales and marketing expenses with no assurance that a
    sale will result.
 
    The sales cycle for our Equipment systems can be a year or
    longer, involving individuals from many different areas of our
    company and numerous product presentations and demonstrations
    for our prospective customers. Our sales process for these
    systems also commonly includes production of samples,
    customization of our product and installation of evaluation
    systems in the factories of our prospective customers. We do not
    enter into long-term contracts with our customers, and therefore
    until an order is actually submitted by a customer there is no
    binding commitment to purchase our systems.
 
    Our Imaging Instrumentation business is also subject to long
    sales cycles because many of our products, such as our LIVAR
    system, often must be designed into our customers
    products, which are often complex
    state-of-the-art
    products. These development cycles are often multi-year, and our
    sales are contingent on our customers successfully integrating
    our product into their product, completing development of their
    product and then obtaining production orders for their product
    from the U.S. government or its allies.
 
    As a result, we may not recognize revenue from our products for
    extended periods of time after we have completed development and
    made initial shipments of our products, during which time we may
    expend substantial funds and management time and effort with no
    assurance that a sale will result.
 
    We
    operate in an intensely competitive marketplace, and our
    competitors have greater resources than we do.
 
    In the market for our disk sputtering systems, we have
    experienced competition from competitors such as Anelva
    Corporation, which is a subsidiary of Canon, and Oerlikon, each
    of which has sold substantial numbers of systems worldwide. In
    the market for semiconductor equipment, we expect to experience
    competition from competitors such
    
    13
 
    as Applied Materials, LAM Research and Tokyo Electron, Ltd. In
    the market for our military Imaging Instrumentation products, we
    experience competition from companies such as ITT Industries,
    Inc., Northrop Grumman Corporation and BAE. In the markets for
    our commercial Imaging Instrumentation products, we compete with
    companies such as Andor, E2V, Hamamatsu, Texas Instruments and
    Roper Scientific for sensor and camera products, and with
    companies such as Ahura, B&W Tek, Horiba  Jobin
    Yvon, InPhotonics, Ocean Optics, Renishaw, and Smiths Detection
    for portable Raman spectrometer products. Our competitors have
    substantially greater financial, technical, marketing,
    manufacturing and other resources than we do, especially in the
    semiconductor equipment market where we have not previously
    offered a product. We cannot assure you that our competitors
    will not develop enhancements to, or future generations of,
    competitive products that offer superior price or performance
    features. Likewise, we cannot assure you that new competitors
    will not enter our markets and develop such enhanced products.
    Moreover, competition for our customers is intense, and our
    competitors have historically offered substantial pricing
    concessions and incentives to attract our customers or retain
    their existing customers.
 
    We may
    not be successful in maintaining and obtaining the necessary
    export licenses to conduct operations abroad, and the United
    States government may prevent proposed sales to foreign
    customers.
 
    Many of our Imaging Instrumentation products require export
    licenses from United States Government agencies under the Export
    Administration Act, the Trading with the Enemy Act of 1917, the
    Arms Export Act of 1976 and the International Traffic in Arms
    Regulations. This limits the potential market for our products.
    We can give no assurance that we will be successful in obtaining
    all the licenses necessary to export our products. Recently,
    heightened government scrutiny of export licenses for products
    in our market has resulted in lengthened review periods for our
    license applications. Export to countries which are not
    considered by the United States Government to be allies is
    likely to be prohibited, and even sales to U.S. allies may
    be limited. Failure to obtain, delays in obtaining, or
    revocation of previously issued licenses would prevent us from
    selling our products outside the United States, may subject us
    to fines or other penalties, and would have a material adverse
    effect on our business, financial condition and results of
    operations.
 
    Our
    products are complex, constantly evolving and often must be
    customized to individual customer requirements.
 
    The systems we manufacture and sell in our Equipment business
    have a large number of components and are complex, which
    requires us to make substantial investments in research and
    development. This is especially true with the new Lean Etch
    system. If we were to fail to develop, manufacture and market
    new systems or to enhance existing systems, that failure would
    have an adverse effect on our business. We may experience delays
    and technical and manufacturing difficulties in future
    introduction, volume production and acceptance of new systems or
    enhancements. In addition, some of the systems that we
    manufacture must be customized to meet individual customer site
    or operating requirements. In some cases, we market and commit
    to deliver new systems, modules and components with advanced
    features and capabilities that we are still in the process of
    designing. We have limited manufacturing capacity and
    engineering resources and may be unable to complete the
    development, manufacture and shipment of these products, or to
    meet the required technical specifications for these products,
    in a timely manner. Failure to deliver these products on time,
    or failure to deliver products that perform to all contractually
    committed specifications, could have adverse effects on our
    business, including rescheduling of backlog, failure to achieve
    customer acceptance and therefore revenue recognition as
    anticipated, unanticipated rework and warranty costs, penalties
    for non-performance, cancellation of orders, or return of
    products for credit. In addition, we may incur substantial
    unanticipated costs early in a products life cycle, such
    as increased engineering, manufacturing, installation and
    support costs, that we may be unable to pass on to the customer
    and that may affect our gross margins. Sometimes we work closely
    with our customers to develop new features and products. In
    connection with these transactions, we sometimes offer a period
    of exclusivity to these customers.
 
    Our
    Imaging Instrumentation business depends heavily on government
    contracts, which are subject to immediate termination and are
    funded in increments. The termination of or failure to fund one
    or more of these contracts could have a negative impact on our
    operations.
 
    We sell many of our Imaging Instrumentation products and
    services directly to the U.S. government, as well as to
    prime contractors for various U.S. government programs. Our
    revenues from government contracts totaled
    
    14
 
    $14.1 million, $10.2 million, and $6.9 million in
    2007, 2006, and 2005, respectively. Generally, government
    contracts are subject to oversight audits by government
    representatives and contain provisions permitting termination,
    in whole or in part, without prior notice at the
    governments convenience upon the payment of compensation
    only for work done and commitments made at the time of
    termination. We cannot assure you that one or more of the
    government contracts under which our customers or we operate
    will not be terminated under these circumstances. Also, we
    cannot assure you that we or our customers would be able to
    procure new government contracts to offset the revenues lost as
    a result of any termination of existing contracts, nor can we
    assure you that we or our customers will continue to remain in
    good standing as federal contractors.
 
    Furthermore, the funding of multi-year government programs is
    subject to congressional appropriations, and there is no
    guarantee that the U.S. government will make further
    appropriations. The loss of funding for a government program
    would result in a loss of future revenues attributable to that
    program.
 
    In addition, sales to the U.S. government and its prime
    contractors may be affected by changes in procurement policies,
    budget considerations and political developments in the United
    States or abroad. The influence of any of these factors, which
    are beyond our control, could also negatively impact our
    financial condition. We also may experience problems associated
    with advanced designs required by the government, which may
    result in unforeseen technological difficulties and cost
    overruns. Failure to overcome these technological difficulties
    or occurrence of cost overruns would have a material adverse
    effect on our business.
 
    Unexpected
    increases in the cost to develop or manufacture our products
    under fixed-price contracts may cause us to experience
    un-reimbursed cost overruns.
 
    A portion of our revenue is derived from fixed-price development
    and production contracts. Under fixed-price contracts,
    unexpected increases in the cost to develop or manufacture a
    product, whether due to inaccurate estimates in the bidding
    process, unanticipated increases in material costs, reduced
    production volumes, inefficiencies or other factors, are borne
    by us. We have experienced cost overruns in the past that have
    resulted in losses on certain contracts, and may experience
    additional cost overruns in the future. We are required to
    recognize the total estimated impact of cost overruns in the
    period in which they are first identified. Such cost overruns
    could have a material adverse effect on our results of operation
    and financial condition.
 
    Our
    sales of Equipment products are dependent on substantial capital
    investment by our customers, far in excess of the cost of our
    products.
 
    Our customers must make extremely large capital expenditures in
    order to purchase our systems and other related equipment and
    facilities. These costs are far in excess of the cost of our
    systems alone. The magnitude of such capital expenditures
    requires that our customers have access to large amounts of
    capital and that they be willing to invest that capital over
    long periods of time to be able to purchase our equipment. The
    magnetic disk and semiconductor manufacturing industries have
    made significant additions to their production capacity in the
    last few years. Our customers may not be willing or able to
    continue this level of capital investment, especially during a
    downturn in the overall economy, the hard disk drive industry,
    or the semiconductor industry.
 
    Our
    stock price is volatile.
 
    The market price and trading volume of our common stock has been
    subject to significant volatility, and this trend may continue.
    During 2007, the closing price of our common stock, as traded on
    The Nasdaq National Market, fluctuated from a low of $13.23 per
    share to a high of $30.57 per share. More recently, our stock
    price has closed as low as $10.14 per share. The value of our
    common stock may decline regardless of our operating performance
    or prospects. Factors affecting our market price include:
 
     | 
     | 
     | 
    |   | 
         
 | 
    
    our perceived prospects;
 | 
|   | 
    |   | 
         
 | 
    
    hard disk drive market expectations;
 | 
|   | 
    |   | 
         
 | 
    
    variations in our operating results and whether we achieve our
    key business targets;
 | 
|   | 
    |   | 
         
 | 
    
    sales or purchases of large blocks of our stock;
 | 
    
    15
 
 
     | 
     | 
     | 
    |   | 
         
 | 
    
    changes in, or our failure to meet, our revenue and earnings
    estimates;
 | 
|   | 
    |   | 
         
 | 
    
    changes in securities analysts buy or sell recommendations;
 | 
|   | 
    |   | 
         
 | 
    
    differences between our reported results and those expected by
    investors and securities analysts;
 | 
|   | 
    |   | 
         
 | 
    
    announcements of new contracts, products or technological
    innovations by us or our competitors;
 | 
|   | 
    |   | 
         
 | 
    
    market reaction to any acquisitions, joint ventures or strategic
    investments announced by us or our competitors;
 | 
|   | 
    |   | 
         
 | 
    
    our high fixed operating expenses, including research and
    development expenses;
 | 
|   | 
    |   | 
         
 | 
    
    developments in the financial markets; and
 | 
|   | 
    |   | 
         
 | 
    
    general economic, political or stock market conditions in the
    United States and other major regions in which we do business.
 | 
 
    In addition, the general economic, political, stock market and
    industry conditions that may affect the market price of our
    common stock are beyond our control. The market price of our
    common stock at any particular time may not remain the market
    price in the future. In the past, securities class action
    litigation has been instituted against companies following
    periods of volatility in the market price of their securities.
    Any such litigation, if instituted against us, could result in
    substantial costs and a diversion of managements attention
    and resources.
 
    The
    liquidity of our Auction Rate Securities may be impaired, which
    may impact our ability to meet our cash requirements and require
    additional debt funding.
 
    At December 31, 2007, we held $81.5 million of Auction
    Rate Securities. These securities have long-term underlying
    maturities (ranging from 20 to 40 years), but the market
    has historically been highly liquid and the interest rates reset
    every 7 or 28 days. We do not intend to hold these
    securities to maturity, but rather to use the interest rate
    reset feature to sell the securities as needed to provide
    liquidity. Beginning in mid-February of 2008, certain of these
    Auction Rate Securities failed auction due to sell orders
    exceeding buy orders. The funds associated with failed auctions
    will not be accessible until a successful auction occurs or a
    buyer is found outside of the auction process. We do not know
    when, or if, one of these circumstances will occur. All of our
    Auction Rate Securities are student loan structured issues,
    where the loans have been originated under the Department of
    Educations Federal Family Education Loan Program and the
    principal and interest is 97% reinsured by the
    U.S. Department of Education. At this time, there has been
    no change in the AAA rating of these securities, but we cannot
    be certain that no change will occur in the future. We may also
    be required to reclassify all or a part of these securities from
    short-term to long-term investments. If the issuer of the
    auction rate securities is unable to successfully close future
    auctions or does not redeem the auction rate securities, or the
    United States government fails to support its guaranty of the
    obligations, the Company may be required to adjust the carrying
    value of the auction rate securities and record an
    other-than-temporary
    impairment charge. We have entered into a line of credit with
    Citigroup Global Markets Inc. under which approximately
    $20 million is available to us to help secure our ability
    to fund our cash requirements until we are able to liquidate our
    Auction Rate Securities, but if we are unable to maintain the
    line of credit, or if the interest rate of the line of credit is
    prohibitive or the amount of the line of credit is insufficient,
    we could experience difficulties in meeting our cash
    requirements until the market for the Auction Rate Securities
    becomes liquid again and we may have to seek additional debt
    funding to finance our operations.
 
    Changes
    in tax rates or tax liabilities could affect future
    results.
 
    As a global company, we are subject to taxation in the United
    States and various other countries. Significant judgment is
    required to determine and estimate worldwide tax liabilities.
    Our future tax rates could be affected by changes in the
    applicable tax laws, composition of earnings in countries with
    differing tax rates, changes in the valuation of our deferred
    tax assets and liabilities, or changes in the tax laws. Although
    we believe our tax estimates are reasonable, there can be no
    assurance that any final determination will not be materially
    different from the treatment reflected in our historical income
    tax provisions and accruals, which could materially and
    adversely affect our results of operations.
    
    16
 
    Our effective tax rate in both 2007 was well below the
    applicable statutory rates due primarily to permanent
    differences and the utilization of research and development
    credits. In 2006, our effective tax rate was well below the
    applicable statutory rates due primarily to the utilization of
    net operating loss carry-forwards and deferred credits.
 
    We
    have experienced significant growth and contraction in our
    business and operations and if we do not appropriately manage
    this growth and contraction, now and in the future, then our
    operating results will be negatively affected.
 
    Our business has both grown and contracted significantly in
    recent years, in both operations and headcount, and this growth
    and contraction causes significant strain on our infrastructure,
    internal systems and managerial resources. To manage our growth
    and contraction effectively, we must continue to improve and
    enhance our infrastructure, including information technology and
    financial operating and administrative systems and controls, and
    continue managing headcount, capital and processes in an
    efficient manner. Our productivity and the quality of our
    products may be adversely affected if we do not integrate and
    train our new employees quickly and effectively and coordinate
    among our executive, engineering, finance, marketing, sales,
    operations and customer support organizations, all of which add
    to the complexity of our organization and increase our operating
    expenses. We also may be less able to predict and effectively
    control our operating expenses due to the growth and increasing
    complexity of our business. In addition, our information
    technology systems may not grow at a sufficient rate to keep up
    with the processing and information demands placed on them by a
    much larger company. The efforts to continue to expand our
    information technology systems or our inability to do so could
    harm our business. Further, revenues may not grow at a
    sufficient rate to absorb the costs associated with a larger
    overall headcount.
 
    Our future growth may require significant additional resources,
    given that, as we increase our business operations in complexity
    and scale, we may have insufficient management capabilities and
    internal bandwidth to manage our growth and business
    effectively. We cannot assure you that resources will be
    available when we need them or that we will have sufficient
    capital to fund these potential resource needs. If we are unable
    to manage our growth effectively or if we experience a shortfall
    in resources, our results of operations will be harmed.
 
    Our
    current and future success depends on international sales and
    the management of global operations.
 
    In 2007, approximately 82% of our revenues came from regions
    outside the United States. Substantially all of our
    international sales are to customers in Asia, which includes
    products shipped to overseas operations of U.S. companies.
    We currently have international customer support offices in
    Singapore, China, Malaysia, Korea and Japan. We expect that
    international sales will continue to account for a significant
    portion of our total revenue in future years. Certain of our
    manufacturing facilities and suppliers are also located outside
    the United States. Managing our global operations presents
    challenges including, but not limited to, those arising from:
 
     | 
     | 
     | 
    |   | 
         
 | 
    
    varying regional and geopolitical business conditions and
    demands;
 | 
|   | 
    |   | 
         
 | 
    
    global trade issues;
 | 
|   | 
    |   | 
         
 | 
    
    variations in protection of intellectual property and other
    legal rights in different countries;
 | 
|   | 
    |   | 
         
 | 
    
    rising raw material and energy costs;
 | 
|   | 
    |   | 
         
 | 
    
    variations in the ability to develop relationships with
    suppliers and other local businesses;
 | 
|   | 
    |   | 
         
 | 
    
    changes in laws and regulations of the United States (including
    export restrictions) and other countries, as well as their
    interpretation and application;
 | 
|   | 
    |   | 
         
 | 
    
    fluctuations in interest rates and currency exchange rates,
    particularly with the recent decline in the value of the
    U.S. dollar;
 | 
|   | 
    |   | 
         
 | 
    
    the need to provide sufficient levels of technical support in
    different locations;
 | 
|   | 
    |   | 
         
 | 
    
    political instability, natural disasters (such as earthquakes,
    hurricanes or floods), pandemics, terrorism or acts of war where
    we have operations, suppliers or sales;
 | 
    
    17
 
 
     | 
     | 
     | 
    |   | 
         
 | 
    
    cultural differences; and
 | 
|   | 
    |   | 
         
 | 
    
    shipping delays.
 | 
 
    Changes
    in existing financial accounting standards or practices or
    taxation rules or practices may adversely affect our results of
    operations.
 
    Changes in existing accounting or taxation rules or practices,
    new accounting pronouncements or taxation rules, or varying
    interpretations of current accounting pronouncements or taxation
    practice could have a significant adverse effect on our results
    of operations or the manner in which we conduct our business.
    Further, such changes could potentially affect our reporting of
    transactions completed before such changes are effective. In
    June 2006, the FASB issued Interpretation No. 48,
    Accounting for Uncertainty in Income Taxes
    (FIN 48). FIN 48, which was effective
    January 1, 2007, clarifies the accounting for uncertainty
    in income taxes recognized in an enterprises financial
    statements in accordance with FASB Statement No. 109,
    Accounting for Income Taxes. We adopted FIN 48
    in the first quarter of fiscal year 2007.
 
    We are
    required to evaluate our internal control over financial
    reporting under Section 404 of the
    Sarbanes-Oxley
    Act of 2002, and any adverse results from such evaluation could
    result in a loss of investor confidence in our financial reports
    and have an adverse effect on our stock price.
 
    Pursuant to Section 404 of the Sarbanes-Oxley Act of 2002,
    our management must perform evaluations of our internal control
    over financial reporting. Beginning in 2004, our
    Form 10-K
    has included a report by management of their assessment of the
    adequacy of such internal control. Additionally, our independent
    registered public accounting firm must publicly attest to the
    effectiveness of our internal control.
 
    We have completed the evaluation of our internal controls over
    financial reporting as required by Section 404 of the
    Sarbanes-Oxley Act. Although our assessment, testing, and
    evaluation resulted in our conclusion that as of
    December 31, 2007, our internal controls over financial
    reporting were effective, we cannot predict the outcome of our
    testing in future periods. If our internal controls are
    ineffective in future periods, our financial results or the
    market price of our shares could be adversely affected. We will
    incur additional expenses and commitment of managements
    time in connection with further evaluations.
 
    Our
    dependence on suppliers for certain parts, some of them
    sole-sourced, makes us vulnerable to manufacturing interruptions
    and delays, which could affect our ability to meet customer
    demand.
 
    We are a manufacturing business. Purchased parts constitute the
    largest component of our product cost. Our ability to
    manufacture depends on the timely delivery of parts, components
    and subassemblies from suppliers. We obtain some of the key
    components and
    sub-assemblies
    used in our products from a single supplier or a limited group
    of suppliers. If any of our suppliers fail to deliver quality
    parts on a timely basis, we may experience delays in
    manufacturing, which could result in delayed product deliveries
    or increased costs to expedite deliveries or develop alternative
    suppliers. Development of alternative suppliers could require
    redesign of our products.
 
    Our
    business depends on the integrity of our intellectual property
    rights and failure to protect our intellectual property rights
    adequately could have a material adverse effect on our
    business.
 
    The success of our business depends upon the integrity of our
    intellectual property rights, and we cannot assure you that:
 
     | 
     | 
     | 
    |   | 
         
 | 
    
    any of our pending or future patent applications will be allowed
    or that any of the allowed applications will be issued as
    patents or will issue with claims of the scope we sought;
 | 
|   | 
    |   | 
         
 | 
    
    any of our patents will not be invalidated, deemed
    unenforceable, circumvented or challenged;
 | 
|   | 
    |   | 
         
 | 
    
    the rights granted under our patents will provide competitive
    advantages to us;
 | 
    
    18
 
 
     | 
     | 
     | 
    |   | 
         
 | 
    
    other parties will not develop similar products, duplicate our
    products or design around our patents; or
 | 
|   | 
    |   | 
         
 | 
    
    our patent rights, intellectual property laws or our agreements
    will adequately protect our intellectual property or competitive
    position.
 | 
 
    We may
    be subject to claims of intellectual property
    infringement.
 
    From time to time, we have received claims that we are
    infringing third parties intellectual property rights or
    seeking to invalidate our rights. We cannot assure you that
    third parties will not in the future claim that we have
    infringed current or future patents, trademarks or other
    proprietary rights relating to our products. Any claims, with or
    without merit, could be time-consuming, result in costly
    litigation, cause product shipment delays or require us to enter
    into royalty or licensing agreements. Such royalty or licensing
    agreements, if required, may not be available on terms
    acceptable to us.
 
    Our
    success is dependent on recruiting and retaining a highly
    talented work force.
 
    Our employees are vital to our success, and our key management,
    engineering and other employees are difficult to replace. We
    generally do not have employment contracts with our key
    employees. Further, we do not maintain key person life insurance
    on any of our employees. The expansion of high technology
    companies worldwide has increased demand and competition for
    qualified personnel, and has made companies increasingly
    protective of prior employees. It may be difficult for us to
    locate employees who are not subject to non-competition
    agreements and other restrictions.
 
    The majority of our U.S. operations are located in
    Santa Clara, California and Fremont, California, where the
    cost of living and of recruiting employees is high.
    Additionally, our operating results depend, in large part, upon
    our ability to retain and attract qualified management,
    engineering, marketing, manufacturing, customer support, sales
    and administrative personnel. Furthermore, we compete with
    similar industries, such as the semiconductor industry, for the
    same pool of skilled employees. If we are unable to retain key
    personnel, or if we are not able to attract, assimilate or
    retain additional highly qualified employees to meet our needs
    in the future, our business and operations could be harmed.
 
    Changes
    in demand caused by fluctuations in interest and currency
    exchange rates may reduce our international sales.
 
    Sales and operating activities outside of the United States are
    subject to inherent risks, including fluctuations in the value
    of the U.S. dollar relative to foreign currencies, tariffs,
    quotas, taxes and other market barriers, political and economic
    instability, restrictions on the export or import of technology,
    potentially limited intellectual property protection,
    difficulties in staffing and managing international operations
    and potentially adverse tax consequences. We earn a significant
    portion of our revenue from international sales, and there can
    be no assurance that any of these factors will not have an
    adverse effect on our ability to sell our products or operate
    outside the United States.
 
    We currently quote and sell the majority of our products in
    U.S. dollars. From time to time, we may enter into foreign
    currency contracts in an effort to reduce the overall risk of
    currency fluctuations to our business. However, there can be no
    assurance that the offer and sale of products denominated in
    foreign currencies, and the related foreign currency hedging
    activities, will not adversely affect our business.
 
    Our principal competitor for disk sputtering equipment is based
    in Japan and has a cost structure based on the Japanese yen.
    Accordingly, currency fluctuations could cause the price of our
    products to be more or less competitive than our principal
    competitors products. Currency fluctuations will decrease
    or increase our cost structure relative to those of our
    competitors, which could lessen the demand for our products and
    affect our competitive position.
 
    Difficulties
    in integrating past or future acquisitions could adversely
    affect our business.
 
    We have completed a number of acquisitions during our operating
    history. In early 2007, we completed the acquisition of certain
    assets of DeltaNu, LLC, and in the fourth quarter of 2007 we
    completed the acquisition of certain assets of Creative Display
    Systems, LLC. We have spent and will continue to spend
    significant resources
    
    19
 
    identifying and acquiring businesses. The efficient and
    effective integration of our acquired businesses into our
    organization is critical to our growth. Any future acquisitions
    involve numerous risks including difficulties in integrating the
    operations, technologies and products of the acquired companies,
    the diversion of our managements attention from other
    business concerns and the potential loss of key employees of the
    acquired companies. Failure to achieve the anticipated benefits
    of these and any future acquisitions or to successfully
    integrate the operations of the companies we acquire could also
    harm our business, results of operations and cash flows. Any
    future acquisitions may also result in potentially dilutive
    issuance of equity securities, acquisition- or
    divestiture-related write-offs or the assumption of debt and
    contingent liabilities.
 
    We use
    hazardous materials and are subject to risks of non-compliance
    with environmental and safety regulations.
 
    We are subject to a variety of governmental regulations relating
    to the use, storage, discharge, handling, emission, generation,
    manufacture, treatment and disposal of toxic or otherwise
    hazardous substances, chemicals, materials or waste. If we fail
    to comply with current or future regulations, such failure could
    result in suspension of our operations, alteration of our
    manufacturing process, or substantial civil penalties or
    criminal fines against us or our officers, directors or
    employees. Additionally, these regulations could require us to
    acquire expensive remediation or abatement equipment or to incur
    substantial expenses to comply with them. Failure to properly
    manage the use, disposal or storage of, or adequately restrict
    the release of, hazardous or toxic substances could subject us
    to significant liabilities.
 
    Future
    sales of shares of our common stock by our officers, directors
    and affiliates could cause our stock price to
    decline.
 
    Substantially all of our common stock may be sold without
    restriction in the public markets, although shares held by our
    directors, executive officers and affiliates may be subject to
    volume and manner of sale restrictions. Sales of a substantial
    number of shares of common stock in the public market by our
    officers, directors or affiliates or the perception that these
    sales could occur could materially and adversely affect our
    stock price and make it more difficult for us to sell equity
    securities in the future at a time and price we deem appropriate.
 
    Anti-takeover
    provisions in our charter documents and under Delaware law could
    prevent or delay a change in control, which could negatively
    impact the value of our common stock by discouraging a favorable
    merger or acquisition of us.
 
    Our certificate of incorporation authorizes our board of
    directors to issue up to 10,000,000 shares of preferred
    stock and to determine the powers, preferences, privileges,
    rights, including voting rights, qualifications, limitations and
    restrictions of those shares, without any further vote or action
    by the stockholders. The rights of the holders of our common
    stock will be subject to, and may be adversely affected by, the
    rights of the holders of any preferred stock that we may issue
    in the future. The issuance of preferred stock could have the
    effect of delaying, deterring or preventing a change in control
    and could adversely affect the voting power of your shares. In
    addition, provisions of Delaware law and our bylaws could make
    it more difficult for a third party to acquire a majority of our
    outstanding voting stock by discouraging a hostile bid, or
    delaying or deterring a merger, acquisition or tender offer in
    which our stockholders could receive a premium for their shares
    or a proxy contest for control of our company or other changes
    in our management.
 
    We
    could be involved in litigation.
 
    From time to time we may be involved in litigation of various
    types, including litigation alleging infringement of
    intellectual property rights and other claims. For example, in
    July 2006, we filed a patent infringement lawsuit against Unaxis
    USA, Inc. and its affiliates Unaxis Balzers AG and Unaxis
    Balzers, Ltd. alleging infringement by Unaxis of a patent
    relating to our 200 Lean system. See Part I, Item 3 of
    this
    Form 10-K
    for further information regarding this lawsuit. Litigation is
    expensive and can require significant management time and
    attention and could have a negative effect on our results of
    operations or business if we lose or have to settle a case on
    significantly adverse terms.
    
    20
 
    Business
    interruptions could adversely affect our
    operations.
 
    Our operations are vulnerable to interruption by fire,
    earthquake or other natural disaster, quarantines or other
    disruptions associated with infectious diseases, national
    catastrophe, terrorist activities, war, disruptions in our
    computing and communications infrastructure due to power loss,
    telecommunications failure, human error, physical or electronic
    security breaches and computer viruses, and other events beyond
    our control. We do not have a fully implemented detailed
    disaster recovery plan. Despite our implementation of network
    security measures, our tools and servers are vulnerable to
    computer viruses, break-ins and similar disruptions from
    unauthorized tampering with our computer systems and tools
    located at customer sites. Political instability could cause us
    to incur increased costs in transportation, make such
    transportation unreliable, increase our insurance costs and
    cause international currency markets to fluctuate. This same
    instability could have the same effects on our suppliers and
    their ability to timely deliver their products. In addition, we
    do not carry sufficient business interruption insurance to
    compensate us for all losses that may occur, and any losses or
    damages incurred by us could have a material adverse effect on
    our business and results of operations. For example, we
    self-insure earthquake risks, because we believe this is the
    prudent financial decision based on the high cost of the limited
    coverage available in the earthquake insurance market. An
    earthquake could significantly disrupt our operations, most of
    which are conducted in California. It could also significantly
    delay our research and engineering effort on new products, most
    of which is also conducted in California. We take steps to
    minimize the damage that would be caused by an earthquake, but
    there is no certainty that our efforts will prove successful in
    the event of an earthquake.
 
     | 
     | 
    | 
    Item 1B.  
 | 
    
    Unresolved
    Staff Comments
 | 
 
    None.
 
 
    We maintain our corporate headquarters in Santa Clara,
    California. The location, approximate size and type of facility
    of our principal properties are listed below. We lease all of
    our properties and do not own any real estate.
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
    Location
 
 | 
 
 | 
    Square Footage
 | 
 
 | 
 
 | 
    Lease Expire
 | 
 
 | 
 
 | 
 
    Principal Use
 
 | 
|  
 | 
| 
 
    Santa Clara, CA
 
 | 
 
 | 
 
 | 
    169,583
 | 
 
 | 
 
 | 
 
 | 
    Mar 2012
 | 
 
 | 
 
 | 
    Corporate Headquarters; Equipment and Imaging Instrumentation
    Marketing, Manufacturing, Engineering and Customer Support
 | 
| 
 
    Fremont, CA
 
 | 
 
 | 
 
 | 
    9,505
 | 
 
 | 
 
 | 
 
 | 
    Feb 2013
 | 
 
 | 
 
 | 
    Imaging Instrumentation Sensor Fabrication
 | 
| 
 
    Laramie, WY
 
 | 
 
 | 
 
 | 
    4,000
 | 
 
 | 
 
 | 
 
 | 
    Feb 2009
 | 
 
 | 
 
 | 
    Imaging Instrumentation Raman Spectrometer Mfg
 | 
| 
 
    Carlsbad, CA
 
 | 
 
 | 
 
 | 
    10,360
 | 
 
 | 
 
 | 
 
 | 
    May 2010
 | 
 
 | 
 
 | 
    Imaging Instrumentation Micro Display Product Mfg
 | 
| 
 
    Chicago, IL
 
 | 
 
 | 
 
 | 
    120
 | 
 
 | 
 
 | 
 
 | 
    Aug 2008
 | 
 
 | 
 
 | 
    Imaging Instrumentation Micro Display Product Sales
 | 
| 
 
    Singapore
 
 | 
 
 | 
 
 | 
    31,947
 | 
 
 | 
 
 | 
 
 | 
    Jun 2010
 | 
 
 | 
 
 | 
    Equipment Manufacturing and Customer Support
 | 
| 
 
    Korea
 
 | 
 
 | 
 
 | 
    1,558
 | 
 
 | 
 
 | 
 
 | 
    May 2008
 | 
 
 | 
 
 | 
    Equipment Customer Support
 | 
| 
 
    Malaysia
 
 | 
 
 | 
 
 | 
    1,291
 | 
 
 | 
 
 | 
 
 | 
    Aug 2008
 | 
 
 | 
 
 | 
    Equipment Customer Support
 | 
| 
 
    Japan
 
 | 
 
 | 
 
 | 
    1,507
 | 
 
 | 
 
 | 
 
 | 
    Nov 2008
 | 
 
 | 
 
 | 
    Equipment Customer Support
 | 
| 
 
    Shenzhen, China
 
 | 
 
 | 
 
 | 
    2,568
 | 
 
 | 
 
 | 
 
 | 
    Jul 2008
 | 
 
 | 
 
 | 
    Equipment Customer Support
 | 
 
    We consider these properties adequate to meet our current and
    future requirements. We regularly assess the size, capability
    and location of our global infrastructure and periodically make
    adjustments based on these assessments.
    
    21
 
 
     | 
     | 
    | 
    Item 3.  
 | 
    
    Legal
    Proceedings
 | 
 
    Patent
    Infringement Complaint against Unaxis
 
    On July 7, 2006, we filed a patent infringement lawsuit
    against Unaxis USA, Inc. (a wholly owned subsidiary of Oerlikon)
    and its affiliates, Unaxis Balzers AG and Unaxis Balzers, Ltd.,
    in the United States District Court for the Central District of
    California. Our lawsuit against Unaxis asserts infringement by
    Unaxis of United States Patent 6,919,001, which relates to our
    200 Lean system. Our complaint seeks monetary damages and an
    injunction that bars Unaxis from making, using, offering to sell
    or selling in the United States, or importing into the United
    States, Unaxis allegedly infringing product. In the suit,
    we seek damages and a permanent injunction for infringement of
    the same patent. We believe we have meritorious claims, and we
    intend to pursue them vigorously.
 
    On September 12, 2006, Unaxis filed a response to our
    lawsuit in which it asserted non-infringement, invalidity of our
    patent, inequitable conduct by Intevac, patent misuse by
    Intevac, and lack of jurisdiction by the court as defenses.
    Additionally, Unaxis requested a declaratory judgment of patent
    non-infringement, invalidity and unenforceability; asserted our
    violation of the California Business and Professional Code;
    requested that we be enjoined from engaging in any unfair
    competition; and requested that we be required to pay
    Unaxis attorney fees. We believe such claims lack merit,
    and we intend to defend ourselves vigorously.
 
    We replied to Unaxis response on October 3, 2006,
    denying the assertions of non-infringement, invalidity and
    unenforceability of the Intevac patent, and denying any unfair
    competition. With the approval of the Court, we amended our
    complaint on February 6, 2007 to assert an additional
    ground for our infringement claim and to add a request for a
    declaratory judgment of infringement. Unaxis filed a response on
    February 21, 2007, in which it repeated the assertions of
    its September 12, 2006 response.
 
    On May 21, 2007, the Court granted Unaxis request to
    stay the litigation pending reexamination of our United States
    Patent 6,919,001, after the U.S. Patent Office granted
    Unaxis February 27, 2007 reexamination request and
    issued an initial office action rejecting the claims of the
    patent. The Court also ordered the parties to file a joint
    report every 120 days to keep it appraised of the
    reexamination status. Intevac had no input to the initial office
    action determination by the U.S. Patent Office.
 
    On June 20, 2007, we filed a reply to the initial office
    action reexamination. Our reply addresses the office
    actions rejections of the patents original claims
    and proposes amended claims that we believe are supported by the
    original patents specification. Unaxis responded to our
    reply, and the U.S. Patent Office is now considering both
    parties submissions. During the reexamination process, the
    patent remains valid.
 
    Other
    Legal Matters
 
    From time to time, we are involved in claims and legal
    proceedings that arise in the ordinary course of business. We
    expect that the number and significance of these matters will
    increase as our business expands. Any claims or proceedings
    against us, whether meritorious or not, could be time consuming,
    result in costly litigation, require significant amounts of
    management time, result in the diversion of significant
    operational resources, or require us to enter into royalty or
    licensing agreements which, if required, may not be available on
    terms favorable to us or at all. We are not presently party to
    any lawsuit or proceeding that, in our opinion, is likely to
    seriously harm our business.
 
     | 
     | 
    | 
    Item 4.  
 | 
    
    Submission
    of Matters to a Vote of Security-Holders
 | 
 
    No matters were submitted to a vote of security-holders during
    the fourth quarter of the fiscal year covered by this Annual
    Report on
    Form 10-K.
    
    22
 
 
    PART II
 
     | 
     | 
    | 
    Item 5.  
 | 
    
    Market
    for Registrants Common Equity, Related Stockholder Matters
    and Issuer Purchases of Equity Securities
 | 
 
    Price
    Range of Common Stock
 
    Our common stock is listed on The Nasdaq National Market (NASDAQ
    Global Select) under the symbol IVAC. As of
    March 10, 2008, there were approximately 124 holders of
    record of our common stock. Because many of our shares of common
    stock are held by brokers and other institutions on behalf of
    stockholders, we are unable to estimate the total number of
    stockholders represented by these record holders.
 
    The following table sets forth the high and low closing sale
    prices per share as reported on The Nasdaq National Market for
    the periods indicated.
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    High
 | 
 
 | 
 
 | 
    Low
 | 
 
 | 
|  
 | 
| 
 
    Fiscal 2006:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    First Quarter
 
 | 
 
 | 
    $
 | 
    28.80
 | 
 
 | 
 
 | 
    $
 | 
    13.42
 | 
 
 | 
| 
 
    Second Quarter
 
 | 
 
 | 
 
 | 
    30.60
 | 
 
 | 
 
 | 
 
 | 
    18.86
 | 
 
 | 
| 
 
    Third Quarter
 
 | 
 
 | 
 
 | 
    25.35
 | 
 
 | 
 
 | 
 
 | 
    14.81
 | 
 
 | 
| 
 
    Fourth Quarter
 
 | 
 
 | 
 
 | 
    27.94
 | 
 
 | 
 
 | 
 
 | 
    16.29
 | 
 
 | 
| 
 
    Fiscal 2007:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    First Quarter
 
 | 
 
 | 
    $
 | 
    30.57
 | 
 
 | 
 
 | 
    $
 | 
    22.00
 | 
 
 | 
| 
 
    Second Quarter
 
 | 
 
 | 
 
 | 
    26.77
 | 
 
 | 
 
 | 
 
 | 
    18.92
 | 
 
 | 
| 
 
    Third Quarter
 
 | 
 
 | 
 
 | 
    22.37
 | 
 
 | 
 
 | 
 
 | 
    13.23
 | 
 
 | 
| 
 
    Fourth Quarter
 
 | 
 
 | 
 
 | 
    18.12
 | 
 
 | 
 
 | 
 
 | 
    14.01
 | 
 
 | 
 
    Dividend
    Policy
 
    We currently anticipate that we will retain our earnings, if
    any, for use in the operation of our business and do not expect
    to pay cash dividends on our capital stock in the foreseeable
    future.
    
    23
 
    Performance
    Graph
 
    The following graph compares the cumulative total stockholder
    return on our Common Stock with that of the NASDAQ Stock Market
    Total Return Index, a broad market index published by the Center
    for Research in Security Prices (CRSP), and the
    NASDAQ Computer Manufacturers Stock Total Return Index compiled
    by CRSP. The comparison for each of the periods assumes that
    $100 was invested on December 31, 2002 in our Common Stock,
    the stocks included in the NASDAQ Stock Market Total Return
    Index and the stocks included in the NASDAQ Computer
    Manufacturers Stock Total Return Index. These indices, which
    reflect formulas for dividend reinvestment and weighting of
    individual stocks, do not necessarily reflect returns that could
    be achieved by individual investors.
 
    COMPARISON
    OF CUMULATIVE TOTAL RETURN SINCE DECEMBER 31, 2002
    AMONG INTEVAC, NASDAQ STOCK MARKET TOTAL RETURN INDEX AND
    NASDAQ COMPUTER MANUFACTURERS TOTAL RETURN INDEX
 
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
 
 | 
    12/31/02
 | 
 
 | 
 
 | 
 
 | 
    12/31/03
 | 
 
 | 
 
 | 
 
 | 
    12/31/04
 | 
 
 | 
 
 | 
 
 | 
    12/30/05
 | 
 
 | 
 
 | 
 
 | 
    12/29/06
 | 
 
 | 
 
 | 
 
 | 
    12/31/07
 | 
 
 | 
| 
 
    Intevac, Inc. 
 
 | 
 
 | 
 
 | 
    $
 | 
    100
 | 
 
 | 
 
 | 
 
 | 
    $
 | 
    353
 | 
 
 | 
 
 | 
 
 | 
    $
 | 
    190
 | 
 
 | 
 
 | 
 
 | 
    $
 | 
    331
 | 
 
 | 
 
 | 
 
 | 
    $
 | 
    650
 | 
 
 | 
 
 | 
 
 | 
    $
 | 
    364
 | 
 
 | 
| 
 
    Nasdaq Stock Market Total Return Index
 
 | 
 
 | 
 
 | 
 
 | 
    100
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    150
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    163
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    166
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    183
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    198
 | 
 
 | 
| 
 
    Nasdaq Computer Manufacturers Total Return Index
 
 | 
 
 | 
 
 | 
 
 | 
    100
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    139
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    181
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    185
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    189
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    277
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    
    24
 
 
     | 
     | 
    | 
    Item 6.  
 | 
    
    Selected
    Consolidated Financial Data
 | 
 
    The following table presents our selected financial data and is
    qualified by reference to, and should be read in conjunction
    with, the consolidated financial statements of Intevac,
    including the notes thereto, and Managements Discussion
    and Analysis of Financial Condition and Results of Operations,
    each appearing elsewhere in this report.
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    Year Ended December 31,
 | 
 
 | 
| 
 
 | 
 
 | 
    2007
 | 
 
 | 
 
 | 
    2006
 | 
 
 | 
 
 | 
    2005
 | 
 
 | 
 
 | 
    2004
 | 
 
 | 
 
 | 
    2003
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands, except per share data)
 | 
 
 | 
|  
 | 
| 
 
    Consolidated Statement of Operations Data:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Net revenues:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Systems and components
 
 | 
 
 | 
    $
 | 
    202,292
 | 
 
 | 
 
 | 
    $
 | 
    250,158
 | 
 
 | 
 
 | 
    $
 | 
    130,168
 | 
 
 | 
 
 | 
    $
 | 
    61,326
 | 
 
 | 
 
 | 
    $
 | 
    27,738
 | 
 
 | 
| 
 
    Technology development
 
 | 
 
 | 
 
 | 
    13,542
 | 
 
 | 
 
 | 
 
 | 
    9,717
 | 
 
 | 
 
 | 
 
 | 
    7,061
 | 
 
 | 
 
 | 
 
 | 
    8,289
 | 
 
 | 
 
 | 
 
 | 
    8,556
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total net revenues
 
 | 
 
 | 
 
 | 
    215,834
 | 
 
 | 
 
 | 
 
 | 
    259,875
 | 
 
 | 
 
 | 
 
 | 
    137,229
 | 
 
 | 
 
 | 
 
 | 
    69,615
 | 
 
 | 
 
 | 
 
 | 
    36,294
 | 
 
 | 
| 
 
    Cost of net revenues:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Systems and components
 
 | 
 
 | 
 
 | 
    111,514
 | 
 
 | 
 
 | 
 
 | 
    151,287
 | 
 
 | 
 
 | 
 
 | 
    87,525
 | 
 
 | 
 
 | 
 
 | 
    45,528
 | 
 
 | 
 
 | 
 
 | 
    19,689
 | 
 
 | 
| 
 
    Technology development
 
 | 
 
 | 
 
 | 
    7,415
 | 
 
 | 
 
 | 
 
 | 
    6,102
 | 
 
 | 
 
 | 
 
 | 
    5,253
 | 
 
 | 
 
 | 
 
 | 
    6,856
 | 
 
 | 
 
 | 
 
 | 
    6,032
 | 
 
 | 
| 
 
    Inventory provisions
 
 | 
 
 | 
 
 | 
    862
 | 
 
 | 
 
 | 
 
 | 
    1,527
 | 
 
 | 
 
 | 
 
 | 
    873
 | 
 
 | 
 
 | 
 
 | 
    1,375
 | 
 
 | 
 
 | 
 
 | 
    743
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total cost of net revenues
 
 | 
 
 | 
 
 | 
    119,791
 | 
 
 | 
 
 | 
 
 | 
    158,916
 | 
 
 | 
 
 | 
 
 | 
    93,651
 | 
 
 | 
 
 | 
 
 | 
    53,759
 | 
 
 | 
 
 | 
 
 | 
    26,464
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Gross profit
 
 | 
 
 | 
 
 | 
    96,043
 | 
 
 | 
 
 | 
 
 | 
    100,959
 | 
 
 | 
 
 | 
 
 | 
    43,578
 | 
 
 | 
 
 | 
 
 | 
    15,856
 | 
 
 | 
 
 | 
 
 | 
    9,830
 | 
 
 | 
| 
 
    Operating expenses:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Research and development
 
 | 
 
 | 
 
 | 
    40,137
 | 
 
 | 
 
 | 
 
 | 
    30,036
 | 
 
 | 
 
 | 
 
 | 
    14,384
 | 
 
 | 
 
 | 
 
 | 
    11,580
 | 
 
 | 
 
 | 
 
 | 
    12,037
 | 
 
 | 
| 
 
    Selling, general and administrative
 
 | 
 
 | 
 
 | 
    28,470
 | 
 
 | 
 
 | 
 
 | 
    22,924
 | 
 
 | 
 
 | 
 
 | 
    14,477
 | 
 
 | 
 
 | 
 
 | 
    9,525
 | 
 
 | 
 
 | 
 
 | 
    8,448
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total operating expenses
 
 | 
 
 | 
 
 | 
    68,607
 | 
 
 | 
 
 | 
 
 | 
    52,960
 | 
 
 | 
 
 | 
 
 | 
    28,861
 | 
 
 | 
 
 | 
 
 | 
    21,105
 | 
 
 | 
 
 | 
 
 | 
    20,485
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Operating income (loss)
 
 | 
 
 | 
 
 | 
    27,436
 | 
 
 | 
 
 | 
 
 | 
    47,999
 | 
 
 | 
 
 | 
 
 | 
    14,717
 | 
 
 | 
 
 | 
 
 | 
    (5,249
 | 
    )
 | 
 
 | 
 
 | 
    (10,655
 | 
    )
 | 
| 
 
    Interest income
 
 | 
 
 | 
 
 | 
    6,544
 | 
 
 | 
 
 | 
 
 | 
    3,501
 | 
 
 | 
 
 | 
 
 | 
    1,303
 | 
 
 | 
 
 | 
 
 | 
    634
 | 
 
 | 
 
 | 
 
 | 
    269
 | 
 
 | 
| 
 
    Other income (expense), net
 
 | 
 
 | 
 
 | 
    1,598
 | 
 
 | 
 
 | 
 
 | 
    277
 | 
 
 | 
 
 | 
 
 | 
    552
 | 
 
 | 
 
 | 
 
 | 
    381
 | 
 
 | 
 
 | 
 
 | 
    (1,879
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Income (loss) before income taxes
 
 | 
 
 | 
 
 | 
    35,578
 | 
 
 | 
 
 | 
 
 | 
    51,777
 | 
 
 | 
 
 | 
 
 | 
    16,572
 | 
 
 | 
 
 | 
 
 | 
    (4,234
 | 
    )
 | 
 
 | 
 
 | 
    (12,265
 | 
    )
 | 
| 
 
    Provision for (benefit from) income taxes
 
 | 
 
 | 
 
 | 
    8,233
 | 
 
 | 
 
 | 
 
 | 
    5,079
 | 
 
 | 
 
 | 
 
 | 
    421
 | 
 
 | 
 
 | 
 
 | 
    110
 | 
 
 | 
 
 | 
 
 | 
    38
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Net income (loss)
 
 | 
 
 | 
    $
 | 
    27,345
 | 
 
 | 
 
 | 
    $
 | 
    46,698
 | 
 
 | 
 
 | 
    $
 | 
    16,151
 | 
 
 | 
 
 | 
    $
 | 
    (4,344
 | 
    )
 | 
 
 | 
    $
 | 
    (12,303
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Basic earnings (loss) per share:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Net income (loss)
 
 | 
 
 | 
    $
 | 
    1.28
 | 
 
 | 
 
 | 
    $
 | 
    2.22
 | 
 
 | 
 
 | 
    $
 | 
    0.79
 | 
 
 | 
 
 | 
    $
 | 
    (0.22
 | 
    )
 | 
 
 | 
    $
 | 
    (0.95
 | 
    )
 | 
| 
 
    Shares used in per share calculations
 
 | 
 
 | 
 
 | 
    21,447
 | 
 
 | 
 
 | 
 
 | 
    21,015
 | 
 
 | 
 
 | 
 
 | 
    20,462
 | 
 
 | 
 
 | 
 
 | 
    19,749
 | 
 
 | 
 
 | 
 
 | 
    12,948
 | 
 
 | 
| 
 
    Diluted earnings (loss) per share:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Net income (loss)
 
 | 
 
 | 
    $
 | 
    1.23
 | 
 
 | 
 
 | 
    $
 | 
    2.13
 | 
 
 | 
 
 | 
    $
 | 
    0.76
 | 
 
 | 
 
 | 
    $
 | 
    (0.22
 | 
    )
 | 
 
 | 
    $
 | 
    (0.95
 | 
    )
 | 
| 
 
    Shares used in per share calculations
 
 | 
 
 | 
 
 | 
    22,150
 | 
 
 | 
 
 | 
 
 | 
    21,936
 | 
 
 | 
 
 | 
 
 | 
    21,202
 | 
 
 | 
 
 | 
 
 | 
    19,749
 | 
 
 | 
 
 | 
 
 | 
    12,948
 | 
 
 | 
| 
 
    Consolidated Balance Sheet Data:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Cash, cash equivalents and short-term Investments
 
 | 
 
 | 
    $
 | 
    138,658
 | 
 
 | 
 
 | 
    $
 | 
    95,035
 | 
 
 | 
 
 | 
    $
 | 
    49,731
 | 
 
 | 
 
 | 
    $
 | 
    42,034
 | 
 
 | 
 
 | 
    $
 | 
    19,507
 | 
 
 | 
| 
 
    Working capital
 
 | 
 
 | 
 
 | 
    154,630
 | 
 
 | 
 
 | 
 
 | 
    118,061
 | 
 
 | 
 
 | 
 
 | 
    77,353
 | 
 
 | 
 
 | 
 
 | 
    53,100
 | 
 
 | 
 
 | 
 
 | 
    22,638
 | 
 
 | 
| 
 
    Total assets
 
 | 
 
 | 
 
 | 
    215,413
 | 
 
 | 
 
 | 
 
 | 
    206,003
 | 
 
 | 
 
 | 
 
 | 
    130,444
 | 
 
 | 
 
 | 
 
 | 
    79,622
 | 
 
 | 
 
 | 
 
 | 
    55,975
 | 
 
 | 
| 
 
    Long-term debt
 
 | 
 
 | 
 
 | 
    1,898
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
    Total stockholders equity
 
 | 
 
 | 
 
 | 
    185,163
 | 
 
 | 
 
 | 
 
 | 
    144,310
 | 
 
 | 
 
 | 
 
 | 
    87,874
 | 
 
 | 
 
 | 
 
 | 
    69,375
 | 
 
 | 
 
 | 
 
 | 
    30,869
 | 
 
 | 
    
    25
 
 
     | 
     | 
    | 
    Item 7.  
 | 
    
    Managements
    Discussion and Analysis of Financial Condition and Results of
    Operations
 | 
 
    The following discussion and analysis contains
    forward-looking statements which involve risks and
    uncertainties. Words such as believes,
    expects, anticipates and the like
    indicate forward-looking statements. These forward looking
    statements include comments related to our projected revenue,
    gross margin, operating expense, profitability, income tax
    expense, effective tax rate, capital spending and cash balances;
    the adequacy of our cash balances to fund our operations;
    projected volatility in our financial results; projected
    customer requirements for new capacity and technology upgrades
    for our installed base of magnetic disk manufacturing equipment
    and when, and if, our customers will place orders for these
    products; projected change from period to period in the
    customers, and location of customers, that constitute the
    majority of our revenues; the length of development, marketing
    and deployment cycles for military customers; Imaging
    Instrumentations ability to proliferate its technology
    into major military weapons programs and to develop and
    introduce commercial products; and the timing of delivery
    and/or
    acceptance of our backlog for revenue. Our actual results may
    differ materially from the results discussed in the
    forward-looking statements for a variety of reasons, including
    those set forth under Risk Factors and should be
    read in conjunction with the Consolidated Financial Statements
    and related Notes contained elsewhere in this Annual Report on
    Form 10-K.
 
    Overview
 
    Intevacs business consists of two reportable segments:
 
    Equipment:  Intevac is a leader in the design,
    manufacture and marketing of high-productivity lean
    manufacturing systems and has been producing Lean
    Thinking platforms since 1994. We are the leading supplier
    of magnetic media sputtering equipment to the hard disk drive
    industry and offer leading-edge, high-productivity etch systems
    to the semiconductor industry.
 
    Imaging Instrumentation:  Intevac is a leader
    in the development of compact, cost-effective, high-sensitivity
    digital-optical products for the capture and display of
    low-light images and the optical analysis of materials. We
    provide sensors, cameras and systems for commercial applications
    in the inspection, medical, scientific and security industries
    and for government applications such as night vision and
    long-range target identification.
 
    Equipment
    Business
 
    In the early 1990s we developed a system, the MDP-250, to
    deposit magnetic films and protective overcoats onto magnetic
    disks used in hard disk drives. This system gained wide
    acceptance and by the late 1990s was being used to manufacture
    approximately half of the disks used in hard disk drives
    worldwide. In late 2003, we introduced a new system, the 200
    Lean. The hard disk drive industry has gone through significant
    consolidation, and there are now only seven significant
    manufacturers of magnetic disks, some of whom also manufacture
    hard disk drives. As a result of the small number of customers
    and the high average selling price of our products, our
    Equipment revenues tend to be volatile from quarter to quarter.
    In addition, our Equipment business has historically been
    subject to capital spending cycles. For example, in the period
    from 1995 through the middle of 1998, we sold $300 million
    of disk manufacturing equipment. In the period from the middle
    of 1998 thru 2003, our disk equipment revenues averaged
    approximately $20 million per year and consisted of the
    sale of a limited number of systems, technology upgrades, parts
    and service for the installed base of our systems. In 2006, our
    sales of disk manufacturing equipment grew to $248 million
    in annual revenues. In 2007, shipments of new disk sputtering
    systems declined and our revenue from sales of disk
    manufacturing equipment dropped to $197 million.
 
    In the past we also manufactured both deposition and rapid
    thermal processing equipment used in the manufacture of flat
    panel displays. In late 2002, we sold our rapid thermal
    processing product line and stopped actively marketing our flat
    panel deposition product line. From 2000 through 2004,
    cumulative revenues from sales of flat panel display
    manufacturing systems totaled $36.8 million. 2005 revenues
    included $5 million from selling a license to one of our
    flat panel patents and recognizing revenue on the last flat
    panel system we shipped.
    
    26
 
    Imaging
    Instrumentation Business
 
    Developing advanced products for the military involves long
    development cycles, as products move through successive
    multi-year stages of technology demonstration, engineering and
    manufacturing product development, prototype production and then
    product deployment. Each stage in this process requires ongoing
    government funding. Historically, much of our Imaging
    Instrumentation business revenues have been derived from
    contract research and development, rather than product sales. In
    2002, in order to shorten the time to market and to increase the
    number of markets for our imaging products, we began to fund
    development of imaging products for commercial markets. In
    January 2007, we completed the acquisition of the assets and
    certain liabilities of DeltaNu, LLC, a company that pioneered
    development of miniature Raman spectrometer systems. In November
    2007 we completed and acquisition of the assets and certain
    liabilities of Creative Display Systems, LLC, a company that
    specializes in high-performance, micro-display products for
    near-eye and portable applications in defense and commercial
    markets. As a result of these activities and the internal
    development of new products for military and commercial
    applications, the percentage of Imaging Instrumentation revenues
    derived from product sales grew from 15% in 2006 to 27% in 2007
    and is expected to continue to increase in 2008.
 
    Critical
    Accounting Policies
 
    The preparation of financial statements and related disclosures
    in conformity with accounting principles generally accepted in
    the United States of America (US GAAP) requires
    management to make judgments, assumptions and estimates that
    affect the amounts reported. Our significant accounting policies
    are described in Note 2 to the consolidated financial
    statements included in Item 8 of our Annual Report on
    Form 10-K.
    Certain of these significant accounting policies are considered
    to be critical accounting policies, as defined below.
 
    A critical accounting policy is defined as one that is both
    material to the presentation of our financial statements and
    requires management to make difficult, subjective or complex
    judgments that could have a material effect on our financial
    conditions and results of operations. Specifically, critical
    accounting estimates have the following attributes: 1) We
    are required to make assumptions about matters that are highly
    uncertain at the time of the estimate; and 2) different
    estimates we could reasonably have used, or changes in the
    estimate that are reasonably likely to occur, would have a
    material effect on our financial condition or results of
    operations.
 
    Estimates and assumptions about future events and their effects
    cannot be determined with certainty. We base our estimates on
    historical experience and on various other assumptions believed
    to be applicable and reasonable under the circumstances. These
    estimates may change as new events occur, as additional
    information is obtained and as our operating environment
    changes. These changes have historically been minor and have
    been included in our consolidated financial statements as soon
    as they become known. In addition, management is periodically
    faced with uncertainties, the outcomes of which are not within
    its control and will not be known for prolonged periods of time.
    Many of these uncertainties are discussed in the section above
    entitled Risk Factors. Nonetheless, based on a
    critical assessment of our accounting policies and the
    underlying judgments and uncertainties affecting the application
    of those policies, management believes that our consolidated
    financial statements are fairly stated in accordance with US
    GAAP, and provide a meaningful presentation of our financial
    condition and results of operation.
 
    We believe the following critical accounting policies affect the
    more significant judgments and estimates we make in preparing
    our consolidated financial statements. We also have other key
    accounting policies and accounting estimates related to the
    collectibility of trade receivables, customer advances, cash,
    cash equivalents and investments, and prototype product costs.
    We believe that these other accounting policies and other
    accounting estimates either do not generally require us to make
    estimates and judgments that are as difficult or subjective, or
    are less likely to have a material impact on our reported
    results of operation for a given period.
 
    Revenue
    Recognition
 
    Certain of our system sales with customer acceptance provisions
    are accounted for as multiple-element arrangements. If we have
    previously met defined customer acceptance levels with the
    specific type of system, then we recognize revenue for the fair
    market value of the system upon shipment and transfer of title,
    and recognize revenue for the fair market value of installation
    and acceptance services when those services are completed. We
    
    27
 
    estimate the fair market value of the installation and
    acceptance services based on our actual historical experience of
    the relative cost of such installation and acceptance services.
    For systems that have generally not been demonstrated to meet a
    particular customers product specifications prior to
    shipment, revenue recognition is typically deferred until
    customer acceptance. For example, while initial shipments of our
    200 Lean System were recognized as revenue upon customer
    acceptance during 2004, revenue was recognized upon shipment for
    the majority of 200 Leans shipped in 2005, 2006 and 2007. The
    systems in backlog at December 31, 2007 are for a customer
    for whom we have met defined customer acceptance levels, and we
    expect to recognize revenue upon shipment. We anticipate that we
    will recognize revenue on our newly developed systems in 2008
    upon customer acceptance, until such systems meet defined
    customer acceptance levels.
 
    In some instances, hardware that is not essential to the
    functioning of the system may be delivered after acceptance of
    the system. In these cases, we estimate the fair market value of
    the non-essential hardware as if it had been sold on a
    stand-alone basis, and defer recognizing revenue on that value
    until the hardware is delivered.
 
    Revenues for systems without installation and acceptance
    provisions, as well as revenues from technology upgrades, spare
    parts, consumables and products built by the Imaging
    Instrumentation business are recognized when title passes to our
    customer. In certain cases, technology upgrade sales are
    accounted for as multiple-element arrangements, usually split
    between delivery of the parts and installation on the
    customers systems. In these cases, we recognize revenue
    for the fair market value of the parts upon shipment and
    transfer of title, and recognize revenue for the fair market
    value of installation services when those services are completed.
 
    In certain cases, we sell limited rights to our intellectual
    property. Revenue from the sale of any intellectual property
    license will generally be recognized at the inception of the
    license term.
 
    We perform best efforts research and development work under
    various government-sponsored research contracts. These contracts
    are a mixture of cost-plus-fixed-fee (CPFF) and firm
    fixed-price (FFP). Revenue on CPFF contracts is
    recognized in accordance with contract terms, typically as costs
    are incurred. Revenue on FFP contracts is generally recognized
    on the percentage-of-completion method based on costs incurred
    in relation to total estimated costs. Provisions for estimated
    losses on government-sponsored research contracts are recorded
    in the period in which such losses are determined.
 
    Inventories
 
    Inventories are priced using average actual costs and are stated
    at the lower of cost or market. The carrying value of inventory
    is reduced for estimated excess and obsolescence by analyzing
    historical and anticipated demand. In addition, inventories are
    evaluated for potential obsolescence due to the effect of known
    and anticipated engineering changes and new products. If actual
    demand were to be substantially lower than estimated, additional
    inventory adjustments would be required, which could have a
    material adverse effect on our business, financial condition and
    results of operation. A cost-to-market reserve is established
    for
    work-in-progress
    and finished goods inventories when the value of the inventory
    plus the estimated cost to complete exceeds the net realizable
    value of the inventory.
 
    Warranty
 
    We provide for the estimated cost of warranty when revenue is
    recognized. Our warranty is per contract terms and for our
    systems the warranty typically ranges between 12 and
    24 months from customer acceptance. For systems sold
    through our distributor, we offer a 3 month warranty. The
    remainder of any warranty period is the responsibility of the
    distributor. During this warranty period any defective
    non-consumable parts are replaced and installed at no charge to
    the customer. The warranty period on consumable parts is limited
    to their reasonable usable lives. We use estimated repair or
    replacement costs along with our historical warranty experience
    to determine our warranty obligation. We exercise judgment in
    determining the underlying estimates. We also provide for
    estimated retrofit costs, which typically relate to design
    changes or improvements we identify. On a
    case-by-case
    basis, we determine whether or not to retrofit systems in the
    field at no charge to the customer. Should actual warranty costs
    differ substantially from our estimates, revisions to the
    estimated warranty liability would be required, which could have
    a material adverse effect on our business, financial condition
    and results of operations.
    
    28
 
    Income
    Taxes
 
    We account for income taxes in accordance with Statement of
    Financial Accounting Standard No. 109, Accounting for
    Income Taxes, (SFAS 109), which requires
    that deferred tax assets and liabilities be recognized using
    enacted tax rates for the effect of temporary differences
    between book and tax bases of recorded assets and liabilities.
    SFAS 109 also requires that deferred tax assets be reduced
    by a valuation allowance if it is more likely than not that a
    portion of the deferred tax asset will not be realized. As of
    December 31, 2007, $7.3 million of the deferred tax
    asset was valued on the balance sheet, net of a valuation
    allowance of $2.7 million. This represents the amount of
    the deferred tax asset from which we expect to realize a
    benefit. We cannot predict with certainty when, or if, we will
    realize the benefit of the portion of the deferred tax asset
    currently offset with a valuation allowance.
 
    On a quarterly basis, we provide for income taxes based upon an
    annual effective income tax rate. The effective tax rate is
    highly dependent upon the level of our projected earnings, the
    geographic composition of worldwide earnings, tax regulations
    governing each region, net operating loss carry-forwards,
    availability of tax credits and the effectiveness of our tax
    planning strategies. We carefully monitor the changes in many
    factors and adjust our effective income tax rate on a timely
    basis. If actual results differ from the estimates, this could
    have a material effect on our business, financial condition and
    results of operations. For example, as our projected level of
    earnings changed throughout 2007 and we benefited from various
    tax planning strategies, we decreased the annual effective tax
    rate from 31.6% at the end of the first quarter, to 26.9% at the
    end of the second quarter, to 24.0% at the end of the third
    quarter and to 23.1% at the end of the fourth quarter.
 
    The calculation of tax liabilities involves significant judgment
    in estimating the impact of uncertainties in the application of
    complex tax laws. Resolution of these uncertainties in a manner
    inconsistent with our expectations could have a material effect
    on our business, financial condition and results of operations.
 
    Results
    of Operations
 
    Net
    revenues
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    Year Ended December 31,
 | 
 
 | 
 
 | 
    % Change 
    
 | 
 
 | 
 
 | 
    % Change 
    
 | 
 
 | 
| 
 
 | 
 
 | 
    2007
 | 
 
 | 
 
 | 
    2006
 | 
 
 | 
 
 | 
    2005
 | 
 
 | 
 
 | 
    2007 vs. 2006
 | 
 
 | 
 
 | 
    2006 vs. 2005
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands, except percentages)
 | 
 
 | 
|  
 | 
| 
 
    Equipment net revenues
 
 | 
 
 | 
    $
 | 
    196,686
 | 
 
 | 
 
 | 
    $
 | 
    248,482
 | 
 
 | 
 
 | 
    $
 | 
    129,280
 | 
 
 | 
 
 | 
 
 | 
    (21
 | 
    )%
 | 
 
 | 
 
 | 
    92
 | 
    %
 | 
| 
 
    Imaging Instrumentation net revenues
 
 | 
 
 | 
 
 | 
    19,148
 | 
 
 | 
 
 | 
 
 | 
    11,393
 | 
 
 | 
 
 | 
 
 | 
    7,949
 | 
 
 | 
 
 | 
 
 | 
    68
 | 
    %
 | 
 
 | 
 
 | 
    43
 | 
    %
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total net revenues
 
 | 
 
 | 
    $
 | 
    215,834
 | 
 
 | 
 
 | 
    $
 | 
    259,875
 | 
 
 | 
 
 | 
    $
 | 
    137,229
 | 
 
 | 
 
 | 
 
 | 
    (17
 | 
    )%
 | 
 
 | 
 
 | 
    89
 | 
    %
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    Net revenues consist primarily of sales of equipment used to
    manufacture thin-film disks, and, to a lesser extent, related
    equipment and system components; flat panel equipment technology
    license fees; contract research and development related to the
    development of electro-optical sensors, cameras and systems; and
    low light imaging products.
 
    The decrease in Equipment revenues in 2007 was due primarily to
    a reduction in the number of 200 Lean systems delivered. In 2007
    we delivered twenty-nine 200 Lean systems versus forty-six 200
    Lean systems delivered in 2006. Equipment revenue in 2007 also
    included four disk lubrication systems and a significant
    increase in revenue from disk equipment technology upgrades and
    spare parts. We sold a
    D-Star®
    flat panel technology license for $1.3 million. During
    2006, we also sold thirteen disk lubrication systems and had
    significant sales of disk equipment technology upgrades and
    spare parts. During 2005, we sold twenty-three 200 Lean systems,
    six MDP-250 systems and fourteen disk lubrication systems. 2005
    revenues also included $5.0 million of flat panel equipment
    and license sales.
 
    The magnetic disk manufacturing industry consists of a small
    number of large manufacturers. In 2006 Seagate acquired Maxtor,
    and in June 2007, Western Digital announced the acquisition of
    Komag, both of which further concentrated our customer base. We
    currently have seven 200 Lean systems either shipped or in
    backlog, which are scheduled for revenue recognition during
    2008. We expect Equipment revenues in 2008 to be significantly
    lower than in 2007, due to fewer shipments of 200 Lean systems.
    
    29
 
    Imaging Instrumentation revenues increased by 68% to
    $19.1 million in 2007, which consisted of $5.2 million
    of product revenue and $13.9 million of contract research
    and development revenue. The $11.4 million in 2006 Imaging
    Instrumentation revenue consisted of $1.7 million of
    product revenue and $9.7 million of contract research and
    development revenue. The increase in product revenue resulted
    from higher sales of digital night vision camera modules and
    commercial products. Product revenue included contributions from
    DeltaNu, which was acquired on January 31, 2007, and
    Creative Display Systems, which was acquired on November 9,
    2007. The increase in contract research and development revenue
    was the result of a higher volume of contracts and incremental
    revenue generated from contract close-outs. The
    $7.9 million in 2005 Imaging Instrumentation revenues
    consisted of $888,000 of product revenue and $7.0 million
    of contract research and development revenue. In 2008, we expect
    the Imaging Instrumentation revenue to grow significantly, due
    primarily to increased product sales. During 2008, we expect
    over 50% of our revenue to come from product sales. Substantial
    growth in future Imaging Instrumentation revenues is dependent
    on proliferation of our technology into major military weapons
    programs, the ability to obtain export licenses for foreign
    customers, obtaining production subcontracts for these programs,
    and development and sale of commercial products.
 
    Our backlog of orders at December 31, 2007 was
    $34.2 million, as compared to a December 31, 2006
    backlog of $125.0 million. The $34.2 million of
    backlog at December 31, 2007 consisted of
    $28.4 million of Equipment backlog and $5.8 million of
    Imaging Instrumentation backlog. The $125.0 million of
    backlog at December 31, 2006 consisted of
    $119.4 million of Equipment backlog and $5.6 million
    of Imaging Instrumentation backlog. Backlog at December 31,
    2007 includes two 200 Lean systems, as compared to twenty-four
    200 Lean systems in backlog at December 31, 2006. During
    the first two months of 2008, we have received orders for five
    additional 200 Lean systems.
 
    Significant portions of our revenues in any particular period
    have been attributable to sales to a limited number of
    customers. In 2007 sales to Seagate, our Japanese distributor,
    Matsubo, Hitachi Global Storage Technologies, and Fuji Electric
    each accounted for more than 10% of our revenues, and in
    aggregate accounted for 90% of revenues. In 2006, Seagate,
    Matsubo, and Hitachi Global Storage Technologies each accounted
    for more than 10% of our revenues, and in aggregate accounted
    for 93% of revenues. In 2005, Seagate, Matsubo, Hitachi Global
    Storage Technologies and Maxtor each accounted for more than 10%
    of our revenues, and in aggregate accounted for 90% of revenues.
 
    International sales totaled $177.0 million,
    $233.4 million, and $97.5 million in 2007, 2006, and
    2005, respectively, accounting for 82%, 90%, and 71% of net
    revenues. The decrease in international sales in 2007 was
    primarily due to a decrease in net revenues from disk sputtering
    systems. The increase in international sales in 2006 was
    primarily due to an increase in net revenues from disk
    sputtering systems. Substantially all of our international sales
    are to customers in Asia, which includes products shipped to
    overseas operations of U.S. companies. Our mix of domestic
    versus international sales will change from period to period
    depending on the location of our largest customers in each
    period.
 
    Gross
    margin
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    Year Ended December 31,
 | 
 
 | 
 
 | 
    % Change 
    
 | 
 
 | 
 
 | 
    % Change 
    
 | 
 
 | 
| 
 
 | 
 
 | 
    2007
 | 
 
 | 
 
 | 
    2006
 | 
 
 | 
 
 | 
    2005
 | 
 
 | 
 
 | 
    2007 vs. 2006
 | 
 
 | 
 
 | 
    2006 vs. 2005
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    (In thousands, except percentages)
 | 
 
 | 
 
 | 
 
 | 
 
 | 
|  
 | 
| 
 
    Equipment gross profit
 
 | 
 
 | 
    $
 | 
    87,885
 | 
 
 | 
 
 | 
    $
 | 
    97,161
 | 
 
 | 
 
 | 
    $
 | 
    42,623
 | 
 
 | 
 
 | 
 
 | 
    (10
 | 
    )%
 | 
 
 | 
 
 | 
    128
 | 
    %
 | 
| 
 
    %of Equipment net revenues
 
 | 
 
 | 
 
 | 
    44.7
 | 
    %
 | 
 
 | 
 
 | 
    39.1
 | 
    %
 | 
 
 | 
 
 | 
    33.0
 | 
    %
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Imaging Instrumentation gross profit
 
 | 
 
 | 
    $
 | 
    8,158
 | 
 
 | 
 
 | 
    $
 | 
    3,798
 | 
 
 | 
 
 | 
    $
 | 
    955
 | 
 
 | 
 
 | 
 
 | 
    115
 | 
    %
 | 
 
 | 
 
 | 
    298
 | 
    %
 | 
| 
 
    %of Imaging Inst. net revenues
 
 | 
 
 | 
 
 | 
    42.6
 | 
    %
 | 
 
 | 
 
 | 
    33.3
 | 
    %
 | 
 
 | 
 
 | 
    12.0
 | 
    %
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total gross profit
 
 | 
 
 | 
    $
 | 
    96,043
 | 
 
 | 
 
 | 
    $
 | 
    100,959
 | 
 
 | 
 
 | 
    $
 | 
    43,578
 | 
 
 | 
 
 | 
 
 | 
    (5
 | 
    )%
 | 
 
 | 
 
 | 
    132
 | 
    %
 | 
| 
 
    %of net revenues
 
 | 
 
 | 
 
 | 
    44.5
 | 
    %
 | 
 
 | 
 
 | 
    38.8
 | 
    %
 | 
 
 | 
 
 | 
    31.8
 | 
    %
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    Cost of net revenues consists primarily of purchased materials
    and costs attributable to contract research and development, and
    also includes fabrication, assembly, test and installation labor
    and overhead, customer-specific
    
    30
 
    engineering costs, warranty costs, royalties, provisions for
    inventory reserves and scrap. Cost of net revenues for 2007 and
    2006 included $638,000 and $428,000 of equity-based compensation
    expense, respectively.
 
    Equipment gross margin improved to 44.7% in 2007 from 39.1% in
    2006. Our product mix, higher average selling prices and cost
    reduction programs all contributed to the higher gross margin
    for the year. Equipment gross margin in 2006 improved over the
    gross margin achieved in 2005 due primarily to product mix,
    higher average selling prices, cost reduction programs and
    increased volume. We expect the gross margin for the Equipment
    business in 2008 to be somewhat lower than in 2007, primarily as
    a result of a reduction in volume. Gross margins in the
    Equipment business will vary depending on a number of additional
    factors, including product mix, product cost, system
    configuration and pricing, factory utilization, and provisions
    for excess and obsolete inventory.
 
    Imaging Instrumentation gross margin improved to 42.6% in 2007
    from 33.3% in 2006. The increase in gross margin resulted
    primarily from higher margins on development contracts,
    favorable adjustments related to contract closeouts and
    increased product sales. The improvement in Imaging
    Instrumentation gross margin in 2006 as compared to 2005 was
    primarily due to a higher percentage of contract research and
    development revenue being derived from fully funded contracts,
    favorable adjustments related to closing out prior year
    government rate audits and increased product shipments. We
    expect the gross margin for the Imaging Instrumentation business
    in 2008 to improve over 2007, primarily as a result of the
    projected increase in product sales, which typically carry
    higher gross margins.
 
    Research
    and development
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    Year Ended December 31,
 | 
 
 | 
    % Change 
    
 | 
 
 | 
    % Change 
    
 | 
| 
 
 | 
 
 | 
    2007
 | 
 
 | 
    2006
 | 
 
 | 
    2005
 | 
 
 | 
    2007 vs. 2006
 | 
 
 | 
    2006 vs. 2005
 | 
| 
 
 | 
 
 | 
    (In thousands, except percentages)
 | 
|  
 | 
| 
 
    Research and development expense
 
 | 
 
 | 
    $
 | 
    40,137
 | 
 
 | 
 
 | 
    $
 | 
    30,036
 | 
 
 | 
 
 | 
    $
 | 
    14,384
 | 
 
 | 
 
 | 
 
 | 
    34
 | 
    %
 | 
 
 | 
 
 | 
    109
 | 
    %
 | 
| 
 
    % of net revenues
 
 | 
 
 | 
 
 | 
    18.6
 | 
    %
 | 
 
 | 
 
 | 
    11.6
 | 
    %
 | 
 
 | 
 
 | 
    10.5
 | 
    %
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    Research and development expense consists primarily of prototype
    materials, salaries and related costs of employees engaged in
    ongoing research, design and development activities for disk
    sputtering equipment, semiconductor equipment and Imaging
    Instrumentation products. Research and development costs for
    2007 and 2006 included $2.1 million and $1.4 million
    of equity-based compensation expense, respectively.
 
    Research and development spending increased in Equipment during
    2007 as compared to 2006 and in 2006 as compared to 2005. The
    increase in Equipment spending was due primarily to spending on
    the development of our Lean
    Etchtm
    product line to serve the semiconductor market and, to a lesser
    extent, spending for continuing development of our disk
    sputtering products. Imaging Instrumentation research and
    development spending declined slightly in 2007 after a
    significant increase in 2006 as compared to 2005.
 
    Engineering headcount has grown from 89 at the end of 2005 to
    129 at the end of 2006, and to 141 at the end of 2007. We expect
    that research and development spending will decrease slightly in
    2008 due primarily to a reduction in expenditures related to the
    development of our Lean
    Etchtm
    product line.
 
    Research and development expenses do not include costs of
    $7.4 million, $6.1 million, and $5.3 million, in
    2007, 2006, and 2005, respectively, which are related to
    contract research and development and included in cost of net
    revenues.
 
    Selling,
    general and administrative
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    Year Ended December 31,
 | 
 
 | 
    % Change 
    
 | 
 
 | 
    % Change 
    
 | 
| 
 
 | 
 
 | 
    2007
 | 
 
 | 
    2006
 | 
 
 | 
    2005
 | 
 
 | 
    2007 vs. 2006
 | 
 
 | 
    2006 vs. 2005
 | 
| 
 
 | 
 
 | 
    (In thousands, except percentages)
 | 
|  
 | 
| 
 
    Selling, general and administrative expense
 
 | 
 
 | 
    $
 | 
    28,470
 | 
 
 | 
 
 | 
    $
 | 
    22,924
 | 
 
 | 
 
 | 
    $
 | 
    14,477
 | 
 
 | 
 
 | 
 
 | 
    24
 | 
    %
 | 
 
 | 
 
 | 
    58
 | 
    %
 | 
| 
 
    % of net revenues
 
 | 
 
 | 
 
 | 
    13.2
 | 
    %
 | 
 
 | 
 
 | 
    8.8
 | 
    %
 | 
 
 | 
 
 | 
    10.5
 | 
    %
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    Selling, general and administrative expense consists primarily
    of selling, marketing, customer support, financial and
    management costs and also includes production of customer
    samples, travel, liability insurance,
    
    31
 
    legal and professional services and bad debt expense. All
    domestic sales and international sales of disk sputtering
    products in Asia, with the exception of Japan, are typically
    made by Intevacs direct sales force, whereas sales in
    Japan of disk sputtering products and other products are
    typically made by our Japanese distributor, Matsubo, who
    provides services such as sales, installation, warranty and
    customer support. We also have subsidiaries in Singapore and in
    Hong Kong, along with field offices in Japan, Malaysia, Korea
    and Shenzhen, China to support our equipment customers in Asia.
    Selling, general and administrative costs for 2007 and 2006
    included $3.5 million and $1.5 million of equity-based
    compensation expense, respectively.
 
    The increase in selling, general and administrative spending in
    2007 was primarily the result of increases in costs related to
    business development, customer service and support in both the
    Equipment and Imaging Instrumentation businesses, legal expenses
    associated with the Unaxis litigation and higher equity-based
    compensation expense. Our selling, general and administrative
    headcount increased from 63 at the end of 2005 to 77 at the end
    of 2006, and to 111 at the end of 2007. The increase in selling,
    general and administrative spending in 2006 was primarily the
    result of increases in costs related to business development,
    customer service and support in the Equipment business, legal
    expenses associated with the Unaxis litigation and provisions
    for employee profit sharing and bonus plans. We expect that
    selling, general and administrative expenses will increase in
    2008 over the amount spent in 2007 due primarily to a projected
    increase in costs related to customer service and support for
    the Equipment business and the addition of key business
    development personnel in the Imaging Instrumentation business.
    This will be partially offset by lower provisions for employee
    profit sharing and bonus plans, resulting from our expectations
    of lower profits in 2008.
 
    Interest
    income and other, net
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    Year Ended December 31,
 | 
 
 | 
 
 | 
    % Change 
    
 | 
 
 | 
 
 | 
    % Change 
    
 | 
 
 | 
| 
 
 | 
 
 | 
    2007
 | 
 
 | 
 
 | 
    2006
 | 
 
 | 
 
 | 
    2005
 | 
 
 | 
 
 | 
    2007 vs. 2006
 | 
 
 | 
 
 | 
    2006 vs. 2005
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands, except percentages)
 | 
 
 | 
|  
 | 
| 
 
    Interest income and other, net
 
 | 
 
 | 
    $
 | 
    8,142
 | 
 
 | 
 
 | 
    $
 | 
    3,778
 | 
 
 | 
 
 | 
    $
 | 
    1,855
 | 
 
 | 
 
 | 
 
 | 
    116
 | 
    %
 | 
 
 | 
 
 | 
    104
 | 
    %
 | 
 
    Interest income and other, net in 2007 included a
    $1.5 million gain on the redemption of our preferred
    interest in 601 California Avenue LLC, $6.5 million of
    interest income on investments and $129,000 in net other income.
    The increase in interest income in 2007 was driven by higher
    interest rates on our investments and a higher average invested
    balance. Interest income and other, net in 2006 consisted of
    $390,000 of dividends from 601 California Avenue LLC,
    $3.5 million of interest income on investments and $113,000
    in net other expense. Interest income and other, net in 2005
    consisted of $390,000 of dividends from 601 California Avenue
    LLC, $1.3 million of interest income on investments and
    $155,000 of foreign currency gains and losses and other income.
    We expect interest income and other, net to decrease in 2008 due
    to the absence of the one-time real estate gain in 2007 and a
    reduction in interest income due primarily to a reduction in
    interest rates.
 
    Provision
    for income taxes
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    Year Ended December 31,
 | 
 
 | 
 
 | 
    % Change 
    
 | 
 
 | 
 
 | 
    % Change 
    
 | 
 
 | 
| 
 
 | 
 
 | 
    2007
 | 
 
 | 
 
 | 
    2006
 | 
 
 | 
 
 | 
    2005
 | 
 
 | 
 
 | 
    2007 vs. 2006
 | 
 
 | 
 
 | 
    2006 vs. 2005
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands, except percentages)
 | 
 
 | 
|  
 | 
| 
 
    Provision for income taxes
 
 | 
 
 | 
    $
 | 
    8,233
 | 
 
 | 
 
 | 
    $
 | 
    5,079
 | 
 
 | 
 
 | 
    $
 | 
    421
 | 
 
 | 
 
 | 
 
 | 
    62
 | 
    %
 | 
 
 | 
 
 | 
    1106
 | 
    %
 | 
 
    In 2007, we accrued income tax using an effective tax rate of
    23.1% of pretax income. This rate is based on an estimate of our
    annual tax rate calculated in accordance with Statement of
    Financial Accounting Standards No. 109, Accounting
    for Income Taxes. Our tax rate differs from the applicable
    statutory rates due primarily to the utilization of deferred and
    current credits and the effect of permanent differences and
    adjustments of prior permanent differences. Our deferred tax
    asset of $10.1 million is partially offset by a valuation
    allowance, resulting in a net deferred tax asset of
    $7.3 million at December 31, 2007. The valuation
    allowance is attributable to state temporary differences and
    deferred research and development credits that are not
    realizable in 2008. We expect our effective tax rate to decrease
    in 2008 due to research and development credits generated in
    2008, which will be utilized against a lower level of pre-tax
    profits.
 
    In 2006, we accrued income tax using an effective tax rate of
    12% of pretax income. Our net deferred tax asset totaled
    $4.6 million at December 31, 2006, net of a valuation
    allowance of $2.8 million.
    
    32
 
    For 2005, we accrued income tax using an effective tax rate of
    2.5% of pretax income. Our net deferred tax asset totaled zero
    at December 31, 2005, net of a $15.0 million valuation
    allowance.
 
    Liquidity
    and Capital Resources
 
    At December 31, 2007, we had $140.7 million in cash,
    cash equivalents, and investments compared to
    $103.0 million at December 31, 2006. During fiscal
    2007, cash and cash equivalents decreased by $11.8 million,
    due to the net purchase of investments and fixed assets, and the
    acquisitions of the assets and certain liabilities of DeltaNu,
    LLC and Creative Display Systems, LLC, partially offset by the
    cash provided by operating and financing activities.
 
    Cash provided by operating activities in 2007 totaled
    $40.5 million compared to $55.2 million in 2006. The
    decrease in cash provided from operating activities was due
    primarily to the reduction in net income in 2007, adjusted to
    exclude the effect of non-cash charges including depreciation
    and equity-based compensation, and to decreases in accounts
    payable and customer advances, partially offset by decreases in
    accounts receivable and inventory. Accounts receivable totaled
    $14.1 million at December 31, 2007 compared to
    $40.0 million at December 31, 2006. The decrease of
    $25.8 million in the receivable balance was due primarily
    to the reduction in revenue in the second half of 2007 as
    compared to 2006. Net inventories decreased by
    $15.8 million during 2007 due primarily to decreases in
    both raw materials and
    work-in-progress.
    The higher level of net inventory at December 31, 2006 was
    used to support the twenty-four systems in backlog at that time.
    Accounts payable totaled $7.7 million at December 31,
    2007 compared to $16.0 million at December 31, 2006.
    The decrease of $8.3 million relates to the decrease in
    inventory purchases and a slowdown in our business. Accrued
    payroll and related liabilities decreased by $3.2 million
    during 2007 due to a decrease in accruals for bonuses and
    employee profit-sharing. Other accrued liabilities totaled
    $5.5 million at December 31, 2007 compared to
    $6.6 million at December 31, 2006. The decrease of
    $1.2 million relates primarily to reductions in accruals
    for our warranty and tax obligations. Customer advances
    decreased by $21.9 million during 2007. The decrease was
    driven by the reduction in backlog at December 31, 2007.
 
    Investing activities in 2007 used cash of $59.2 million.
    Purchases of investments, net of proceeds from sales and
    maturities, totaled $49.2 million, and capital expenditures
    in 2007 totaled $5.7 million. During 2007, we invested
    $6.7 million in the acquisitions of DeltaNu, LLC and
    Creative Display Systems, LLC, and we sold our investment in 601
    California Avenue LLC. Our investing activities in 2006 used
    cash of $37.3 million as the result of the
    $28.9 million net purchase of investments and
    $8.4 million in capital expenditures.
 
    Financing activities provided cash of $6.9 million in 2007.
    The sale of Intevac common stock to our employees through our
    employee benefit plans provided $3.9 million and we
    realized tax benefits of $3.0 million from equity-based
    compensation. Financing activities provided cash of
    $6.2 million in 2006 due to the sale of Intevac common
    stock to our employees through our employee benefit plans and
    tax benefits from equity-based compensation.
 
    We issued $4.0 million in notes payable related to the
    acquisition of DeltaNu, LLC, which are discounted to
    $3.9 million on the accompanying Consolidated Balance
    Sheet. $2 million of the notes are scheduled to be repaid
    on each of January 31, 2008 and 2009.
 
    We have generated operating income for the last three years,
    after incurring annual operating losses from 1998 through 2004.
    We currently expect to incur a slight operating loss in 2008.
 
    We believe that our existing cash, cash equivalents and
    short-term investments will be sufficient to meet our cash
    requirements for the foreseeable future. We intend to undertake
    approximately $8 million in capital expenditures during the
    next 12 months.
    
    33
 
    Contractual
    Obligations
 
    In the normal course of business, we enter into various
    contractual obligations that will be settled in cash. These
    obligations consist primarily of operating lease and purchase
    orders placed in the normal course of business. The expected
    future cash flows required to meet these obligations as of
    December 31, 2007 are shown in the table below. More
    information on the operating lease obligations is available in
    Part II, Item 8, Financial Statements and
    Supplementary Data.
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    Payments Due by Period
 | 
 
 | 
| 
 
 | 
 
 | 
    Total
 | 
 
 | 
 
 | 
    < 1 Year
 | 
 
 | 
 
 | 
    1-3 Years
 | 
 
 | 
 
 | 
    3-5 Years
 | 
 
 | 
 
 | 
    > 5 Years
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    Operating lease obligations
 
 | 
 
 | 
    $
 | 
    10,530
 | 
 
 | 
 
 | 
    $
 | 
    2,534
 | 
 
 | 
 
 | 
    $
 | 
    4,906
 | 
 
 | 
 
 | 
    $
 | 
    3,054
 | 
 
 | 
 
 | 
    $
 | 
    36
 | 
 
 | 
| 
 
    Purchase obligations
 
 | 
 
 | 
 
 | 
    9,392
 | 
 
 | 
 
 | 
 
 | 
    9,392
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total
 
 | 
 
 | 
    $
 | 
    19,922
 | 
 
 | 
 
 | 
    $
 | 
    11,926
 | 
 
 | 
 
 | 
    $
 | 
    4,906
 | 
 
 | 
 
 | 
    $
 | 
    3,054
 | 
 
 | 
 
 | 
    $
 | 
    36
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    Off-Balance
    Sheet Arrangements
 
    As of December 31, 2007, we did not have any material
    off-balance sheet arrangements (as defined in
    Item 303(a)(4)(ii) of
    Regulation S-K).
 
     | 
     | 
    | 
    Item 7A.  
 | 
    
    Quantitative
    and Qualitative Disclosures About Market Risk
 | 
 
    Interest rate risk.  Our exposure to market
    risk for changes in interest rates relates primarily to our
    investment portfolio. We do not use derivative financial
    instruments in our investment portfolio. We place our
    investments with high quality credit issuers and, by policy,
    limit the amount of credit exposure to any one issuer.
    Short-term investments typically consist of investments in A1/P1
    rated commercial paper, auction rate securities and debt
    instruments issued by the U.S. government and its agencies.
 
    The table below presents principal amounts and related
    weighted-average interest rates by year of maturity for our
    investment portfolio at December 31, 2007.
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    Fair 
    
 | 
 
 | 
| 
 
 | 
 
 | 
    2008
 | 
 
 | 
 
 | 
    2009
 | 
 
 | 
 
 | 
    2010
 | 
 
 | 
 
 | 
    Beyond
 | 
 
 | 
 
 | 
    Total
 | 
 
 | 
 
 | 
    Value
 | 
 
 | 
|  
 | 
| 
 
    Cash equivalents
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Fixed rate amounts
 
 | 
 
 | 
    $
 | 
    7,750
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    7,750
 | 
 
 | 
 
 | 
    $
 | 
    7,750
 | 
 
 | 
| 
 
    Weighted-average rate
 
 | 
 
 | 
 
 | 
    4.28
 | 
    %
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Variable rate amounts
 
 | 
 
 | 
    $
 | 
    7,973
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    $
 | 
    7,973
 | 
 
 | 
 
 | 
    $
 | 
    7,976
 | 
 
 | 
| 
 
    Weighted-average rate
 
 | 
 
 | 
 
 | 
    4.82
 | 
    %
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Short-term investments
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Fixed rate amounts
 
 | 
 
 | 
    $
 | 
    110,985
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    110,985
 | 
 
 | 
 
 | 
    $
 | 
    111,019
 | 
 
 | 
| 
 
    Weighted-average rate
 
 | 
 
 | 
 
 | 
    5.53
 | 
    %
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Long-term investments
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Fixed rate amounts
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    2,009
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    2,009
 | 
 
 | 
 
 | 
    $
 | 
    2,010
 | 
 
 | 
| 
 
    Weighted-average rate
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    4.43
 | 
    %
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total investment portfolio
 
 | 
 
 | 
    $
 | 
    126,708
 | 
 
 | 
 
 | 
    $
 | 
    2,009
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    128,717
 | 
 
 | 
 
 | 
    $
 | 
    128,755
 | 
 
 | 
 
    Due to the short-term nature of the substantial portion of our
    investments, we believe that we do not have any material
    exposure to changes in the fair value of our investment
    portfolio as a result of changes in interest rates. Refer to
    footnote 13 of Notes To Consolidated Financial Statements for
    current issues around our investments in Auction Rate Securities.
 
    Foreign exchange risk.  From time to time, we
    enter into foreign currency forward exchange contracts to
    economically hedge certain of our anticipated foreign currency
    transaction, translation and re-measurement exposures. The
    objective of these contracts is to minimize the impact of
    foreign currency exchange rate movements on our operating
    results. We had no foreign currency forward exchange contracts
    during any of the years ended December 31, 2007, 2006 and
    2005.
    
    34
 
 
     | 
     | 
    | 
    Item 8.  
 | 
    
    Financial
    Statements and Supplementary Data
 | 
 
    INTEVAC,
    INC.
 
    CONSOLIDATED FINANCIAL STATEMENTS
    Contents
 
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    Page
 | 
|  
 | 
| 
 
    Report of Independent Registered Public Accounting Firm
 
 | 
 
 | 
 
 | 
    36
 | 
 
 | 
| 
 
    Consolidated Balance Sheets
 
 | 
 
 | 
 
 | 
    37
 | 
 
 | 
| 
 
    Consolidated Statements of Income and Comprehensive Income
 
 | 
 
 | 
 
 | 
    38
 | 
 
 | 
| 
 
    Consolidated Statement of Stockholders Equity
 
 | 
 
 | 
 
 | 
    39
 | 
 
 | 
| 
 
    Consolidated Statements of Cash Flows
 
 | 
 
 | 
 
 | 
    40
 | 
 
 | 
| 
 
    Notes to Consolidated Financial Statements
 
 | 
 
 | 
 
 | 
    41
 | 
 
 | 
    
    35
 
 
    REPORT OF
    INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
    Board of Directors and Stockholders
    Intevac, Inc.
 
    We have audited the accompanying balance sheets of Intevac, Inc.
    (a Delaware corporation) and subsidiaries (collectively, the
    Company) as of December 31, 2007 and 2006, and
    the related consolidated statements of income and comprehensive
    income, stockholders equity, and cash flows for each of
    the three years in the period ended December 31, 2007.
    These financial statements are the responsibility of the
    Companys management. Our responsibility is to express an
    opinion on these financial statements based on our audits.
 
    We conducted our audits in accordance with the standards of the
    Public Company Accounting Oversight Board (United States). Those
    standards require that we plan and perform the audit to obtain
    reasonable assurance about whether the financial statements are
    free of material misstatement. An audit includes examining, on a
    test basis, evidence supporting the amounts and disclosures in
    the financial statements. An audit also includes assessing the
    accounting principles used and significant estimates made by
    management, as well as evaluating the overall financial
    statement presentation. We believe that our audits provide a
    reasonable basis for our opinion.
 
    In our opinion, the consolidated financial statements referred
    to above present fairly, in all material respects, the financial
    position of Intevac, Inc. as of December 31, 2007 and 2006,
    and the results of their operations and their cash flows for
    each of the three years in the period ended December 31,
    2007 in conformity with accounting principles generally accepted
    in the United States of America.
 
    Our audits were conducted for the purpose of forming an opinion
    on the basic consolidated financial statements taken as a whole.
    The Schedule II is presented for purposes of additional
    analysis and is not a required part of the basic financial
    statements. This schedule has been subjected to the auditing
    procedures applied in the audit of the basic financial
    statements and, in our opinion, is fairly stated in all material
    respects in relation to the basic financial statements taken as
    a whole.
 
    As discussed in Note 10 to the consolidated financial
    statements, effective January 1, 2007, the Company adopted
    the provisions of Financial Accounting Standards Board
    Interpretation No. 48, Accounting for Uncertainty in Income
    Taxes.
 
    We also have audited, in accordance with the standards of the
    Public Company Accounting Oversight Board (United States),
    Intevac, Inc.s internal control over financial reporting
    as of December 31, 2007, based on criteria established in
    Internal Control  Integrated Framework issued
    by the Committee of Sponsoring Organizations of the Treadway
    Commission (COSO) and our report dated March 14, 2008,
    expressed an unqualified opinion on the effective operation of
    internal control over financial reporting.
 
 
    San Jose, California
    March 14, 2008
    
    36
 
    INTEVAC,
    INC.
 
    CONSOLIDATED
    BALANCE SHEETS
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    December 31,
 | 
 
 | 
| 
 
 | 
 
 | 
    2007
 | 
 
 | 
 
 | 
    2006
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    ASSETS
 
 | 
| 
 
    Current assets:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Cash and cash equivalents
 
 | 
 
 | 
    $
 | 
    27,673
 | 
 
 | 
 
 | 
    $
 | 
    39,440
 | 
 
 | 
| 
 
    Short-term investments
 
 | 
 
 | 
 
 | 
    110,985
 | 
 
 | 
 
 | 
 
 | 
    55,595
 | 
 
 | 
| 
 
    Trade and other accounts receivable, net of allowances of $57
    and $143 at December 31, 2007 and 2006, respectively
 
 | 
 
 | 
 
 | 
    14,142
 | 
 
 | 
 
 | 
 
 | 
    39,927
 | 
 
 | 
| 
 
    Inventories, including $2,276 and $5,765 held at customer
    locations at December 31, 2007 and 2006, respectively
 
 | 
 
 | 
 
 | 
    22,133
 | 
 
 | 
 
 | 
 
 | 
    37,942
 | 
 
 | 
| 
 
    Prepaid expenses and other current assets
 
 | 
 
 | 
 
 | 
    4,162
 | 
 
 | 
 
 | 
 
 | 
    2,506
 | 
 
 | 
| 
 
    Deferred tax assets
 
 | 
 
 | 
 
 | 
    3,609
 | 
 
 | 
 
 | 
 
 | 
    3,269
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total current assets
 
 | 
 
 | 
 
 | 
    182,704
 | 
 
 | 
 
 | 
 
 | 
    178,679
 | 
 
 | 
| 
 
    Property, plant and equipment, at cost:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Leasehold improvements
 
 | 
 
 | 
 
 | 
    12,631
 | 
 
 | 
 
 | 
 
 | 
    11,062
 | 
 
 | 
| 
 
    Machinery and equipment
 
 | 
 
 | 
 
 | 
    27,185
 | 
 
 | 
 
 | 
 
 | 
    23,926
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
    39,816
 | 
 
 | 
 
 | 
 
 | 
    34,988
 | 
 
 | 
| 
 
    Less accumulated depreciation and amortization
 
 | 
 
 | 
 
 | 
    24,414
 | 
 
 | 
 
 | 
 
 | 
    21,442
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
    15,402
 | 
 
 | 
 
 | 
 
 | 
    13,546
 | 
 
 | 
| 
 
    Long-term investments
 
 | 
 
 | 
 
 | 
    2,009
 | 
 
 | 
 
 | 
 
 | 
    8,000
 | 
 
 | 
| 
 
    Investment in 601 California Avenue LLC
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    2,431
 | 
 
 | 
| 
 
    Goodwill
 
 | 
 
 | 
 
 | 
    7,905
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
    Other intangible assets, net of amortization of $218
 
 | 
 
 | 
 
 | 
    1,805
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
    Deferred income taxes and other long term assets
 
 | 
 
 | 
 
 | 
    5,588
 | 
 
 | 
 
 | 
 
 | 
    3,347
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total assets
 
 | 
 
 | 
    $
 | 
    215,413
 | 
 
 | 
 
 | 
    $
 | 
    206,003
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
 | 
| 
    LIABILITIES AND STOCKHOLDERS EQUITY
 | 
| 
 
    Current liabilities:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Notes payable
 
 | 
 
 | 
    $
 | 
    1,992
 | 
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
| 
 
    Accounts payable
 
 | 
 
 | 
 
 | 
    7,678
 | 
 
 | 
 
 | 
 
 | 
    15,994
 | 
 
 | 
| 
 
    Accrued payroll and related liabilities
 
 | 
 
 | 
 
 | 
    8,610
 | 
 
 | 
 
 | 
 
 | 
    11,769
 | 
 
 | 
| 
 
    Other accrued liabilities
 
 | 
 
 | 
 
 | 
    5,454
 | 
 
 | 
 
 | 
 
 | 
    6,612
 | 
 
 | 
| 
 
    Customer advances
 
 | 
 
 | 
 
 | 
    4,340
 | 
 
 | 
 
 | 
 
 | 
    26,243
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total current liabilities
 
 | 
 
 | 
 
 | 
    28,074
 | 
 
 | 
 
 | 
 
 | 
    60,618
 | 
 
 | 
| 
 
    Other long-term liabilities
 
 | 
 
 | 
 
 | 
    278
 | 
 
 | 
 
 | 
 
 | 
    1,075
 | 
 
 | 
| 
 
    Long-term notes payable
 
 | 
 
 | 
 
 | 
    1,898
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
    Stockholders equity:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Undesignated preferred stock, $0.001 par value,
    10,000 shares authorized, no shares issued and outstanding
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
    Common stock, $0.001 par value at December 31, 2007
    and no par value at December 31, 2006:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Authorized shares  50,000
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Issued and outstanding shares  21,591 and 21,188 at
    December 31, 2007 and 2006, respectively
 
 | 
 
 | 
 
 | 
    22
 | 
 
 | 
 
 | 
 
 | 
    99,468
 | 
 
 | 
| 
 
    Additional
    paid-in-capital
 
 | 
 
 | 
 
 | 
    120,056
 | 
 
 | 
 
 | 
 
 | 
    7,319
 | 
 
 | 
| 
 
    Accumulated other comprehensive income
 
 | 
 
 | 
 
 | 
    571
 | 
 
 | 
 
 | 
 
 | 
    354
 | 
 
 | 
| 
 
    Retained earnings
 
 | 
 
 | 
 
 | 
    64,514
 | 
 
 | 
 
 | 
 
 | 
    37,169
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total stockholders equity
 
 | 
 
 | 
 
 | 
    185,163
 | 
 
 | 
 
 | 
 
 | 
    144,310
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total liabilities and stockholders equity
 
 | 
 
 | 
    $
 | 
    215,413
 | 
 
 | 
 
 | 
    $
 | 
    206,003
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    See accompanying notes.
    
    37
 
    INTEVAC,
    INC.
 
    CONSOLIDATED
    STATEMENTS OF INCOME AND COMPREHENSIVE INCOME
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    Years Ended December 31,
 | 
 
 | 
| 
 
 | 
 
 | 
    2007
 | 
 
 | 
 
 | 
    2006
 | 
 
 | 
 
 | 
    2005
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands, except per share amounts)
 | 
 
 | 
|  
 | 
| 
 
    Net revenues:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Systems and components
 
 | 
 
 | 
    $
 | 
    202,292
 | 
 
 | 
 
 | 
    $
 | 
    250,158
 | 
 
 | 
 
 | 
    $
 | 
    130,168
 | 
 
 | 
| 
 
    Technology development
 
 | 
 
 | 
 
 | 
    13,542
 | 
 
 | 
 
 | 
 
 | 
    9,717
 | 
 
 | 
 
 | 
 
 | 
    7,061
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total net revenues
 
 | 
 
 | 
 
 | 
    215,834
 | 
 
 | 
 
 | 
 
 | 
    259,875
 | 
 
 | 
 
 | 
 
 | 
    137,229
 | 
 
 | 
| 
 
    Cost of net revenues:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Systems and components
 
 | 
 
 | 
 
 | 
    111,514
 | 
 
 | 
 
 | 
 
 | 
    151,287
 | 
 
 | 
 
 | 
 
 | 
    87,525
 | 
 
 | 
| 
 
    Technology development
 
 | 
 
 | 
 
 | 
    7,415
 | 
 
 | 
 
 | 
 
 | 
    6,102
 | 
 
 | 
 
 | 
 
 | 
    5,253
 | 
 
 | 
| 
 
    Inventory provisions
 
 | 
 
 | 
 
 | 
    862
 | 
 
 | 
 
 | 
 
 | 
    1,527
 | 
 
 | 
 
 | 
 
 | 
    873
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total cost of net revenues
 
 | 
 
 | 
 
 | 
    119,791
 | 
 
 | 
 
 | 
 
 | 
    158,916
 | 
 
 | 
 
 | 
 
 | 
    93,651
 | 
 
 | 
| 
 
    Gross profit
 
 | 
 
 | 
 
 | 
    96,043
 | 
 
 | 
 
 | 
 
 | 
    100,959
 | 
 
 | 
 
 | 
 
 | 
    43,578
 | 
 
 | 
| 
 
    Operating expenses:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Research and development
 
 | 
 
 | 
 
 | 
    40,137
 | 
 
 | 
 
 | 
 
 | 
    30,036
 | 
 
 | 
 
 | 
 
 | 
    14,384
 | 
 
 | 
| 
 
    Selling, general and administrative
 
 | 
 
 | 
 
 | 
    28,470
 | 
 
 | 
 
 | 
 
 | 
    22,924
 | 
 
 | 
 
 | 
 
 | 
    14,477
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total operating expenses
 
 | 
 
 | 
 
 | 
    68,607
 | 
 
 | 
 
 | 
 
 | 
    52,960
 | 
 
 | 
 
 | 
 
 | 
    28,861
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Operating income
 
 | 
 
 | 
 
 | 
    27,436
 | 
 
 | 
 
 | 
 
 | 
    47,999
 | 
 
 | 
 
 | 
 
 | 
    14,717
 | 
 
 | 
| 
 
    Interest income
 
 | 
 
 | 
 
 | 
    6,544
 | 
 
 | 
 
 | 
 
 | 
    3,501
 | 
 
 | 
 
 | 
 
 | 
    1,303
 | 
 
 | 
| 
 
    Other income
 
 | 
 
 | 
 
 | 
    1,598
 | 
 
 | 
 
 | 
 
 | 
    277
 | 
 
 | 
 
 | 
 
 | 
    552
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Income before income taxes
 
 | 
 
 | 
 
 | 
    35,578
 | 
 
 | 
 
 | 
 
 | 
    51,777
 | 
 
 | 
 
 | 
 
 | 
    16,572
 | 
 
 | 
| 
 
    Provision for income taxes
 
 | 
 
 | 
 
 | 
    8,233
 | 
 
 | 
 
 | 
 
 | 
    5,079
 | 
 
 | 
 
 | 
 
 | 
    421
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Net income
 
 | 
 
 | 
    $
 | 
    27,345
 | 
 
 | 
 
 | 
    $
 | 
    46,698
 | 
 
 | 
 
 | 
    $
 | 
    16,151
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Other comprehensive income, net of income taxes:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Foreign currency translation adjustments
 
 | 
 
 | 
 
 | 
    217
 | 
 
 | 
 
 | 
 
 | 
    116
 | 
 
 | 
 
 | 
 
 | 
    (15
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total comprehensive income
 
 | 
 
 | 
    $
 | 
    27,562
 | 
 
 | 
 
 | 
    $
 | 
    46,814
 | 
 
 | 
 
 | 
    $
 | 
    16,136
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Basic income per share:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Net income
 
 | 
 
 | 
    $
 | 
    1.28
 | 
 
 | 
 
 | 
    $
 | 
    2.22
 | 
 
 | 
 
 | 
    $
 | 
    0.79
 | 
 
 | 
| 
 
    Shares used in per share amounts
 
 | 
 
 | 
 
 | 
    21,447
 | 
 
 | 
 
 | 
 
 | 
    21,015
 | 
 
 | 
 
 | 
 
 | 
    20,462
 | 
 
 | 
| 
 
    Diluted income per share:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Net income
 
 | 
 
 | 
    $
 | 
    1.23
 | 
 
 | 
 
 | 
    $
 | 
    2.13
 | 
 
 | 
 
 | 
    $
 | 
    0.76
 | 
 
 | 
| 
 
    Shares used in per share amounts
 
 | 
 
 | 
 
 | 
    22,150
 | 
 
 | 
 
 | 
 
 | 
    21,936
 | 
 
 | 
 
 | 
 
 | 
    21,202
 | 
 
 | 
 
    See accompanying notes.
    
    38
 
    INTEVAC,
    INC.
 
    CONSOLIDATED
    STATEMENT OF STOCKHOLDERS EQUITY
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    Accumulated 
    
 | 
 
 | 
 
 | 
    Retained 
    
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    Additional 
    
 | 
 
 | 
 
 | 
    Other 
    
 | 
 
 | 
 
 | 
    Earnings 
    
 | 
 
 | 
 
 | 
    Total 
    
 | 
 
 | 
| 
 
 | 
 
 | 
    Common Stock
 | 
 
 | 
 
 | 
    Paid-In 
    
 | 
 
 | 
 
 | 
    Comprehensive 
    
 | 
 
 | 
 
 | 
    (Accumulated 
    
 | 
 
 | 
 
 | 
    Stockholders 
    
 | 
 
 | 
| 
 
 | 
 
 | 
    Shares
 | 
 
 | 
 
 | 
    Amount
 | 
 
 | 
 
 | 
    Capital
 | 
 
 | 
 
 | 
    Income
 | 
 
 | 
 
 | 
    Deficit)
 | 
 
 | 
 
 | 
    Equity
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    Balance at December 31, 2004
 
 | 
 
 | 
 
 | 
    20,182
 | 
 
 | 
 
 | 
    $
 | 
    93,634
 | 
 
 | 
 
 | 
    $
 | 
    1,168
 | 
 
 | 
 
 | 
    $
 | 
    253
 | 
 
 | 
 
 | 
    $
 | 
    (25,680
 | 
    )
 | 
 
 | 
    $
 | 
    69,375
 | 
 
 | 
| 
 
    Shares issued in connection with:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Exercise of stock options
 
 | 
 
 | 
 
 | 
    358
 | 
 
 | 
 
 | 
 
 | 
    1,856
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    1,856
 | 
 
 | 
| 
 
    Employee stock purchase plan
 
 | 
 
 | 
 
 | 
    129
 | 
 
 | 
 
 | 
 
 | 
    488
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    488
 | 
 
 | 
| 
 
    Compensation expense in form of stock options
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    19
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    19
 | 
 
 | 
| 
 
    Foreign currency translation adjustment
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    (15
 | 
    )
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    (15
 | 
    )
 | 
| 
 
    Net income
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    16,151
 | 
 
 | 
 
 | 
 
 | 
    16,151
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Balance at December 31, 2005
 
 | 
 
 | 
 
 | 
    20,669
 | 
 
 | 
 
 | 
    $
 | 
    95,978
 | 
 
 | 
 
 | 
    $
 | 
    1,187
 | 
 
 | 
 
 | 
    $
 | 
    238
 | 
 
 | 
 
 | 
    $
 | 
    (9,529
 | 
    )
 | 
 
 | 
    $
 | 
    87,874
 | 
 
 | 
| 
 
    Shares issued in connection with:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Exercise of stock options
 
 | 
 
 | 
 
 | 
    360
 | 
 
 | 
 
 | 
 
 | 
    2,666
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    2,666
 | 
 
 | 
| 
 
    Employee stock purchase plan
 
 | 
 
 | 
 
 | 
    159
 | 
 
 | 
 
 | 
 
 | 
    824
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    824
 | 
 
 | 
| 
 
    Income tax benefits realized from activity in employee stock
    plans
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    2,707
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    2,707
 | 
 
 | 
| 
 
    Stock-based compensation expense
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    3,425
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    3,425
 | 
 
 | 
| 
 
    Foreign currency translation adjustment
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    116
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    116
 | 
 
 | 
| 
 
    Net income
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    46,698
 | 
 
 | 
 
 | 
 
 | 
    46,698
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Balance at December 31, 2006
 
 | 
 
 | 
 
 | 
    21,188
 | 
 
 | 
 
 | 
    $
 | 
    99,468
 | 
 
 | 
 
 | 
    $
 | 
    7,319
 | 
 
 | 
 
 | 
    $
 | 
    354
 | 
 
 | 
 
 | 
    $
 | 
    37,169
 | 
 
 | 
 
 | 
    $
 | 
    144,310
 | 
 
 | 
| 
 
    Shares issued in connection with:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Exercise of stock options
 
 | 
 
 | 
 
 | 
    313
 | 
 
 | 
 
 | 
 
 | 
    2,141
 | 
 
 | 
 
 | 
 
 | 
    353
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    2,494
 | 
 
 | 
| 
 
    Employee stock purchase plan
 
 | 
 
 | 
 
 | 
    90
 | 
 
 | 
 
 | 
 
 | 
    671
 | 
 
 | 
 
 | 
 
 | 
    704
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    1,375
 | 
 
 | 
| 
 
    Reclassification of par value for
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Delaware reincorporation
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    (102,258
 | 
    )
 | 
 
 | 
 
 | 
    102,258
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
    Income tax benefits realized from activity in employee stock
    plans
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    3,009
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    3,009
 | 
 
 | 
| 
 
    Stock-based compensation expense
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    6,379
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    6,379
 | 
 
 | 
| 
 
    Foreign currency translation adjustment
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    34
 | 
 
 | 
 
 | 
 
 | 
    217
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    251
 | 
 
 | 
| 
 
    Net income
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    27,345
 | 
 
 | 
 
 | 
 
 | 
    27,345
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Balance at December 31, 2007
 
 | 
 
 | 
 
 | 
    21,591
 | 
 
 | 
 
 | 
    $
 | 
    22
 | 
 
 | 
 
 | 
    $
 | 
    120,056
 | 
 
 | 
 
 | 
    $
 | 
    571
 | 
 
 | 
 
 | 
    $
 | 
    64,514
 | 
 
 | 
 
 | 
    $
 | 
    185,163
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    See accompanying notes.
    
    39
 
    INTEVAC,
    INC.
 
    CONSOLIDATED
    STATEMENTS OF CASH FLOWS
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    Years Ended December 31,
 | 
 
 | 
| 
 
 | 
 
 | 
    2007
 | 
 
 | 
 
 | 
    2006
 | 
 
 | 
 
 | 
    2005
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    Operating activities
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Net income
 
 | 
 
 | 
    $
 | 
    27,345
 | 
 
 | 
 
 | 
    $
 | 
    46,698
 | 
 
 | 
 
 | 
    $
 | 
    16,151
 | 
 
 | 
| 
 
    Adjustments to reconcile net income to net cash and cash
    equivalents provided by operating activities:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Depreciation & amortization
 
 | 
 
 | 
 
 | 
    4,203
 | 
 
 | 
 
 | 
 
 | 
    2,846
 | 
 
 | 
 
 | 
 
 | 
    2,150
 | 
 
 | 
| 
 
    Net accretion of investment premiums and discounts
 
 | 
 
 | 
 
 | 
    (175
 | 
    )
 | 
 
 | 
 
 | 
    (264
 | 
    )
 | 
 
 | 
 
 | 
    (55
 | 
    )
 | 
| 
 
    Amortization of intangible assets
 
 | 
 
 | 
 
 | 
    218
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
    Inventory provisions
 
 | 
 
 | 
 
 | 
    862
 | 
 
 | 
 
 | 
 
 | 
    1,527
 | 
 
 | 
 
 | 
 
 | 
    873
 | 
 
 | 
| 
 
    Equity-based compensation
 
 | 
 
 | 
 
 | 
    6,379
 | 
 
 | 
 
 | 
 
 | 
    3,425
 | 
 
 | 
 
 | 
 
 | 
    19
 | 
 
 | 
| 
 
    Deferred income taxes
 
 | 
 
 | 
 
 | 
    (1,654
 | 
    )
 | 
 
 | 
 
 | 
    (4,581
 | 
    )
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
    Tax benefit from equity-based compensation
 
 | 
 
 | 
 
 | 
    (3,009
 | 
    )
 | 
 
 | 
 
 | 
    (2,707
 | 
    )
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
    Loss on disposal of equipment
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    39
 | 
 
 | 
 
 | 
 
 | 
    4
 | 
 
 | 
| 
 
    Changes in assets and liabilities:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Accounts receivable
 
 | 
 
 | 
 
 | 
    26,687
 | 
 
 | 
 
 | 
 
 | 
    2,928
 | 
 
 | 
 
 | 
 
 | 
    (38,081
 | 
    )
 | 
| 
 
    Inventory
 
 | 
 
 | 
 
 | 
    15,686
 | 
 
 | 
 
 | 
 
 | 
    (14,590
 | 
    )
 | 
 
 | 
 
 | 
    (10,354
 | 
    )
 | 
| 
 
    Prepaid expenses and other assets
 
 | 
 
 | 
 
 | 
    (2,537
 | 
    )
 | 
 
 | 
 
 | 
    (1,903
 | 
    )
 | 
 
 | 
 
 | 
    (1,661
 | 
    )
 | 
| 
 
    Accounts payable
 
 | 
 
 | 
 
 | 
    (8,841
 | 
    )
 | 
 
 | 
 
 | 
    8,904
 | 
 
 | 
 
 | 
 
 | 
    5,402
 | 
 
 | 
| 
 
    Accrued payroll and other accrued liabilities
 
 | 
 
 | 
 
 | 
    (2,673
 | 
    )
 | 
 
 | 
 
 | 
    9,762
 | 
 
 | 
 
 | 
 
 | 
    7,645
 | 
 
 | 
| 
 
    Customer advances
 
 | 
 
 | 
 
 | 
    (22,027
 | 
    )
 | 
 
 | 
 
 | 
    3,107
 | 
 
 | 
 
 | 
 
 | 
    19,303
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total adjustments
 
 | 
 
 | 
 
 | 
    13,119
 | 
 
 | 
 
 | 
 
 | 
    8,493
 | 
 
 | 
 
 | 
 
 | 
    (14,755
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Net cash and cash equivalents provided by operating activities
 
 | 
 
 | 
 
 | 
    40,464
 | 
 
 | 
 
 | 
 
 | 
    55,191
 | 
 
 | 
 
 | 
 
 | 
    1,396
 | 
 
 | 
| 
 
    Investing activities
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Purchase of investments
 
 | 
 
 | 
 
 | 
    (175,624
 | 
    )
 | 
 
 | 
 
 | 
    (152,280
 | 
    )
 | 
 
 | 
 
 | 
    (100,140
 | 
    )
 | 
| 
 
    Proceeds from sales and maturities of investments
 
 | 
 
 | 
 
 | 
    126,400
 | 
 
 | 
 
 | 
 
 | 
    123,425
 | 
 
 | 
 
 | 
 
 | 
    98,350
 | 
 
 | 
| 
 
    Sale of investment in 601 California Avenue LLC
 
 | 
 
 | 
 
 | 
    2,431
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
    Acquisition of DeltaNu, LLC, net of cash acquired
 
 | 
 
 | 
 
 | 
    (1,913
 | 
    )
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
    Acquisition of Creative Display Systems, LLC, net of cash
    acquired
 
 | 
 
 | 
 
 | 
    (4,782
 | 
    )
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
    Purchase of equipment
 
 | 
 
 | 
 
 | 
    (5,735
 | 
    )
 | 
 
 | 
 
 | 
    (8,423
 | 
    )
 | 
 
 | 
 
 | 
    (4,140
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Net cash and cash equivalents used in investing activities
 
 | 
 
 | 
 
 | 
    (59,223
 | 
    )
 | 
 
 | 
 
 | 
    (37,278
 | 
    )
 | 
 
 | 
 
 | 
    (5,930
 | 
    )
 | 
| 
 
    Financing activities
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Proceeds from issuance of common stock
 
 | 
 
 | 
 
 | 
    3,869
 | 
 
 | 
 
 | 
 
 | 
    3,490
 | 
 
 | 
 
 | 
 
 | 
    2,344
 | 
 
 | 
| 
 
    Tax benefit from equity-based compensation plans
 
 | 
 
 | 
 
 | 
    3,009
 | 
 
 | 
 
 | 
 
 | 
    2,707
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Net cash and cash equivalents provided by financing activities
 
 | 
 
 | 
 
 | 
    6,878
 | 
 
 | 
 
 | 
 
 | 
    6,197
 | 
 
 | 
 
 | 
 
 | 
    2,344
 | 
 
 | 
| 
 
    Effect of exchange rate changes on cash
 
 | 
 
 | 
 
 | 
    114
 | 
 
 | 
 
 | 
 
 | 
    75
 | 
 
 | 
 
 | 
 
 | 
    (10
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Net increase (decrease) in cash and cash equivalents
 
 | 
 
 | 
 
 | 
    (11,767
 | 
    )
 | 
 
 | 
 
 | 
    24,185
 | 
 
 | 
 
 | 
 
 | 
    (2,200
 | 
    )
 | 
| 
 
    Cash and cash equivalents at beginning of period
 
 | 
 
 | 
 
 | 
    39,440
 | 
 
 | 
 
 | 
 
 | 
    15,255
 | 
 
 | 
 
 | 
 
 | 
    17,455
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Cash and cash equivalents at end of period
 
 | 
 
 | 
    $
 | 
    27,673
 | 
 
 | 
 
 | 
    $
 | 
    39,440
 | 
 
 | 
 
 | 
    $
 | 
    15,255
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Cash paid (received) for:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Income taxes
 
 | 
 
 | 
    $
 | 
    11,644
 | 
 
 | 
 
 | 
    $
 | 
    5,722
 | 
 
 | 
 
 | 
    $
 | 
    2
 | 
 
 | 
| 
 
    Income tax refund
 
 | 
 
 | 
 
 | 
    (259
 | 
    )
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
    Other non-cash changes:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Notes payable issued for the acquisition of DeltaNu, LLC
 
 | 
 
 | 
    $
 | 
    3,890
 | 
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
 
    See accompanying notes.
    
    40
 
    INTEVAC,
    INC.
 
    NOTES TO
    CONSOLIDATED FINANCIAL STATEMENTS
 
     | 
     | 
    | 
    1.  
 | 
    
    Business
    and Nature of Operations
 | 
 
    Intevacs business consists of two reportable segments:
 
    Equipment:  Intevac is a leader in the design,
    manufacture and marketing of high-productivity lean
    manufacturing systems and has been producing Lean
    Thinking platforms since 1994. We are the leading supplier
    of magnetic media sputtering equipment to the hard disk drive
    industry and offer leading-edge, high-productivity etch systems
    to the semiconductor industry.
 
    Imaging Instrumentation:  Intevac is a leader
    in the development of compact, cost-effective, high-sensitivity
    digital-optical products for the capture and display of
    low-light images and the optical analysis of materials. We
    provide sensors, cameras and systems for commercial applications
    in the inspection, medical, scientific and security industries
    and for government applications such as night vision and
    long-range target identification.
 
    The majority of our revenue is currently derived from our
    Equipment business, and we expect that the majority of our
    revenues for the next several years will continue to be derived
    from our Equipment business.
 
     | 
     | 
    | 
    2.  
 | 
    
    Summary
    of Significant Accounting Policies
 | 
 
    Basis
    of Presentation
 
    The consolidated financial statements include the accounts of
    Intevac and its wholly owned subsidiaries. All inter-company
    transactions and balances have been eliminated.
 
    Revenue
    Recognition
 
    We recognize revenue using guidance from SEC Staff Accounting
    Bulletin No. 104, Revenue Recognition. Our
    policy allows revenue recognition when persuasive evidence of an
    arrangement exists, delivery has occurred or services have been
    rendered, the price is fixed or determinable, and collectibility
    is reasonably assured.
 
    Certain of our system sales with customer acceptance provisions
    are accounted for as multiple-element arrangements. If we have
    previously met defined customer acceptance levels with the
    specific type of system, then we recognize revenue for the fair
    market value of the system upon shipment and transfer of title,
    and recognize revenue for the fair market value of installation
    and acceptance services when those services are completed. We
    estimate the fair market value of installation and acceptance
    services based on our actual historical experience of the
    relative cost of such installation and acceptance services.. For
    systems that have generally not been demonstrated to meet
    product specifications prior to shipment, revenue recognition is
    usually deferred until customer acceptance. In the event that
    our customer chooses not to complete installation and
    acceptance, and our obligations under the contract to complete
    installation, acceptance or any other tasks, with the exception
    of warranty obligations, have been fully discharged, then we
    recognize any remaining revenue to the extent that
    collectibility under the contract is reasonably assured.
 
    Accounting Treatment for Systems.  During the
    period that a system is undergoing customer acceptance (either
    distributor or end user), the value of the system remains in
    inventory, and any payments received, or amounts invoiced,
    related to the system are included in customer advances. When
    revenue is recognized on the system, the inventory is charged to
    cost of net revenues, the customer advance is liquidated, and
    the customer is billed for the unpaid balance of the system
    revenue.
 
    In some instances, hardware that is not essential to the
    functioning of the system may be delivered after acceptance of
    the system. In these cases, we estimate the fair market value of
    the non-essential hardware as if it had been sold on a
    stand-alone basis, and defer recognizing revenue on that value
    until the hardware is delivered.
 
    Occasionally, we are asked by our customers to delay delivery of
    products that they have accepted, and to temporarily hold the
    product at our facility. To determine revenue recognition when
    the product is not immediately
    
    41
 
 
    INTEVAC,
    INC.
 
    NOTES TO CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    shipped to the customer, we apply the criteria outlined in the
    SEC Enforcement Release No. 108, which is consistent with
    APB Statement 4, paragraph 150. All of the criteria must be
    met in order for revenue to be recognized.
 
    Other Systems and Non-System Revenue
    Recognition.  Revenues for systems without
    installation and acceptance provisions, as well as revenues from
    technology upgrades, spare parts, consumables and products built
    by the Imaging Instrumentation business are recognized when
    title passes to our customer. In certain cases, technology
    upgrade sales are accounted for as multiple-element
    arrangements, usually split between delivery of the parts and
    installation on the customers systems. In these cases, we
    recognize revenue for the fair market value of the parts upon
    shipment and transfer of title, and recognize revenue for the
    fair market value of installation services when those services
    are completed. Service and maintenance contract revenue, which
    to date has been insignificant, is recognized ratably over
    applicable contract periods or as the service is performed.
 
    Obligations After Shipment.  Our shipping terms
    are generally FOB shipping point, but in some cases are FOB
    destination. For systems sold directly to the end user, our
    obligations remaining after shipment typically include
    installation, end user factory acceptance and warranty. For
    systems sold to distributors, typically the distributor assumes
    responsibility for installation and end user customer
    acceptance. In some cases, the distributor will assume some or
    all of the warranty liability. For products other than systems
    and system upgrades, warranty is the only obligation we have
    after shipment.
 
    In certain cases, we sell limited rights to our intellectual
    property. Revenue from the sale of any intellectual property
    license will generally be recognized at the inception of the
    license term.
 
    Technology Development Revenue Recognition.  We
    perform research and development work under various
    government-sponsored research contracts. Generally these
    contracts are best efforts cost-plus-fixed-fee
    (CPFF) contracts or firm fixed-price
    (FFP) contracts. On best efforts CPFF contracts we
    typically commit to perform certain research and development
    efforts up to an agreed upon amount. In connection with these
    contracts, we receive funding on an incremental basis up to a
    ceiling. On FFP contracts we typically commit to perform certain
    development and production efforts for a fixed price.
 
    Our CPFF contracts are accounted for under ARB No. 43,
    Chapter 11, Section A, which addresses
    Cost-Plus-Fixed-Fee Contracts. The contracts are all cost-type,
    with financial terms that are a mixture of fixed fee, no fee and
    cost sharing. Revenue on these contracts is recognized in
    accordance with contract terms, typically as costs are incurred.
    In the event that total cost incurred under a particular
    contract over-runs its agreed upon amount, we may be liable for
    the additional costs.
 
    Our FFP contracts are accounted for under
    SOP 81-1
    Accounting for Performance of Construction-Type and
    Certain Production-Type Contracts. Revenue on FFP
    contracts is generally recognized on the percentage-of-
    completion method based on costs incurred in relation to the
    total estimated costs. Provisions for estimated losses on FFP
    research contracts are recorded in the period in which such
    losses are determined.
 
    The deliverables under each CPFF or FFP contract range from
    providing reports to providing hardware. In the majority of the
    contracts there is no obligation for either party to continue
    the program once the funds have been expended. The efforts can
    be terminated at any time for convenience, in which case we
    would be reimbursed for our actual incurred costs, plus fee, if
    applicable, for the completed effort. We own the entire right,
    title and interest to each invention discovered under the
    contract, unless we specifically give up that right. The
    U.S. Government has a
    paid-up
    license to use any invention or intellectual property developed
    under government funded contracts for government purposes only.
    In addition, we have, from time to time, negotiated with third
    parties to fund a portion of our costs in return for granting
    them a joint interest in the technology rights developed
    pursuant to the contract.
 
    Trade
    Receivables and Doubtful Accounts
 
    We evaluate the collectibility of trade receivables on an
    ongoing basis and provide reserves against potential losses when
    appropriate. Management analyzes historical bad debts, customer
    concentrations, customer credit
    
    42
 
 
    INTEVAC,
    INC.
 
    NOTES TO CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    worthiness, changes in customer payment tendencies and current
    economic trends when evaluating the adequacy of the allowance
    for doubtful accounts. Customer accounts are written off against
    the allowance when the amount is deemed uncollectible.
 
    Included in trade receivables are unbilled receivables related
    to government contracts of $1.9 million and
    $1.0 million at December 31, 2007 and
    December 31, 2006, respectively, which includes $250,000
    and $313,000 of fee retention, respectively.
 
    Warranty
 
    We provide for the estimated cost of warranty when revenue is
    recognized. Our warranty is per contract terms and for our
    systems the warranty typically ranges between 12 and
    24 months from customer acceptance. For systems sold
    through our distributor, we offer a 3 month warranty. The
    remainder of any warranty period is the responsibility of the
    distributor. During this warranty period any defective
    non-consumable parts are replaced and installed at no charge to
    the customer. The warranty period on consumable parts is limited
    to their reasonable usable lives. We use estimated repair or
    replacement costs along with our historical warranty experience
    to determine our warranty obligation. We exercise judgment in
    determining the underlying estimates. We also provide for
    estimated retrofit costs, which typically relate to design
    changes or improvements we identify. On a
    case-by-case
    basis, we determine whether or not to retrofit systems in the
    field at no charge to the customer.
 
    On the Consolidated Balance Sheet, the short-term portion of the
    warranty provision is included in other accrued liabilities,
    while the long-term portion is included in other long-term
    liabilities. The expense associated with product warranties
    issued or adjusted is included in cost of net revenues on the
    Consolidated Statement of Income and Comprehensive Income.
 
    The following table displays the activity in the warranty
    provision account for 2007 and 2006:
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    2007
 | 
 
 | 
 
 | 
    2006
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    Beginning balance
 
 | 
 
 | 
    $
 | 
    5,283
 | 
 
 | 
 
 | 
    $
 | 
    3,399
 | 
 
 | 
| 
 
    Expenditures incurred under warranties
 
 | 
 
 | 
 
 | 
    (4,158
 | 
    )
 | 
 
 | 
 
 | 
    (3,695
 | 
    )
 | 
| 
 
    Accruals for product warranties issued during the reporting
    period
 
 | 
 
 | 
 
 | 
    2,137
 | 
 
 | 
 
 | 
 
 | 
    4,354
 | 
 
 | 
| 
 
    Adjustments to previously existing warranty accruals
 
 | 
 
 | 
 
 | 
    (170
 | 
    )
 | 
 
 | 
 
 | 
    1,225
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Ending balance
 
 | 
 
 | 
    $
 | 
    3,092
 | 
 
 | 
 
 | 
    $
 | 
    5,283
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    The following table displays the balance sheet classification of
    the warranty provision account at December 31, 2007 and
    2006:
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    December 31,
 | 
 
 | 
| 
 
 | 
 
 | 
    2007
 | 
 
 | 
 
 | 
    2006
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    Other accrued liabilities
 
 | 
 
 | 
    $
 | 
    2,814
 | 
 
 | 
 
 | 
    $
 | 
    4,208
 | 
 
 | 
| 
 
    Other long-term liabilities
 
 | 
 
 | 
 
 | 
    278
 | 
 
 | 
 
 | 
 
 | 
    1,075
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total warranty provision
 
 | 
 
 | 
    $
 | 
    3,092
 | 
 
 | 
 
 | 
    $
 | 
    5,283
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    Guarantees
 
    We have entered into agreements with customers and suppliers
    that include limited intellectual property indemnification
    obligations that are customary in the industry. These guarantees
    generally require us to compensate the other party for certain
    damages and costs incurred as a result of third party
    intellectual property claims arising from these transactions.
    The nature of the intellectual property indemnification
    obligations prevents us from making a reasonable estimate of the
    maximum potential amount we could be required to pay our
    customers and
    
    43
 
 
    INTEVAC,
    INC.
 
    NOTES TO CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    suppliers. Historically, we have not made any significant
    indemnification payments under such agreements, and no amount
    has been accrued in the accompanying consolidated financial
    statements with respect to these indemnification obligations.
 
    Income
    Taxes
 
    We account for income taxes in accordance with Statement of
    Financial Accounting Standard No. 109, Accounting for
    Income Taxes, (SFAS 109), which requires
    that deferred tax assets and liabilities be recognized using
    enacted tax rates for the effect of temporary differences
    between book and tax bases of recorded assets and liabilities.
    SFAS 109 also requires that deferred tax assets be reduced
    by a valuation allowance if it is more likely than not that a
    portion of the deferred tax asset will not be realized.
 
    On a quarterly basis, we provide for income taxes based upon an
    annual effective income tax rate. The effective tax rate is
    highly dependent upon the level of our projected earnings, the
    geographic composition of worldwide earnings, tax regulations
    governing each region, net operating loss carry-forwards,
    availability of tax credits and the effectiveness of our tax
    planning strategies. We carefully monitor the changes in many
    factors and adjust our effective income tax rate on a timely
    basis. If actual results differ from the estimates, this could
    have a material effect on our business, financial condition and
    results of operations. For example, as our projected level of
    earnings changed throughout 2007 and we benefitted from various
    tax planning strategies, we decreased the annual effective tax
    rate from 31.6% at the end of the first quarter, to 26.9% at the
    end of the second quarter, to 24.0% at the end of the third
    quarter and to 23.1% at the end of the fourth quarter.
 
    The calculation of tax liabilities involves significant judgment
    in estimating the impact of uncertainties in the application of
    complex tax laws. Resolution of these uncertainties in a manner
    inconsistent with our expectations could have a material effect
    on our business, financial condition and results of operations.
 
    We recognize accrued interest and penalties related to
    unrecognized tax benefits in the provision for income taxes.
 
    Customer
    Advances
 
    Customer advances generally represent nonrefundable deposits
    invoiced by the Company in connection with receiving customer
    purchase orders and other events preceding acceptance of
    systems. Customer advances related to products that have not
    been shipped to customers and included in accounts receivable
    were $0 and $17.1 million at December 31, 2007 and
    December 31, 2006, respectively.
 
    Cash,
    Cash Equivalents and Short-term Investments
 
    Our investment portfolio consists of cash, cash equivalents and
    investments in debt securities and municipal bonds. We consider
    all highly liquid investments with a maturity of three months or
    less when purchased to be cash equivalents. Investments in debt
    securities and municipal bonds consists principally of highly
    rated debt instruments with maturities generally between one and
    25 months.
    
    44
 
 
    INTEVAC,
    INC.
 
    NOTES TO CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    We account for our investments in debt securities and auction
    rate securities in accordance with Statement of Accounting
    Standards No. 115 Accounting for Certain Investments
    in Debt and Equity Securities, which requires certain
    securities to be categorized as either trading,
    available-for-sale or held-to-maturity. Available-for-sale
    securities, consisting solely of Auction Rate Securities, are
    carried at fair value, with unrealized gains and losses recorded
    within other comprehensive income (loss) as a separate component
    of stockholders equity. Auction Rate Securities have
    long-term underlying maturities (ranging from 20 to
    40 years), however the market has historically been highly
    liquid and the interest rates reset every 7 or 28 days. Our
    intent is not to hold these securities to maturity, but rather
    to use the interest rate reset feature to sell securities to
    provide liquidity as needed. Our practice is to invest in these
    securities for higher yields compared to cash equivalents.
    Held-to-maturity securities are carried at amortized cost. We
    have no trading securities. The cost of investment securities
    sold is determined by the specific identification method.
    Interest income is recorded using an effective interest rate,
    with the associated premium or discount amortized to interest
    income. Realized gains and losses and declines in value judged
    to be other than temporary, if any, on available for sales
    securities are included in earnings. The table below presents
    the amortized principal amount, major security type and
    maturities for our investments in debt securities and Auction
    Rate Securities.
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    December 31, 
    
 | 
 
 | 
 
 | 
    December 31, 
    
 | 
 
 | 
| 
 
 | 
 
 | 
    2007
 | 
 
 | 
 
 | 
    2006
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    Amortized principal amount:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Debt securities issued by U.S. government agencies
 
 | 
 
 | 
    $
 | 
    29,744
 | 
 
 | 
 
 | 
    $
 | 
    8,000
 | 
 
 | 
| 
 
    Auction rate securities
 
 | 
 
 | 
 
 | 
    81,450
 | 
 
 | 
 
 | 
 
 | 
    53,595
 | 
 
 | 
| 
 
    Corporate debt securities
 
 | 
 
 | 
 
 | 
    1,800
 | 
 
 | 
 
 | 
 
 | 
    2,000
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total investments in debt securities
 
 | 
 
 | 
    $
 | 
    112,994
 | 
 
 | 
 
 | 
    $
 | 
    63,595
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Short-term investments
 
 | 
 
 | 
    $
 | 
    110,985
 | 
 
 | 
 
 | 
    $
 | 
    55,595
 | 
 
 | 
| 
 
    Long-term investments
 
 | 
 
 | 
 
 | 
    2,009
 | 
 
 | 
 
 | 
 
 | 
    8,000
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total investments in debt securities
 
 | 
 
 | 
    $
 | 
    112,994
 | 
 
 | 
 
 | 
    $
 | 
    63,595
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Approximate fair value of investments in debt securities
 
 | 
 
 | 
    $
 | 
    113,029
 | 
 
 | 
 
 | 
    $
 | 
    63,585
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    The change in the fair value of our investments is attributable
    to changes in interest rates and not credit quality. In
    accordance with
    EITF 03-01,
    we have the ability and intent to hold these investments until
    fair value recovers, which may be maturity, and we do not
    consider these investments to be other-than-temporarily impaired
    at December 31, 2006. As of December 31, 2007, fair
    value of our investments in debt securities exceeds book value,
    and there is no impairment. In the first quarter of 2008, our
    Auction Rate Securities have experienced multiple failed
    auctions. See footnote 13 for further disclosure on the current
    market situation.
 
    Cash and cash equivalents represent cash accounts, money market
    funds and investments with a duration of 90 days or less at
    purchase. Cash balances held in foreign bank accounts totaled
    $4.3 million and $1.6 million at December 31,
    2007 and December 31, 2006, respectively. Included in
    accounts payable is $2.1 million and $2.4 million of
    book overdraft at December 31, 2007 and December 31,
    2006, respectively.
 
    Valuation
    of Long-lived and Intangible Assets
 
    We assess the impairment of identifiable intangibles and
    long-lived assets whenever events or changes in circumstances
    indicate that the carrying value may not be recoverable. Factors
    we consider important which could trigger an impairment review
    include the following:
 
     | 
     | 
     | 
    |   | 
         
 | 
    
    significant underperformance relative to expected historical or
    projected future operating results;
 | 
|   | 
    |   | 
         
 | 
    
    significant changes in the manner of our use of the acquired
    assets or the strategy for our overall business; and
 | 
|   | 
    |   | 
         
 | 
    
    significant negative industry or economic trends.
 | 
    
    45
 
 
    INTEVAC,
    INC.
 
    NOTES TO CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
 
    When we determine that the carrying value of long-lived assets,
    intangibles or goodwill may not be recoverable based upon the
    existence of one or more of the above indicators of impairment,
    we measure any impairment based on a projected discounted cash
    flow method using a discount rate determined by our management
    to be commensurate with the risk inherent in our current
    business model.
 
    Prototype
    Costs
 
    Prototype product costs that are not paid for under research and
    development contracts and are in excess of fair market value are
    charged to research and development expense.
 
    Foreign
    Exchange Contracts
 
    We may enter into foreign currency forward exchange contracts to
    hedge certain of our foreign currency transaction, translation
    and re-measurement exposures. Our accounting policies for some
    of these instruments are based on our designation of such
    instruments as hedging transactions. Instruments not designated
    as a hedge transaction will be marked to market at
    the end of each accounting period. The criteria we use for
    designating an instrument as a hedge include effectiveness in
    exposure reduction and one-to-one matching of the derivative
    financial instrument to the underlying transaction being hedged.
    Gains and losses on foreign currency forward exchange contracts
    that are designated and effective as hedges of existing
    transactions are recognized in income in the same period as
    losses and gains on the underlying transactions are recognized
    and generally offset.
 
    As of December 31, 2007 and 2006, we had no foreign
    currency forward exchange contracts outstanding.
 
    Foreign
    Currency Translation
 
    The functional currency of our foreign subsidiaries, with the
    exception of Hong Kong, is the local currency of the country in
    which the respective subsidiary operates. Hong Kongs
    functional currency is the U.S. dollar. Assets and
    liabilities recorded in foreign currencies are translated at
    year-end exchange rates; revenues and expenses are translated at
    average exchange rates during the year. The effect of foreign
    currency translation adjustments are included in
    stockholders equity as a component of Accumulated
    other comprehensive income in the accompanying
    consolidated balance sheets. The effects of foreign currency
    transactions are included in Other income in the
    determination of net income. Net gains or (losses) from foreign
    currency transactions were $62,000, ($55,000) and $7,000 in
    2007, 2006 and 2005, respectively.
 
    Financial
    Instruments
 
    The carrying amount of our short-term financial instruments
    (cash and cash equivalents, short-term investments, accounts
    receivable and certain other liabilities) approximates fair
    value due to the short-term maturity of those instruments.
 
    Inventories
 
    In fiscal 2007, we changed our accounting method for valuing
    inventory from a standard cost system, which approximated
    first-in,
    first-out, to the average actual cost method. The new method of
    accounting for inventory is deemed preferable as we moved from a
    system which approximated a GAAP valuation method to a GAAP
    valuation method. The change in inventory accounting method did
    not have a material impact on any of the periods presented
    herein.
    
    46
 
 
    INTEVAC,
    INC.
 
    NOTES TO CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    Inventories are stated at the lower of average cost or market
    and consist of the following:
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    December 31,
 | 
 
 | 
| 
 
 | 
 
 | 
    2007
 | 
 
 | 
 
 | 
    2006
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    Raw materials
 
 | 
 
 | 
    $
 | 
    13,666
 | 
 
 | 
 
 | 
    $
 | 
    19,906
 | 
 
 | 
| 
 
    Work-in-progress
 
 | 
 
 | 
 
 | 
    6,191
 | 
 
 | 
 
 | 
 
 | 
    12,271
 | 
 
 | 
| 
 
    Finished goods
 
 | 
 
 | 
 
 | 
    2,276
 | 
 
 | 
 
 | 
 
 | 
    5,765
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
 | 
 
 | 
    $
 | 
    22,133
 | 
 
 | 
 
 | 
    $
 | 
    37,942
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    Finished goods inventory consists primarily of completed systems
    at customer sites that are undergoing installation and
    acceptance testing.
 
    Inventory reserves included in the above numbers were
    $7.8 million and $9.1 million at December 31,
    2007 and 2006, respectively. Each quarter, we analyze our
    inventory (raw materials,
    work-in-progress
    and finished goods) against the forecast demand for the next
    12 months. Raw materials with no forecast requirements in
    that period are considered excess and inventory provisions are
    established to write those items down to zero net book value.
    Work-in-progress
    and finished goods inventories with no forecast requirements in
    that period are typically written down to the lower of cost or
    market. During this process, some inventory is identified as
    having no future use or value to us and is disposed of against
    the reserves.
 
    The following table displays the activity in the inventory
    provision account for 2007 and 2006:
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    2007
 | 
 
 | 
 
 | 
    2006
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    Beginning balance
 
 | 
 
 | 
    $
 | 
    9,128
 | 
 
 | 
 
 | 
    $
 | 
    10,988
 | 
 
 | 
| 
 
    New provisions in cost of sales
 
 | 
 
 | 
 
 | 
    862
 | 
 
 | 
 
 | 
 
 | 
    1,527
 | 
 
 | 
| 
 
    New provisions for refurbishment of consigned products
 
 | 
 
 | 
 
 | 
    139
 | 
 
 | 
 
 | 
 
 | 
    10
 | 
 
 | 
| 
 
    Disposals of inventory
 
 | 
 
 | 
 
 | 
    (2,395
 | 
    )
 | 
 
 | 
 
 | 
    (3,355
 | 
    )
 | 
| 
 
    Miscellaneous adjustments
 
 | 
 
 | 
 
 | 
    16
 | 
 
 | 
 
 | 
 
 | 
    (42
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Ending balance
 
 | 
 
 | 
    $
 | 
    7,750
 | 
 
 | 
 
 | 
    $
 | 
    9,128
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    Property,
    Plant and Equipment
 
    Equipment and leasehold improvements are carried at cost less
    accumulated depreciation and amortization. Gains and losses on
    dispositions are reflected in the Consolidated Statements of
    Income and Comprehensive Income.
 
    Depreciation is computed using the straight-line method over the
    estimated useful lives of the assets as follows:
 
    |   | 	
      | 	
      | 	
| 
 
    Computers and software
 
 | 
 
 | 
    3 years
 | 
| 
 
    Machinery and equipment
 
 | 
 
 | 
    5 years
 | 
| 
 
    Furniture
 
 | 
 
 | 
    7 years
 | 
| 
 
    Vehicles
 
 | 
 
 | 
    4 years
 | 
| 
 
    Leasehold improvements
 
 | 
 
 | 
    Remaining lease term
 | 
 
    Comprehensive
    Income
 
    SFAS No. 130, Reporting Comprehensive
    Income requires unrealized gains or losses on foreign
    currency translation adjustments to be included in other
    comprehensive income. As of December 31, 2007, the $571,000
    
    47
 
 
    INTEVAC,
    INC.
 
    NOTES TO CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    balance of accumulated other comprehensive income is comprised
    entirely of accumulated foreign currency translation adjustments.
 
    Employee
    Stock Plans
 
    We have adopted equity-based compensation plans that provide for
    the grant to employees of equity-based awards, including
    incentive or non-statutory stock options, restricted stock,
    stock appreciation rights, performance units and performance
    shares. In addition, these plans provide for the grant of
    non-statutory stock options to non-employee directors and
    consultants. We also have an Employee Stock Purchase Plan, which
    provides our employees with the opportunity to purchase Intevac
    common stock at a discount through payroll deductions. See
    Note 3 for a complete description of these plans and their
    accounting treatment.
 
    Financial
    Presentation
 
    Certain prior year amounts in the Consolidated Financial
    Statements have been reclassified to conform to 2007
    presentation. The reclassifications had no material effect on
    total assets, liabilities, equity, net income (loss) or
    comprehensive income (loss) previously reported.
 
    Net
    income per share
 
    The following table sets forth the computation of basic and
    diluted income per share:
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    2007
 | 
 
 | 
 
 | 
    2006
 | 
 
 | 
 
 | 
    2005
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    Numerator:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Numerator for diluted earnings per share  income
    available to common stockholders
 
 | 
 
 | 
    $
 | 
    27,345
 | 
 
 | 
 
 | 
    $
 | 
    46,698
 | 
 
 | 
 
 | 
    $
 | 
    16,151
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Denominator:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Denominator for basic earnings per share 
    weighted-average shares
 
 | 
 
 | 
 
 | 
    21,447
 | 
 
 | 
 
 | 
 
 | 
    21,015
 | 
 
 | 
 
 | 
 
 | 
    20,462
 | 
 
 | 
| 
 
    Effect of dilutive securities:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Employee stock options(1)
 
 | 
 
 | 
 
 | 
    703
 | 
 
 | 
 
 | 
 
 | 
    921
 | 
 
 | 
 
 | 
 
 | 
    740
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Dilutive potential common shares
 
 | 
 
 | 
 
 | 
    703
 | 
 
 | 
 
 | 
 
 | 
    921
 | 
 
 | 
 
 | 
 
 | 
    740
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Denominator for diluted earnings per share  adjusted
 
 | 
 
 | 
 
 | 
    22,150
 | 
 
 | 
 
 | 
 
 | 
    21,936
 | 
 
 | 
 
 | 
 
 | 
    21,202
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 
     | 
     | 
     | 
    | 
    (1)  | 
     | 
    
    Potentially dilutive securities, consisting of shares issuable
    upon exercise of employee stock options, are excluded from the
    calculation of diluted EPS if their effect would be
    anti-dilutive. The weighted average number of employee stock
    options excluded from the twelve-month periods ended
    December 31, 2007, 2006, and 2005 was 784,684, 426,606, and
    226,804 respectively. | 
 
    Use of
    Estimates
 
    The preparation of financial statements in conformity with
    accounting principles generally accepted in the United States of
    America requires management to make estimates and assumptions
    that affect the reported amounts of assets and liabilities and
    disclosure of contingent assets and liabilities at the date of
    the financial statements and the reported amounts of revenue and
    expenses during the reporting period. Actual results could
    differ from those estimates, and such differences may be
    material to the financial statements.
    
    48
 
 
    INTEVAC,
    INC.
 
    NOTES TO CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    New
    Accounting Pronouncements
 
    In September 2006, the FASB issued Statement of Financial
    Accounting Standard No. 157, Fair Value
    Measurements (SFAS 157).
    SFAS 157 defines fair value, establishes a framework for
    measuring fair value in generally accepted accounting principles
    and expands disclosures about fair value measurements.
    FAS 157 is effective for fiscal years beginning after
    November 15, 2007 for financial assets and liabilities, as
    well as for any other assets and liabilities that are carried at
    fair value on a recurring basis in financial statements. In
    November 2007, the FASB provided a one year deferral for the
    implementation of FAS 157 for other nonfinancial assets and
    liabilities. We will adopt SFAS 157 beginning in the first
    quarter of fiscal year 2008 and we do not expect SFAS 157
    to have a material impact on our financial condition, results of
    operations or cash flows.
 
    In February 2008, the FASB issued FASB Staff Position
    SFAS 157-1,
    Application of FASB Statement No. 157 to FASB
    Statement No. 13 and Other Accounting Pronouncements That
    Address Fair Value Measurements for Purposes of Lease
    Classification or Measurement under Statement 13
    (FSP
    FAS 157-1).
    FSP
    FAS 157-1
    defers the effective date of SFAS 157 for all non-financial
    assets and non-financial liabilities, except those that are
    recognized or disclosed at fair value in the financial
    statements on a recurring basis. FSP
    FAS 157-1
    also excludes from the scope of SFAS 157 certain leasing
    transactions accounted for under SFAS No. 13,
    Accounting for Leases. We will adopt FSP
    FAS 157-1
    beginning in the first quarter of fiscal year 2008 and we do not
    expect FSP
    FAS 157-1
    to have a material impact on our financial condition, results of
    operations or cash flows.
 
    In February 2007, the FASB issued Statement of Financial
    Accounting Standards No. 159, The Fair Value
    Option for Financial Assets and Financial
    Liabilities  Including an amendment of FASB Statement
    No. 115 (SFAS 159).
    SFAS 159 permits entities to choose to measure many
    financial instruments and certain other items at fair value. The
    fair value option established by SFAS 159 permits all
    entities to choose to measure eligible items at fair value at
    specified election dates and report unrealized gains and losses
    on items for which the fair value option has been elected in
    earnings at each subsequent reporting date. SFAS 159 is
    effective for fiscal years beginning after November 15,
    2007. We do not expect to apply this fair value option to our
    current financial instruments, and as such, do not expect
    SFAS 159 to have a material impact on our financial
    condition, results of operations or cash flows.
 
    In December 2007 the FASB issued Statement of Financial
    Accounting Standards No. 141(R), Business
    Combinations (SFAS 141R).
    SFAS 141R retains the fundamental acquisition method of
    accounting established in Statement 141; however, among other
    things, SFAS 141R requires recognition of assets and
    liabilities of non-controlling interests acquired, fair value
    measurement of consideration and contingent consideration,
    expense recognition for transaction costs and certain
    integration costs, recognition of the fair value of
    contingencies, and adjustments to income tax expense for changes
    in an acquirers existing valuation allowances or uncertain
    tax positions that result from the business combination.
    SFAS 141R is effective for annual reporting periods
    beginning after December 15, 2008 and shall be applied
    prospectively. We have not yet completed our assessment of the
    impact SFAS 141R will have on our financial condition,
    results of operations or cash flows.
 
     | 
     | 
    | 
    3.  
 | 
    
    Stock-Based
    Compensation
 | 
 
    On January 1, 2006, we adopted Statement of Financial
    Accounting Standards No. 123 (revised 2004),
    Share-Based Payment, (SFAS 123(R))
    which requires the measurement and recognition of compensation
    expense for all share-based payment awards made to employees and
    directors, including equity awards related to the 2004 Equity
    Incentive Plan (the 2004 Plan) and employee stock
    purchases related to the 2003 Employee Stock Purchase Plan (the
    ESPP), based on estimated fair values.
    SFAS 123(R) supersedes our previous accounting under
    Accounting Principles Board Opinion No. 25,
    Accounting for Stock Issued to Employees (APB
    25) for periods beginning in fiscal 2006. In March 2005,
    the Securities and Exchange Commission issued Staff Accounting
    Bulletin No. 107 (SAB 107) relating
    to SFAS 123(R). We have applied the provisions of
    SAB 107 in our adoption of SFAS 123(R).
    
    49
 
 
    INTEVAC,
    INC.
 
    NOTES TO CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    We adopted SFAS 123(R) using the modified prospective
    transition method, which requires the application of the
    accounting standard as of January 1, 2006, the first day of
    our fiscal year 2006. Our Consolidated Financial Statements as
    of and for the twelve months ended December 31, 2007 and
    December 31, 2006 reflect the impact of SFAS 123(R).
    In accordance with the modified prospective transition method,
    our Consolidated Financial Statements for prior periods have not
    been restated to reflect, and do not include, the impact of
    SFAS 123(R). Stock-based compensation expense recognized
    under SFAS 123(R) for the twelve months ended
    December 31, 2007 and December 31, 2006 was
    $6.3 million and $3.4 million, respectively, which
    consisted of stock-based compensation expense related to the
    grant of stock options under the 2004 Plan and stock purchase
    rights under the ESPP. There was $19,000 of stock-based
    compensation expense related to the grant of stock options or
    stock purchase rights recognized during the twelve months ended
    December 31, 2005.
 
    SFAS 123(R) requires companies to estimate the fair value
    of share-based payment awards on the date of grant using an
    option-pricing model. The value of the portion of the award that
    is ultimately expected to vest is recognized as expense in our
    Consolidated Statement of Income over the requisite service
    period using the graded vesting attribution method. Prior to the
    adoption of SFAS 123(R), we accounted for employee equity
    awards and employee stock purchases using the intrinsic value
    method in accordance with APB 25 as allowed under Statement of
    Financial Accounting Standards No. 123, Accounting
    for Stock-Based Compensation (SFAS 123).
    Under the intrinsic value method, no stock-based compensation
    expense had been recognized in our Consolidated Statement of
    Income, because the exercise price of our stock options granted
    to employees and directors equaled the fair market value of the
    underlying stock at the date of grant.
 
    Stock-based compensation expense recognized during the period is
    based on the value of the portion of share-based payment awards
    that is ultimately expected to vest during the period.
    Stock-based compensation expense recognized in our Consolidated
    Statement of Income for the years ended December 31, 2007
    and December 31, 2006 included compensation expense for
    share-based payment awards granted prior to, but not yet vested
    as of, December 31, 2005 based on the grant date fair value
    estimated in accordance with the pro forma provisions of
    SFAS 123 and compensation expense for the share-based
    payment awards granted subsequent to December 31, 2005
    based on the grant date fair value estimated in accordance with
    the provisions of SFAS 123(R). As stock-based compensation
    expense recognized in the Consolidated Statement of Income for
    fiscal 2007 and 2006 is based on awards ultimately expected to
    vest, it has been reduced for estimated annual forfeitures.
    SFAS 123(R) requires forfeitures to be estimated at the
    time of grant and revised, if necessary, in subsequent periods
    if actual forfeitures differ from those estimates. In our pro
    forma information required under SFAS 123 for the periods
    prior to fiscal 2006, the Company accounted for forfeitures as
    they occurred.
 
    Descriptions
    of Plans
 
    2004
    Equity Incentive Plan
 
    In 2004, our Board of Directors and our stockholders approved
    adoption of the 2004 Plan. The 2004 Plan serves as the successor
    equity incentive program to our 1995 Stock Option/Stock Issuance
    Plan (the 1995 Plan). Upon adoption of the 2004
    Plan, all remaining shares available for issuance under the 1995
    Plan were transferred to the 2004 Plan.
 
    Our 2004 Plan is a broad-based, long-term retention program
    intended to attract and retain qualified management and
    employees, and align stockholder and employee interests. The
    2004 Plan permits the grant of incentive or non-statutory stock
    options, restricted stock, stock appreciation rights,
    performance units and performance shares. Option price, vesting
    period, and other terms are determined by the administrator of
    the 2004 Plan, but the option price shall generally not be less
    than 100% of the fair market value per share on the date of
    grant. As of December 31, 2007, 3,227,707 shares of
    common stock were authorized for future issuance under the 2004
    Plan. Options granted under the 2004 Plan are exercisable upon
    vesting and vest over periods of up to five years. Options
    currently expire no later than ten years from the date of grant.
    The 2004 Plan expires no later than March 10, 2014.
    
    50
 
 
    INTEVAC,
    INC.
 
    NOTES TO CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    During the year ended December 31, 2007, we granted 750,000
    stock options with an estimated total grant-date fair value of
    $7.4 million, including 3,000 shares granted to a
    consultant with a grant date fair value of $24,000. Of this
    amount, we estimated that the stock-based compensation for
    option grants that will be forfeited, and are therefore not
    expected to vest, was $1.6 million.
 
    2003
    Employee Stock Purchase Plan
 
    In 2003, our stockholders approved adoption of the ESPP, which
    serves as the successor to the Employee Stock Purchase Plan
    originally adopted in 1995. Upon adoption of the ESPP, all
    shares available for issuance under the prior plan were
    transferred to the ESPP. Our ESPP provides that eligible
    employees may purchase our common stock through payroll
    deductions at a price equal to 85% of the lower of the fair
    market value at the beginning of the applicable offering period
    or at the end of each applicable purchase interval. Offering
    periods are generally two years in length, and consist of a
    series of six-month purchase intervals. Eligible employees may
    join the ESPP at the beginning of any six-month purchase
    interval. Under the terms of the ESPP, employees can choose to
    have up to 10% of their base earnings withheld to purchase our
    common stock. Under the ESPP, we sold 90,018, 158,859 and
    129,217 shares to employees in 2007, 2006 and 2005,
    respectively. As of December 31, 2007, 297,919 shares
    remained available for issuance under the 2003 ESPP.
 
    During the year ended December 31, 2007, we granted
    purchase rights with an estimated total grant-date value of
    $2.0 million.
 
    Impact
    of the Adoption of SFAS 123(R)
 
    The effect of recording stock-based compensation for the years
    ended December 31, 2007 and December 31, 2006 was as
    follows (in thousands, except per share data):
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    2007
 | 
 
 | 
 
 | 
    2006
 | 
 
 | 
|  
 | 
| 
 
    Stock-based compensation by type of award:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Stock options
 
 | 
 
 | 
    $
 | 
    5,517
 | 
 
 | 
 
 | 
    $
 | 
    2,803
 | 
 
 | 
| 
 
    Employee stock purchase plan
 
 | 
 
 | 
 
 | 
    864
 | 
 
 | 
 
 | 
 
 | 
    622
 | 
 
 | 
| 
 
    Amounts capitalized as inventory
 
 | 
 
 | 
 
 | 
    (111
 | 
    )
 | 
 
 | 
 
 | 
    (69
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total stock-based compensation
 
 | 
 
 | 
 
 | 
    6,270
 | 
 
 | 
 
 | 
 
 | 
    3,356
 | 
 
 | 
| 
 
    Tax effect on stock-based compensation
 
 | 
 
 | 
 
 | 
    (1,451
 | 
    )
 | 
 
 | 
 
 | 
    (403
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Net effect on net income
 
 | 
 
 | 
    $
 | 
    4,819
 | 
 
 | 
 
 | 
    $
 | 
    2,953
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Effect on earnings per share:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Basic
 
 | 
 
 | 
    $
 | 
    0.22
 | 
 
 | 
 
 | 
    $
 | 
    0.14
 | 
 
 | 
| 
 
    Diluted
 
 | 
 
 | 
    $
 | 
    0.22
 | 
 
 | 
 
 | 
    $
 | 
    0.13
 | 
 
 | 
 
    Approximately $180,000 and $69,000 of stock-based compensation
    is included in inventory as of December 31, 2007 and
    December 31, 2006, respectively. No stock-based
    compensation was capitalized to inventory prior to our adoption
    of the provisions of SFAS 123(R) in the first quarter of
    2006.
 
    Valuation
    Assumptions
 
    The fair value of share-based payment awards is estimated at the
    grant date using the Black-Scholes Merton option valuation
    model. The determination of fair value of share-based payment
    awards on the date of grant using an option-pricing model is
    affected by our stock price as well as assumptions regarding a
    number of highly complex and subjective variables. These
    variables include, but are not limited to, our expected stock
    price volatility over the term of the awards, and actual
    employee stock option exercise behavior.
    
    51
 
 
    INTEVAC,
    INC.
 
    NOTES TO CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    We estimate the fair value of stock options consistent with the
    provisions of SFAS 123(R), SAB No. 107 and our
    prior period pro forma disclosures of net earnings, including
    stock-based compensation expense (determined under a fair value
    method as prescribed by SFAS 123). The weighted-average
    estimated fair value of employee stock options granted during
    the twelve months ended December 31, 2007 and
    December 31, 2006 was $9.89 per share and $11.22 per share,
    respectively. The weighted-average estimated fair value of
    employee stock purchase rights granted pursuant to the ESPP
    during the twelve months ended December 31, 2007 and
    December 31, 2006 was $8.23 per share and $9.68 per share,
    respectively. The fair value of each option and employee stock
    purchase right grant is estimated on the date of grant using the
    Black-Scholes Merton option valuation model with the following
    weighted-average assumptions:
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    2007
 | 
 
 | 
 
 | 
    2006
 | 
 
 | 
|  
 | 
| 
 
    Stock Options:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Expected volatility
 
 | 
 
 | 
 
 | 
    66.67
 | 
    %
 | 
 
 | 
 
 | 
    74.44
 | 
    %
 | 
| 
 
    Risk free interest rate
 
 | 
 
 | 
 
 | 
    4.05
 | 
    %
 | 
 
 | 
 
 | 
    4.68
 | 
    %
 | 
| 
 
    Expected term of options (in years)
 
 | 
 
 | 
 
 | 
    4.49
 | 
 
 | 
 
 | 
 
 | 
    4.71
 | 
 
 | 
| 
 
    Dividend yield
 
 | 
 
 | 
 
 | 
    None
 | 
 
 | 
 
 | 
 
 | 
    None
 | 
 
 | 
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    2007
 | 
 
 | 
 
 | 
    2006
 | 
 
 | 
|  
 | 
| 
 
    Stock Purchase Rights:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Expected volatility
 
 | 
 
 | 
 
 | 
    63.15
 | 
    %
 | 
 
 | 
 
 | 
    59.25
 | 
    %
 | 
| 
 
    Risk free interest rate
 
 | 
 
 | 
 
 | 
    3.94
 | 
    %
 | 
 
 | 
 
 | 
    4.67
 | 
    %
 | 
| 
 
    Expected term of purchase rights (in years)
 
 | 
 
 | 
 
 | 
    1.97
 | 
 
 | 
 
 | 
 
 | 
    1.92
 | 
 
 | 
| 
 
    Dividend yield
 
 | 
 
 | 
 
 | 
    None
 | 
 
 | 
 
 | 
 
 | 
    None
 | 
 
 | 
 
    The computation of the expected volatility assumptions used in
    the Black-Scholes Merton calculations for new grants and
    purchase rights is based on the historical volatility of our
    stock price, measured over a period equal to the expected term
    of the grant or purchase right. The risk-free interest rate is
    based on the yield available on U.S. Treasury Strips with
    an equivalent remaining term. The expected life of employee
    stock options represents the weighted-average period that the
    stock options are expected to remain outstanding and was
    determined based on historical experience of similar awards,
    giving consideration to the contractual terms of the stock-based
    awards and vesting schedules. The expected life of purchase
    rights is the period of time remaining in the current offering
    period. The dividend yield assumption is based on our history of
    not paying dividends and the assumption of not paying dividends
    in the future.
    
    52
 
 
    INTEVAC,
    INC.
 
    NOTES TO CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    Stock
    Plan Activity
 
    2004
    Equity Incentive Plan
 
    A summary of activity under the above captioned plan is as
    follows:
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    Weighted 
    
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    Average 
    
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    Weighted 
    
 | 
 
 | 
 
 | 
    Remaining 
    
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    Average 
    
 | 
 
 | 
 
 | 
    Contractual 
    
 | 
 
 | 
 
 | 
    Aggregate 
    
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    Exercise 
    
 | 
 
 | 
 
 | 
    Term 
    
 | 
 
 | 
 
 | 
    Intrinsic 
    
 | 
 
 | 
| 
 
 | 
 
 | 
    Shares
 | 
 
 | 
 
 | 
    Price
 | 
 
 | 
 
 | 
    (Years)
 | 
 
 | 
 
 | 
    Value
 | 
 
 | 
|  
 | 
| 
 
    Options outstanding at December 31, 2006
 
 | 
 
 | 
 
 | 
    2,354,215
 | 
 
 | 
 
 | 
    $
 | 
    11.47
 | 
 
 | 
 
 | 
 
 | 
    7.93
 | 
 
 | 
 
 | 
    $
 | 
    34,107,462
 | 
 
 | 
| 
 
    Options granted
 
 | 
 
 | 
 
 | 
    750,000
 | 
 
 | 
 
 | 
    $
 | 
    17.73
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Options forfeited
 
 | 
 
 | 
 
 | 
    (203,483
 | 
    )
 | 
 
 | 
    $
 | 
    15.74
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Options exercised
 
 | 
 
 | 
 
 | 
    (312,878
 | 
    )
 | 
 
 | 
    $
 | 
    7.97
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Options outstanding at December 31, 2007
 
 | 
 
 | 
 
 | 
    2,587,854
 | 
 
 | 
 
 | 
    $
 | 
    13.37
 | 
 
 | 
 
 | 
 
 | 
    7.64
 | 
 
 | 
 
 | 
    $
 | 
    8,004,456
 | 
 
 | 
| 
 
    Vested and expected to vest at December 31, 2007
 
 | 
 
 | 
 
 | 
    2,213,972
 | 
 
 | 
 
 | 
    $
 | 
    12.97
 | 
 
 | 
 
 | 
 
 | 
    7.50
 | 
 
 | 
 
 | 
    $
 | 
    7,488,818
 | 
 
 | 
| 
 
    Options exercisable at December 31, 2007
 
 | 
 
 | 
 
 | 
    894,800
 | 
 
 | 
 
 | 
    $
 | 
    9.31
 | 
 
 | 
 
 | 
 
 | 
    6.09
 | 
 
 | 
 
 | 
    $
 | 
    5,322,412
 | 
 
 | 
 
    The aggregate intrinsic value in the table above represents the
    total pretax intrinsic value, based on our closing stock price
    of $14.54 as of December 31, 2007, which would have been
    received by the option holders had all option holders exercised
    their options as of that date. During fiscal years 2007, 2006
    and 2005 the aggregate intrinsic value of options exercised
    under our Equity Incentive Plan was $5.1 million,
    $4.8 million and $2.1 million, respectively,
    determined as of the date of option exercise.
 
    The options outstanding and currently exercisable at
    December 31, 2007 were in the following exercise price
    ranges:
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    Options Outstanding
 | 
 
 | 
 
 | 
    Options Exercisable
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    Weighted 
    
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    Average 
    
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    Remaining 
    
 | 
 
 | 
 
 | 
    Weighted 
    
 | 
 
 | 
 
 | 
    Number 
    
 | 
 
 | 
 
 | 
    Weighted 
    
 | 
 
 | 
| 
 
 | 
 
 | 
    Number of Shares 
    
 | 
 
 | 
 
 | 
    Contractual Term 
    
 | 
 
 | 
 
 | 
    Average 
    
 | 
 
 | 
 
 | 
    Vested and 
    
 | 
 
 | 
 
 | 
    Average 
    
 | 
 
 | 
| 
 
    Range of Exercise Prices
 
 | 
 
 | 
    Outstanding
 | 
 
 | 
 
 | 
    (In Years)
 | 
 
 | 
 
 | 
    Exercise Price
 | 
 
 | 
 
 | 
    Exercisable
 | 
 
 | 
 
 | 
    Exercise Price
 | 
 
 | 
|  
 | 
| 
 
    $ 2.63 - $ 4.06
 
 | 
 
 | 
 
 | 
    316,114
 | 
 
 | 
 
 | 
 
 | 
    4.51
 | 
 
 | 
 
 | 
    $
 | 
    2.99
 | 
 
 | 
 
 | 
 
 | 
    288,530
 | 
 
 | 
 
 | 
    $
 | 
    2.88
 | 
 
 | 
| 
 
    $ 4.12 - $ 7.72
 
 | 
 
 | 
 
 | 
    358,175
 | 
 
 | 
 
 | 
 
 | 
    6.53
 | 
 
 | 
 
 | 
    $
 | 
    7.04
 | 
 
 | 
 
 | 
 
 | 
    111,025
 | 
 
 | 
 
 | 
    $
 | 
    6.28
 | 
 
 | 
| 
 
    $ 7.77 - $10.69
 
 | 
 
 | 
 
 | 
    275,765
 | 
 
 | 
 
 | 
 
 | 
    6.88
 | 
 
 | 
 
 | 
    $
 | 
    9.20
 | 
 
 | 
 
 | 
 
 | 
    182,665
 | 
 
 | 
 
 | 
    $
 | 
    9.86
 | 
 
 | 
| 
 
    $10.95 - $15.40
 
 | 
 
 | 
 
 | 
    280,950
 | 
 
 | 
 
 | 
 
 | 
    8.45
 | 
 
 | 
 
 | 
    $
 | 
    14.24
 | 
 
 | 
 
 | 
 
 | 
    116,250
 | 
 
 | 
 
 | 
    $
 | 
    12.93
 | 
 
 | 
| 
 
    $15.50 - $15.81
 
 | 
 
 | 
 
 | 
    157,125
 | 
 
 | 
 
 | 
 
 | 
    7.95
 | 
 
 | 
 
 | 
    $
 | 
    15.80
 | 
 
 | 
 
 | 
 
 | 
    39,000
 | 
 
 | 
 
 | 
    $
 | 
    15.79
 | 
 
 | 
| 
 
    $16.13 - $16.13
 
 | 
 
 | 
 
 | 
    720,475
 | 
 
 | 
 
 | 
 
 | 
    9.01
 | 
 
 | 
 
 | 
    $
 | 
    16.13
 | 
 
 | 
 
 | 
 
 | 
    85,080
 | 
 
 | 
 
 | 
    $
 | 
    16.13
 | 
 
 | 
| 
 
    $16.87 - $22.01
 
 | 
 
 | 
 
 | 
    283,000
 | 
 
 | 
 
 | 
 
 | 
    8.60
 | 
 
 | 
 
 | 
    $
 | 
    19.49
 | 
 
 | 
 
 | 
 
 | 
    44,000
 | 
 
 | 
 
 | 
    $
 | 
    19.03
 | 
 
 | 
| 
 
    $22.40 - $29.45
 
 | 
 
 | 
 
 | 
    196,250
 | 
 
 | 
 
 | 
 
 | 
    7.94
 | 
 
 | 
 
 | 
    $
 | 
    25.41
 | 
 
 | 
 
 | 
 
 | 
    28,250
 | 
 
 | 
 
 | 
    $
 | 
    23.91
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    $ 2.63 - $29.45
 
 | 
 
 | 
 
 | 
    2,587,854
 | 
 
 | 
 
 | 
 
 | 
    7.64
 | 
 
 | 
 
 | 
    $
 | 
    13.37
 | 
 
 | 
 
 | 
 
 | 
    894,800
 | 
 
 | 
 
 | 
    $
 | 
    9.31
 | 
 
 | 
 
    As of December 31, 2007, the unrecognized deferred
    stock-based compensation balance related to stock options was
    $10.3 million and will be recognized over an estimated
    weighted average amortization period of 1.63 years. The
    amortization period is based on the expected term of the option,
    which is defined as the period from grant date to exercise date.
    
    53
 
 
    INTEVAC,
    INC.
 
    NOTES TO CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    2003
    Employee Stock Purchase Plan
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    Weighted 
    
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    Weighted 
    
 | 
 
 | 
 
 | 
    Average 
    
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    Average 
    
 | 
 
 | 
 
 | 
    Remaining 
    
 | 
 
 | 
 
 | 
    Aggregate 
    
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    Exercise 
    
 | 
 
 | 
 
 | 
    Contractual 
    
 | 
 
 | 
 
 | 
    Intrinsic 
    
 | 
 
 | 
| 
 
 | 
 
 | 
    Shares
 | 
 
 | 
 
 | 
    Price
 | 
 
 | 
 
 | 
    Term (Years)
 | 
 
 | 
 
 | 
    Value
 | 
 
 | 
|  
 | 
| 
 
    Purchase rights outstanding at December 31, 2007
 
 | 
 
 | 
 
 | 
    354,816
 | 
 
 | 
 
 | 
    $
 | 
    11.70
 | 
 
 | 
 
 | 
 
 | 
    1.04
 | 
 
 | 
 
 | 
    $
 | 
    1,008,826
 | 
 
 | 
| 
 
    Vested and expected to vest at December 31, 2007
 
 | 
 
 | 
 
 | 
    313,050
 | 
 
 | 
 
 | 
    $
 | 
    11.42
 | 
 
 | 
 
 | 
 
 | 
    0.97
 | 
 
 | 
 
 | 
    $
 | 
    976,332
 | 
 
 | 
 
    The aggregate intrinsic value in the table above represents the
    total pretax intrinsic value, based on our closing stock price
    of $14.54 as of December 31, 2007, which would have been
    received by the purchase right holders had all purchase right
    holders exercised their purchase rights as of that date. During
    fiscal years 2007, 2006 and 2005 the aggregate intrinsic value
    of purchase rights exercised under our ESPP was $317,000,
    $2.1 million and $806,000, respectively, determined as of
    the date of purchase.
 
    During the twelve months ended December 31, 2007,
    90,018 shares were purchased at an average per share price
    of $15.27. At December 31, 2007, there were
    297,919 shares available to be issued under the ESPP.
 
    As of December 31, 2007, the unrecorded deferred
    stock-based compensation balance related to purchase rights was
    $1.5 million and will be recognized over an estimated
    weighted average recognition period of 1.04 years. The
    recognition period is based on the expected term of the purchase
    right, which is defined as the period from grant date to
    expiration of the offering period.
 
    Prior to
    the Adoption of SFAS No. 123(R)
 
    Prior to the adoption of SFAS No. 123(R), we provided
    the disclosures required under SFAS No. 123,
    Accounting for Stock-Based Compensation, as amended
    by SFAS No. 148, Accounting for Stock-Based
    Compensation  Transition and Disclosures.
    Consistent with the disclosure provisions of SFAS 148, our
    net income (loss) and basic and diluted earnings per share would
    have been adjusted to the pro forma amounts indicated below (in
    thousands, except per share data):
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    2005
 | 
 
 | 
|  
 | 
| 
 
    Net income as reported
 
 | 
 
 | 
    $
 | 
    16,151
 | 
 
 | 
| 
 
    Deduct: Total stock-based employee compensation expense
    determined under fair value based method for all awards, net of
    related tax effects
 
 | 
 
 | 
 
 | 
    (2,907
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Pro forma net income
 
 | 
 
 | 
    $
 | 
    13,244
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Earnings per share:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Basic  as reported
 
 | 
 
 | 
    $
 | 
    0.79
 | 
 
 | 
| 
 
    Basic  pro forma
 
 | 
 
 | 
    $
 | 
    0.65
 | 
 
 | 
| 
 
    Diluted  as reported
 
 | 
 
 | 
    $
 | 
    0.76
 | 
 
 | 
| 
 
    Diluted  pro forma
 
 | 
 
 | 
    $
 | 
    0.62
 | 
 
 | 
    
    54
 
 
    INTEVAC,
    INC.
 
    NOTES TO CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    The weighted-average fair value of stock options granted was
    $6.58 for the year ended December 31, 2005. The
    weighted-average fair value of purchase rights granted was $5.14
    for the year ended December 31, 2005. The fair value of
    each option grant and purchase right was estimated on the date
    of grant using the Black-Scholes Merton option valuation model
    with the following weighted average assumptions:
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    Stock Options
 | 
 
 | 
 
 | 
    Purchase Rights
 | 
 
 | 
|  
 | 
| 
 
    Expected volatility
 
 | 
 
 | 
 
 | 
    92.30
 | 
    %
 | 
 
 | 
 
 | 
    91.74
 | 
    %
 | 
| 
 
    Risk free interest rate
 
 | 
 
 | 
 
 | 
    4.30
 | 
    %
 | 
 
 | 
 
 | 
    3.89
 | 
    %
 | 
| 
 
    Expected term of options and purchase rights (in years)
 
 | 
 
 | 
 
 | 
    5.99
 | 
 
 | 
 
 | 
 
 | 
    1.27
 | 
 
 | 
| 
 
    Dividend yield
 
 | 
 
 | 
 
 | 
    None
 | 
 
 | 
 
 | 
 
 | 
    None
 | 
 
 | 
 
    On October 27, 2005, our Board of Directors approved
    accelerating the vesting of approximately 306,000
    out-of-the-money unvested common stock options
    previously awarded to employees and officers under our stock
    option plans. Vesting was accelerated for stock options that had
    exercise prices greater than or equal to $9.06 per share, which
    was the closing price of our common stock on October 27,
    2005. In connection with the modification of the terms of these
    options to accelerate their vesting, approximately
    $1.5 million is reflected as a non-cash compensation
    expense on a pro-forma basis in accordance with SFAS 123 in
    the pro-forma table above for the year ended December 31,
    2005. This action was taken to reduce the impact of future
    compensation expense that we would otherwise be required to
    recognize in future consolidated statements of operations
    pursuant to SFAS 123R.
 
 
    Delta
    Nu, LLC
 
    On January 31, 2007, we completed the acquisition of the
    assets and certain liabilities of DeltaNu, LLC
    (DeltaNu) for a total purchase price of
    $6 million. The purchase price was comprised of
    $2 million cash paid at the close of the acquisition and
    $2 million due on each of January 31, 2008 and
    January 31, 2009, which is in the form of a note. These
    notes do not bear interest. Interest is imputed, and the related
    Notes Payable are recorded at a discounted in the accompanying
    Consolidated Balance Sheet. As a result of the discount on the
    notes, the total allocated purchase price is $5.8 million.
    DeltaNu is a Laramie, Wyoming company specializing in small
    footprint and handheld Raman spectrometry instruments.
 
    We accounted for the acquisition as a taxable purchase
    transaction and, accordingly, the purchase price has been
    allocated to tangible assets, liabilities assumed, and
    identifiable intangible assets acquired based on their estimated
    fair values on the acquisition date. The excess of the purchase
    price over the aggregate fair values was recorded as goodwill.
    The fair value assigned to identifiable intangible assets
    acquired is determined using the income approach, which
    discounts expected future cash flows to present value using
    estimates and assumptions determined by management. Purchased
    intangible assets are amortized on a straight-line basis over
    the respective useful lives. Our allocation of the purchase
    price is summarized below (in thousands):
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
| 
 
    Net liabilities assumed, net of cash of $4
 
 | 
 
 | 
    $
 | 
    (31
 | 
    )
 | 
| 
 
    Backlog
 
 | 
 
 | 
 
 | 
    120
 | 
 
 | 
| 
 
    Trademarks/names
 
 | 
 
 | 
 
 | 
    120
 | 
 
 | 
| 
 
    Customer relationships
 
 | 
 
 | 
 
 | 
    60
 | 
 
 | 
| 
 
    Non-compete agreements
 
 | 
 
 | 
 
 | 
    100
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
    369
 | 
 
 | 
| 
 
    Goodwill
 
 | 
 
 | 
 
 | 
    5,434
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total
 
 | 
 
 | 
    $
 | 
    5,803
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    
    55
 
 
    INTEVAC,
    INC.
 
    NOTES TO CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    The $5.8 million allocated purchase price consists of
    $2.0 million paid in cash, $3.7 million in notes
    payable (present value at January 31, 2007) and
    $87,000 in acquisition-related expenses. The estimated useful
    economic lives of the identified intangible assets acquired are
    two years for the customer relationships and non-compete
    agreements and approximately four months for the backlog. The
    trademark/names asset has an indefinite life.
 
    Creative
    Display Systems, LLC
 
    On November 9, 2007, we completed the acquisition of the
    assets and certain liabilities of Creative Display Systems, LLC
    (CDS) for a total purchase price of $6 million
    cash paid at the close of the acquisition. CDS is a Carlsbad,
    California company specializing in high-performance
    micro-display products for near-eye and portable applications in
    defense and commercial markets.
 
    We accounted for the acquisition as a taxable purchase
    transaction and, accordingly, the purchase price has been
    allocated to tangible assets, liabilities assumed, and
    identifiable intangible assets acquired based on their estimated
    fair values on the acquisition date. The excess of the purchase
    price over the aggregate fair values was recorded as goodwill.
    The fair value assigned to identifiable intangible assets
    acquired is determined using the income approach, which
    discounts expected future cash flows to present value using
    estimates and assumptions determined by management. Purchased
    intangible assets are amortized on a straight-line basis over
    the respective useful lives. Our allocation of the purchase
    price is summarized below (in thousands):
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
| 
 
    Net assets acquired, net of cash of $130
 
 | 
 
 | 
    $
 | 
    1,896
 | 
 
 | 
| 
 
    Technology  I-Port
 
 | 
 
 | 
 
 | 
    375
 | 
 
 | 
| 
 
    Technology  Optical Display
 
 | 
 
 | 
 
 | 
    515
 | 
 
 | 
| 
 
    Backlog
 
 | 
 
 | 
 
 | 
    110
 | 
 
 | 
| 
 
    Customer relationships
 
 | 
 
 | 
 
 | 
    560
 | 
 
 | 
| 
 
    Non-compete agreements
 
 | 
 
 | 
 
 | 
    40
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
    3,496
 | 
 
 | 
| 
 
    Goodwill
 
 | 
 
 | 
 
 | 
    2,471
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total
 
 | 
 
 | 
    $
 | 
    5,967
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    The $6.0 million allocated purchase price consists of
    $6.0 million paid in cash and $97,000 in
    acquisition-related expenses, less cash acquired of $130,000.
    The estimated useful economic lives of the identified intangible
    assets acquired are ten years for the technology, thirteen years
    for the customer relationships, three years for the non-compete
    agreements and approximately three months for the backlog.
 
    In accordance with SFAS No. 141, we allocated the
    excess of the cost of the acquired entities over the net amounts
    of assets acquired and liabilities assumed to goodwill. At
    December 31, 2007, we had recorded $7.9 million of
    goodwill on our Consolidated Balance Sheet. In accordance with
    SFAS No. 142, goodwill is not amortized. Instead, it
    is tested for impairment on an annual basis or more frequently
    upon the occurrence of circumstances that indicate that goodwill
    may be impaired. We did not record any impairment of goodwill
    during fiscal 2007.
    
    56
 
 
    INTEVAC,
    INC.
 
    NOTES TO CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    Total amortization expense for the year ended December 31,
    2007 was $218,000. Future amortization expense for the existing
    amortizable intangible assets for the years ending
    December 31, is as follows:
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
| 
 
    2008
 
 | 
 
 | 
    $
 | 
    335,000
 | 
 
 | 
| 
 
    2009
 
 | 
 
 | 
 
 | 
    152,000
 | 
 
 | 
| 
 
    2010
 
 | 
 
 | 
 
 | 
    143,000
 | 
 
 | 
| 
 
    2011
 
 | 
 
 | 
 
 | 
    132,000
 | 
 
 | 
| 
 
    2012
 
 | 
 
 | 
 
 | 
    132,000
 | 
 
 | 
| 
 
    Beyond
 
 | 
 
 | 
 
 | 
    768,000
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total
 
 | 
 
 | 
    $
 | 
    1,662,000
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    The results of operations for the acquired businesses have been
    included in our consolidated statements of operations for the
    period subsequent to our acquisition of DeltaNu and CDS. The
    results of operations for DeltaNu and CDS for periods prior to
    this acquisition were not material to our consolidated
    statements of operations and, accordingly, pro forma financial
    information has not been presented.
 
 
    Credit
    Risk and Significant Customers
 
    Financial instruments that potentially subject us to significant
    concentrations of credit risk consist of cash equivalents,
    short- and long-term investments, accounts receivable and
    foreign exchange forward contracts. We generally invest our
    excess cash in money market funds, Auction Rate Securities,
    commercial paper and debt securities of the U.S. government
    and its agencies, which each have contracted maturities of
    25 months or less and an average maturity in aggregate of
    one year or less. By policy, our investments in commercial
    paper, Auction Rate Securities, certificates of deposit,
    Eurodollar time deposits, or bankers acceptances are rated
    AAA or better, and we limit the amount of credit exposure to any
    one issuer.
 
    Our accounts receivable tend to be concentrated in a limited
    number of customers. At December 31, 2007, three customers
    accounted for 14%, 12% and 11%, respectively, of our accounts
    receivable and in aggregate accounted for 38% of net accounts
    receivable. At December 31, 2006, three customers accounted
    for 39%, 34% and 13%, respectively, of our accounts receivable
    and in aggregate accounted for 86% of net accounts receivable.
    At December 31, 2005, four customers accounted for 33%,
    22%, 20% and 18%, respectively, of our accounts receivable and
    in aggregate accounted for 93% of net accounts receivable.
 
    Our largest customers tend to change from period to period.
    Historically, a significant portion of our revenues in any
    particular period have been attributable to sales to a limited
    number of customers. In 2007, four customers accounted for 31%,
    23%, 23% and 13%, respectively, of our consolidated net revenues
    and in aggregate accounted for 90% of net revenues. In 2006,
    three customers accounted for 52%, 22% and 19%, respectively, of
    our consolidated net revenues and in aggregate accounted for 93%
    of net revenues. In 2005, four customers accounted for 41%, 24%,
    14% and 11%, respectively, of our consolidated net revenues and
    in aggregate accounted for 90% of net revenues. Intevac performs
    credit evaluations of its customers financial condition
    and generally requires deposits on system orders but does not
    generally require collateral or other security to support
    customer receivables.
 
    Products
 
    Disk manufacturing products contributed a significant portion of
    our revenues in 2007, 2006, and 2005. We expect that our ability
    to maintain or expand our current levels of revenues in the
    future will depend upon continuing market demand for our
    products; our success in enhancing our existing systems and
    developing and manufacturing competitive disk manufacturing
    equipment, such as our 200 Lean; our success in developing both
    military and
    
    57
 
 
    INTEVAC,
    INC.
 
    NOTES TO CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    commercial products based on our low light technology; and our
    success in utilizing our expertise in complex manufacturing
    equipment to develop new equipment products for semiconductor
    manufacturing.
 
 
    601
    California Avenue LLC
 
    In 1995, we entered into a Limited Liability Company Operating
    Agreement (the Operating Agreement), with 601
    California Avenue LLC (the LLC), a California
    limited liability company formed and owned by Intevac and
    certain stockholders of Intevac. Under the Operating Agreement
    we transferred our leasehold interest in the site of our
    discontinued night vision business in exchange for a Preferred
    Share in the LLC with a face value of $3.9 million. During
    1996, the LLC formed a joint venture with Stanford University
    (the Stanford JV) to develop and lease the property.
    In December 2007, the Stanford JV sold the property, and LLC
    redeemed Intevacs $3.9 million Preferred Share.
 
    We accounted for the investment under the cost method and
    originally recorded our investment in the LLC at $2,431,000,
    which represented our historical carrying value of the leasehold
    interest in the site. The Company received dividends of
    $292,500, $390,000 and $390,000 in 2007, 2006 and 2005,
    respectively, from LLC. These dividends and the $1,469,000 gain
    realized upon redemption of the Preferred Share in December 2007
    were included in other income and expense.
 
     | 
     | 
    | 
    7.  
 | 
    
    Commitments
    and Contingencies
 | 
 
    Leases
 
    We lease certain facilities under non-cancelable operating
    leases that expire at various times up to February 2013. Certain
    of our leases contain provisions for rental adjustments,
    including a provision based on increases in the Bay Area
    Consumer Price Index. Included in other long term assets on the
    Consolidated Balance Sheets is $1.8 million of prepaid rent
    related to the effective rent on our long-term lease for our
    Santa Clara facility. The facility leases require Intevac
    to pay for all normal maintenance costs.
 
    Future minimum rental payments under these leases at
    December 31, 2007 are as follows (in thousands):
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
| 
 
    2008
 
 | 
 
 | 
    $
 | 
    2,534
 | 
 
 | 
| 
 
    2009
 
 | 
 
 | 
 
 | 
    2,520
 | 
 
 | 
| 
 
    2010
 
 | 
 
 | 
 
 | 
    2,386
 | 
 
 | 
| 
 
    2011
 
 | 
 
 | 
 
 | 
    2,310
 | 
 
 | 
| 
 
    2012
 
 | 
 
 | 
 
 | 
    744
 | 
 
 | 
| 
 
    Beyond
 
 | 
 
 | 
 
 | 
    36
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total
 
 | 
 
 | 
    $
 | 
    10,530
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    Gross rental expense was approximately $3,300,000, $2,726,000,
    and $2,454,000 for the years ended December 31, 2007, 2006,
    and 2005, respectively.
 
    Contingencies
 
    From time to time, we may have certain contingent liabilities
    that arise in the ordinary course of our business activities. We
    account for contingent liabilities when it is probable that
    future expenditures will be made and such expenditures can be
    reasonably estimated.
 
    On July 7, 2006, we filed a patent infringement lawsuit
    against Unaxis USA, Inc. (a wholly owned subsidiary of Oerlikon)
    and its affiliates, Unaxis Balzers AG and Unaxis Balzers, Ltd.,
    in the United States District Court for the Central District of
    California. Our lawsuit against Unaxis asserts infringement by
    Unaxis of United States Patent
    
    58
 
 
    INTEVAC,
    INC.
 
    NOTES TO CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    6,919,001, which relates to our 200 Lean system. Our complaint
    seeks monetary damages and an injunction that would bar Unaxis
    from making, using, offering to sell or selling in the United
    States, or importing into the United States, Unaxis
    allegedly infringing product. We believe we have meritorious
    claims, and we intend to pursue them vigorously.
 
    On September 12, 2006, Unaxis filed a response to our
    lawsuit in which it asserted non-infringement, invalidity of our
    patent, inequitable conduct by Intevac, patent misuse by
    Intevac, and lack of jurisdiction by the Court as defenses.
    Additionally, Unaxis requested a declaratory judgment of patent
    non-infringement, invalidity and unenforceability; asserted that
    Intevac violated the California Business and Professional Code;
    requested that we be enjoined from engaging in any unfair
    competition; and requested that we be required to pay
    Unaxis attorney fees. We believe such claims lack merit,
    and we intend to defend ourselves vigorously.
 
    We replied to Unaxis response on October 3, 2006,
    denying the assertions of non-infringement, invalidity and
    unenforceability of the Intevac patent, and denying any unfair
    competition. With the approval of the Court, we amended our
    complaint on February 6, 2007 to assert an additional
    ground for our infringement claim and to add a request for a
    declaratory judgment of infringement. Unaxis filed a response on
    February 21, 2007, in which it repeated the assertions of
    its September 12, 2006 response.
 
    On May 21, 2007, the Court granted Unaxis request to
    stay the litigation pending reexamination of our United States
    Patent 6,919,001, after the U.S. Patent Office granted
    Unaxis February 27, 2007 reexamination request and
    issued an initial office action rejecting the claims of the
    patent. The Court also ordered the parties to file a joint
    report every 120 days to keep it appraised of the
    reexamination status. Intevac had no input to the initial office
    action determination by the U.S. Patent Office.
 
    On June 20, 2007, we filed a reply to the initial office
    action reexamination. Our reply addresses the office
    actions rejections of the patents original claims
    and proposes amended claims that we believe are supported by the
    original patents specification. Unaxis responded to our
    reply, and the U.S. Patent Office is now considering both
    parties submissions. During the reexamination process, the
    patent remains valid.
 
 
    Employee
    Savings and Retirement Plan
 
    In 1991, we established a defined contribution retirement plan
    with 401(k) plan features. The plan covers all United States
    employees eighteen years and older. Employees may make
    contributions by a percentage reduction in their salaries, not
    to exceed the statutorily prescribed annual limit. We made cash
    contributions of $481,000, $437,000 and $327,000 for the years
    ended December 31, 2007, 2006, and 2005, respectively.
    Employees may choose among twelve investment options for their
    contributions and their share of Intevacs contributions,
    and they are able to move funds between investment options at
    any time. Intevacs common stock is not one of the
    investment options. Administrative expenses relating to the plan
    are insignificant.
 
    Employee
    Bonus Plans
 
    We have various employee bonus plans. A profit-sharing plan
    provides for the distribution of a percentage of pre-tax profits
    to substantially all of our employees not eligible for other
    performance-based incentive plans, up to a maximum percentage of
    compensation. Other plans award annual or quarterly bonuses to
    our executives and key contributors based on the achievement of
    profitability and other specific performance criteria. Charges
    to expense under these plans were $5.2 million,
    $8.3 million and $3.2 million for the years ended
    December 31, 2007, 2006 and 2005, respectively.
    
    59
 
 
    INTEVAC,
    INC.
 
    NOTES TO CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
 
    Segment
    Description
 
    We have two reportable operating segments: Equipment and Imaging
    Instrumentation. Our Equipment business is a leader in the
    design, manufacture and marketing of high-productivity
    lean manufacturing systems and has been producing
    Lean Thinking platforms since 1994. We are the
    leading supplier of magnetic media sputtering equipment to the
    hard disk drive industry and offer leading-edge,
    high-productivity etch systems to the semiconductor industry.
    Our Imaging Instrumentation business is a leader in the
    development of compact, cost-effective, high-sensitivity
    digital-optical products for the capture and display of
    low-light images and the optical analysis of materials. We
    provide sensors, cameras and systems for commercial applications
    in the inspection, medical, scientific and security industries
    and for government applications such as night vision and
    long-range target identification.
 
    Included in corporate activities are general corporate expenses,
    less an allocation of corporate expenses to operating units
    equal to 3% of net revenues. Assets of corporate activities
    include unallocated cash and short-term investments, deferred
    tax assets and other assets.
 
    Segment
    Profit or Loss and Segment Assets
 
    We evaluate performance and allocate resources based on a number
    of factors, including profit or loss from operations and future
    revenue potential. The accounting policies of the reportable
    segments are the same as those described in the summary of
    significant accounting policies.
 
    Business
    Segment Net Revenues
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    2007
 | 
 
 | 
 
 | 
    2006
 | 
 
 | 
 
 | 
    2005
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    Equipment
 
 | 
 
 | 
    $
 | 
    196,686
 | 
 
 | 
 
 | 
    $
 | 
    248,482
 | 
 
 | 
 
 | 
    $
 | 
    129,280
 | 
 
 | 
| 
 
    Imaging Instrumentation
 
 | 
 
 | 
 
 | 
    19,148
 | 
 
 | 
 
 | 
 
 | 
    11,393
 | 
 
 | 
 
 | 
 
 | 
    7,949
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total
 
 | 
 
 | 
    $
 | 
    215,834
 | 
 
 | 
 
 | 
    $
 | 
    259,875
 | 
 
 | 
 
 | 
    $
 | 
    137,229
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    Business
    Segment Profit (Loss)
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    2007
 | 
 
 | 
 
 | 
    2006
 | 
 
 | 
 
 | 
    2005
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    Equipment(1)(2)
 
 | 
 
 | 
    $
 | 
    32,903
 | 
 
 | 
 
 | 
    $
 | 
    52,223
 | 
 
 | 
 
 | 
    $
 | 
    20,413
 | 
 
 | 
| 
 
    Imaging Instrumentation(3)(4)
 
 | 
 
 | 
 
 | 
    (2,919
 | 
    )
 | 
 
 | 
 
 | 
    (4,826
 | 
    )
 | 
 
 | 
 
 | 
    (5,798
 | 
    )
 | 
| 
 
    Corporate activities(5)
 
 | 
 
 | 
 
 | 
    (2,548
 | 
    )
 | 
 
 | 
 
 | 
    602
 | 
 
 | 
 
 | 
 
 | 
    102
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Operating income
 
 | 
 
 | 
 
 | 
    27,436
 | 
 
 | 
 
 | 
 
 | 
    47,999
 | 
 
 | 
 
 | 
 
 | 
    14,717
 | 
 
 | 
| 
 
    Interest income
 
 | 
 
 | 
 
 | 
    6,544
 | 
 
 | 
 
 | 
 
 | 
    3,501
 | 
 
 | 
 
 | 
 
 | 
    1,303
 | 
 
 | 
| 
 
    Other income and expense, net
 
 | 
 
 | 
 
 | 
    1,598
 | 
 
 | 
 
 | 
 
 | 
    277
 | 
 
 | 
 
 | 
 
 | 
    552
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Income before income taxes
 
 | 
 
 | 
    $
 | 
    35,578
 | 
 
 | 
 
 | 
    $
 | 
    51,777
 | 
 
 | 
 
 | 
    $
 | 
    16,572
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 
     | 
     | 
     | 
    | 
    (1)  | 
     | 
    
    Includes inventory provisions of $839,000, $1.4 million and
    $782,000 in 2007, 2006 and 2005, respectively. | 
|   | 
    | 
    (2)  | 
     | 
    
    Includes stock-based compensation expense of $3.0 million
    and $2.1 million in 2007 and 2006, respectively. | 
|   | 
    | 
    (3)  | 
     | 
    
    Includes inventory provisions of $23,000, $124,000 and $91,000
    in 2007, 2006 and 2005, respectively. | 
|   | 
    | 
    (4)  | 
     | 
    
    Includes stock-based compensation expense of $1.4 million
    and $525,000 in 2007 and 2006, respectively. | 
|   | 
    | 
    (5)  | 
     | 
    
    Includes stock-based compensation expense of $1.7 million
    and $777,000 in 2007 and 2006, respectively. | 
    
    60
 
 
    INTEVAC,
    INC.
 
    NOTES TO CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
 
    Business
    Segment Assets
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    2007
 | 
 
 | 
 
 | 
    2006
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    Equipment
 
 | 
 
 | 
    $
 | 
    36,637
 | 
 
 | 
 
 | 
    $
 | 
    84,366
 | 
 
 | 
| 
 
    Imaging Instrumentation
 
 | 
 
 | 
 
 | 
    26,715
 | 
 
 | 
 
 | 
 
 | 
    7,379
 | 
 
 | 
| 
 
    Corporate activities
 
 | 
 
 | 
 
 | 
    152,061
 | 
 
 | 
 
 | 
 
 | 
    114,258
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total assets
 
 | 
 
 | 
    $
 | 
    215,413
 | 
 
 | 
 
 | 
    $
 | 
    206,003
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    Business
    Segment Property, Plant & Equipment
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
    Additions
 
 | 
 
 | 
    2007
 | 
 
 | 
 
 | 
    2006
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    Equipment
 
 | 
 
 | 
    $
 | 
    2,816
 | 
 
 | 
 
 | 
    $
 | 
    5,702
 | 
 
 | 
| 
 
    Imaging Instrumentation
 
 | 
 
 | 
 
 | 
    858
 | 
 
 | 
 
 | 
 
 | 
    979
 | 
 
 | 
| 
 
    Corporate activities
 
 | 
 
 | 
 
 | 
    2,061
 | 
 
 | 
 
 | 
 
 | 
    1,742
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total additions
 
 | 
 
 | 
    $
 | 
    5,735
 | 
 
 | 
 
 | 
    $
 | 
    8,423
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
    Depreciation
 
 | 
 
 | 
    2007
 | 
 
 | 
 
 | 
    2006
 | 
 
 | 
 
 | 
    2005
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    Equipment
 
 | 
 
 | 
    $
 | 
    2,228
 | 
 
 | 
 
 | 
    $
 | 
    1,120
 | 
 
 | 
 
 | 
    $
 | 
    822
 | 
 
 | 
| 
 
    Imaging Instrumentation
 
 | 
 
 | 
 
 | 
    1,274
 | 
 
 | 
 
 | 
 
 | 
    1,217
 | 
 
 | 
 
 | 
 
 | 
    1,054
 | 
 
 | 
| 
 
    Corporate activities
 
 | 
 
 | 
 
 | 
    701
 | 
 
 | 
 
 | 
 
 | 
    509
 | 
 
 | 
 
 | 
 
 | 
    274
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total depreciation
 
 | 
 
 | 
    $
 | 
    4,203
 | 
 
 | 
 
 | 
    $
 | 
    2,846
 | 
 
 | 
 
 | 
    $
 | 
    2,150
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
    Geographic Breakdown
 
 | 
 
 | 
    2007
 | 
 
 | 
 
 | 
    2006
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    United States
 
 | 
 
 | 
    $
 | 
    14,368
 | 
 
 | 
 
 | 
    $
 | 
    12,690
 | 
 
 | 
| 
 
    Asia
 
 | 
 
 | 
 
 | 
    1,034
 | 
 
 | 
 
 | 
 
 | 
    856
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Net property, plant & equipment
 
 | 
 
 | 
    $
 | 
    15,402
 | 
 
 | 
 
 | 
    $
 | 
    13,546
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    Geographic
    Area Net Trade Revenues
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    2007
 | 
 
 | 
 
 | 
    2006
 | 
 
 | 
 
 | 
    2005
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    United States
 
 | 
 
 | 
    $
 | 
    38,801
 | 
 
 | 
 
 | 
    $
 | 
    26,473
 | 
 
 | 
 
 | 
    $
 | 
    39,754
 | 
 
 | 
| 
 
    Asia
 
 | 
 
 | 
 
 | 
    175,907
 | 
 
 | 
 
 | 
 
 | 
    233,158
 | 
 
 | 
 
 | 
 
 | 
    96,694
 | 
 
 | 
| 
 
    Europe
 
 | 
 
 | 
 
 | 
    1,083
 | 
 
 | 
 
 | 
 
 | 
    244
 | 
 
 | 
 
 | 
 
 | 
    781
 | 
 
 | 
| 
 
    Rest of world
 
 | 
 
 | 
 
 | 
    43
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total revenues
 
 | 
 
 | 
    $
 | 
    215,834
 | 
 
 | 
 
 | 
    $
 | 
    259,875
 | 
 
 | 
 
 | 
    $
 | 
    137,229
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    Revenues are attributable to the geographic area in which our
    customers are located. Net trade revenues in Asia includes
    shipments to Singapore, China, Japan and Malaysia.
    
    61
 
 
    INTEVAC,
    INC.
 
    NOTES TO CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
 
    The provision for income taxes on income from continuing
    operations consists of the following (in thousands):
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    Years Ended December 31,
 | 
 
 | 
| 
 
 | 
 
 | 
    2007
 | 
 
 | 
 
 | 
    2006
 | 
 
 | 
 
 | 
    2005
 | 
 
 | 
|  
 | 
| 
 
    Federal:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Current
 
 | 
 
 | 
    $
 | 
    9,534
 | 
 
 | 
 
 | 
    $
 | 
    9,479
 | 
 
 | 
 
 | 
    $
 | 
    392
 | 
 
 | 
| 
 
    Deferred
 
 | 
 
 | 
 
 | 
    (1,507
 | 
    )
 | 
 
 | 
 
 | 
    (3,750
 | 
    )
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
    8,027
 | 
 
 | 
 
 | 
 
 | 
    5,729
 | 
 
 | 
 
 | 
 
 | 
    392
 | 
 
 | 
| 
 
    State:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Current
 
 | 
 
 | 
 
 | 
    3
 | 
 
 | 
 
 | 
 
 | 
    2
 | 
 
 | 
 
 | 
 
 | 
    9
 | 
 
 | 
| 
 
    Deferred
 
 | 
 
 | 
 
 | 
    (147
 | 
    )
 | 
 
 | 
 
 | 
    (831
 | 
    )
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
    (144
 | 
    )
 | 
 
 | 
 
 | 
    (829
 | 
    )
 | 
 
 | 
 
 | 
    9
 | 
 
 | 
| 
 
    Foreign:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Current
 
 | 
 
 | 
 
 | 
    350
 | 
 
 | 
 
 | 
 
 | 
    179
 | 
 
 | 
 
 | 
 
 | 
    20
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total
 
 | 
 
 | 
    $
 | 
    8,233
 | 
 
 | 
 
 | 
    $
 | 
    5,079
 | 
 
 | 
 
 | 
    $
 | 
    421
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    Income before income taxes consisted of the following (in
    thousands):
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    Years Ended December 31,
 | 
 
 | 
| 
 
 | 
 
 | 
    2007
 | 
 
 | 
 
 | 
    2006
 | 
 
 | 
 
 | 
    2005
 | 
 
 | 
|  
 | 
| 
 
    U.S. 
 
 | 
 
 | 
    $
 | 
    32,066
 | 
 
 | 
 
 | 
    $
 | 
    51,004
 | 
 
 | 
 
 | 
    $
 | 
    16,319
 | 
 
 | 
| 
 
    Foreign
 
 | 
 
 | 
 
 | 
    3,512
 | 
 
 | 
 
 | 
 
 | 
    773
 | 
 
 | 
 
 | 
 
 | 
    253
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
 | 
 
 | 
    $
 | 
    35,578
 | 
 
 | 
 
 | 
    $
 | 
    51,777
 | 
 
 | 
 
 | 
    $
 | 
    16,572
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    The tax benefits associated with exercises of nonqualified stock
    options and disqualifying dispositions of stock acquired through
    incentive stock options and the employee stock purchase plan
    reduced taxes currently payable for 2007 and 2006 by
    $3.0 million and $2.7 million, respectively. Such
    benefits were credited to additional paid-in capital.
    
    62
 
 
    INTEVAC,
    INC.
 
    NOTES TO CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    Deferred income taxes reflect the net tax effects of temporary
    differences between the carrying amounts of assets and
    liabilities for financial reporting purposes and the amounts for
    income tax purposes. Significant components of our deferred tax
    assets computed in accordance with SFAS No. 109 are as
    follows (in thousands):
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    December 31,
 | 
 
 | 
| 
 
 | 
 
 | 
    2007
 | 
 
 | 
 
 | 
    2006
 | 
 
 | 
|  
 | 
| 
 
    Deferred tax assets:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Vacation, rent, warranty and other accruals
 
 | 
 
 | 
    $
 | 
    1,142
 | 
 
 | 
 
 | 
    $
 | 
    2,090
 | 
 
 | 
| 
 
    Depreciation and amortization
 
 | 
 
 | 
 
 | 
    186
 | 
 
 | 
 
 | 
 
 | 
    44
 | 
 
 | 
| 
 
    Inventory valuation
 
 | 
 
 | 
 
 | 
    3,217
 | 
 
 | 
 
 | 
 
 | 
    3,135
 | 
 
 | 
| 
 
    Deferred income
 
 | 
 
 | 
 
 | 
    99
 | 
 
 | 
 
 | 
 
 | 
    248
 | 
 
 | 
| 
 
    Equity-based compensation
 
 | 
 
 | 
 
 | 
    3,003
 | 
 
 | 
 
 | 
 
 | 
    1,084
 | 
 
 | 
| 
 
    Research and other tax credit carry-forwards
 
 | 
 
 | 
 
 | 
    2,472
 | 
 
 | 
 
 | 
 
 | 
    590
 | 
 
 | 
| 
 
    Other
 
 | 
 
 | 
 
 | 
    (47
 | 
    )
 | 
 
 | 
 
 | 
    234
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
    10,072
 | 
 
 | 
 
 | 
 
 | 
    7,425
 | 
 
 | 
| 
 
    Valuation allowance for deferred tax assets
 
 | 
 
 | 
 
 | 
    (2,723
 | 
    )
 | 
 
 | 
 
 | 
    (2,844
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Net deferred tax assets
 
 | 
 
 | 
    $
 | 
    7,349
 | 
 
 | 
 
 | 
    $
 | 
    4,581
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    As reported on the balance sheet:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Current assets
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Deferred tax assets
 
 | 
 
 | 
    $
 | 
    4,133
 | 
 
 | 
 
 | 
    $
 | 
    4,488
 | 
 
 | 
| 
 
    Valuation allowance for deferred tax assets
 
 | 
 
 | 
 
 | 
    (524
 | 
    )
 | 
 
 | 
 
 | 
    (1,219
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Net current deferred tax assets
 
 | 
 
 | 
 
 | 
    3,609
 | 
 
 | 
 
 | 
 
 | 
    3,269
 | 
 
 | 
| 
 
    Other long term assets
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Deferred tax assets
 
 | 
 
 | 
 
 | 
    5,939
 | 
 
 | 
 
 | 
 
 | 
    2,937
 | 
 
 | 
| 
 
    Valuation allowance for deferred tax assets
 
 | 
 
 | 
 
 | 
    (2,199
 | 
    )
 | 
 
 | 
 
 | 
    (1,625
 | 
    )
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Net non-current deferred tax assets
 
 | 
 
 | 
 
 | 
    3,740
 | 
 
 | 
 
 | 
 
 | 
    1,312
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Net deferred tax assets
 
 | 
 
 | 
    $
 | 
    7,349
 | 
 
 | 
 
 | 
    $
 | 
    4,581
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    The valuation allowance of $2.7 million is attributable to
    temporary differences and deferred research and development
    credits that are not realizable in 2008. State research credit
    carry-forwards of $1.5 million, net of a $1.0 million
    valuation allowance, do not expire.
    
    63
 
 
    INTEVAC,
    INC.
 
    NOTES TO CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    A reconciliation of the income tax provision on income from
    continuing operations at the federal statutory rate of 35% to
    the income tax provision at the effective tax rate is as follows
    (in thousands):
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    Years Ended December 31,
 | 
 
 | 
| 
 
 | 
 
 | 
    2007
 | 
 
 | 
 
 | 
    2006
 | 
 
 | 
 
 | 
    2005
 | 
 
 | 
|  
 | 
| 
 
    Income taxes at the federal statutory rate
 
 | 
 
 | 
    $
 | 
    12,452
 | 
 
 | 
 
 | 
    $
 | 
    18,122
 | 
 
 | 
 
 | 
    $
 | 
    5,795
 | 
 
 | 
| 
 
    State income taxes, net of federal benefit
 
 | 
 
 | 
 
 | 
    27
 | 
 
 | 
 
 | 
 
 | 
    (539
 | 
    )
 | 
 
 | 
 
 | 
    6
 | 
 
 | 
| 
 
    Effect of foreign operations taxes at various rates
 
 | 
 
 | 
 
 | 
    (879
 | 
    )
 | 
 
 | 
 
 | 
    (93
 | 
    )
 | 
 
 | 
 
 | 
    (39
 | 
    )
 | 
| 
 
    Research tax credits
 
 | 
 
 | 
 
 | 
    (1,800
 | 
    )
 | 
 
 | 
 
 | 
    (2,128
 | 
    )
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
    Effect of tax rate changes, permanent differences and
    adjustments of prior deferrals
 
 | 
 
 | 
 
 | 
    (1,699
 | 
    )
 | 
 
 | 
 
 | 
    (38
 | 
    )
 | 
 
 | 
 
 | 
    (430
 | 
    )
 | 
| 
 
    Stock-based compensation
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    1,943
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
    Change in valuation allowance
 
 | 
 
 | 
 
 | 
    (121
 | 
    )
 | 
 
 | 
 
 | 
    (12,188
 | 
    )
 | 
 
 | 
 
 | 
    (4,911
 | 
    )
 | 
| 
 
    Other
 
 | 
 
 | 
 
 | 
    253
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total
 
 | 
 
 | 
    $
 | 
    8,233
 | 
 
 | 
 
 | 
    $
 | 
    5,079
 | 
 
 | 
 
 | 
    $
 | 
    421
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
    Included in the above rate reconciliation is $2.7 million
    of favorable federal and state adjustments related to prior
    estimates for Domestic Activities Production Deduction,
    Extra-Territorial Income, research and development credits and
    deferred tax assets.
 
    We have not provided for U.S. federal income and foreign
    withholding taxes on approximately $5.3 million of
    undistributed earnings from
    non-U.S. operations
    as of December 31, 2007 because we intend to reinvest such
    earnings indefinitely outside of the United States. If we were
    to distribute these earnings, foreign tax credits may become
    available under current law to reduce the resulting
    U.S. income tax liability. Determination of the amount of
    unrecognized deferred tax liability related to these earnings is
    not practicable. We will remit the non-indefinitely reinvested
    earnings of our
    non-U.S. subsidiaries
    where excess cash has accumulated and we determine that it is
    advantageous for business operations, tax or cash reasons.
 
    We adopted the provisions of FASB Interpretation Number 48,
    Accounting for Uncertainty in Income Taxes,
    (FIN 48) on January 1, 2007. As required
    by FIN 48, which clarifies SFAS No. 109,
    Accounting for Income Taxes, we recognize the
    financial statement benefit of a tax position only after
    determining that the relevant tax authority would more likely
    than not sustain the position following an audit. For tax
    positions meeting the more-likely-than-not threshold, the amount
    recognized in the financial statements is the largest benefit
    that has a greater than 50 percent likelihood of being
    realized upon ultimate settlement with the relevant tax
    authority. During 2007, we applied FIN 48 to all tax
    positions for which the statute of limitations remained open and
    determined that there would be no material impact on the
    financial statements for any years still subject to a potential
    tax audit. We did recognized an immaterial increase in the
    liability for unrecognized tax benefits. This liability arose
    due to a change in the state and local reporting methodology,
    which might affect certain tax attributes.
 
    We did not accrue any interest or penalties related to these
    unrecognized tax benefits because we have other tax attributes
    which would offset any potential taxes due.
 
    We are subject to income taxes in the U.S. federal
    jurisdiction, and various states and foreign jurisdictions. Tax
    regulations within each jurisdiction are subject to the
    interpretation of the related tax laws and regulations and
    require significant judgment to apply. With few exceptions, we
    are not subject to U.S. federal, state and local, or
    international jurisdictions income tax examinations by tax
    authorities for the years before 2004. Presently, there are no
    active income tax examinations in the jurisdictions where we
    operates.
    
    64
 
 
    INTEVAC,
    INC.
 
    NOTES TO CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
     | 
     | 
    | 
    11.  
 | 
    
    Other
    Accrued Liabilities
 | 
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    December 31,
 | 
 
 | 
| 
 
 | 
 
 | 
    2007
 | 
 
 | 
 
 | 
    2006
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    Accrued product warranties
 
 | 
 
 | 
    $
 | 
    2,814
 | 
 
 | 
 
 | 
    $
 | 
    4,208
 | 
 
 | 
| 
 
    Accrued taxes
 
 | 
 
 | 
 
 | 
    185
 | 
 
 | 
 
 | 
 
 | 
    1,533
 | 
 
 | 
| 
 
    Deferred income
 
 | 
 
 | 
 
 | 
    1,541
 | 
 
 | 
 
 | 
 
 | 
    573
 | 
 
 | 
| 
 
    Other
 
 | 
 
 | 
 
 | 
    914
 | 
 
 | 
 
 | 
 
 | 
    298
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total other accrued liabilities
 
 | 
 
 | 
    $
 | 
    5,454
 | 
 
 | 
 
 | 
    $
 | 
    6,612
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
     | 
     | 
    | 
    12.  
 | 
    
    Quarterly
    Consolidated Results of Operations (Unaudited)
 | 
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    Three Months Ended
 | 
 
 | 
| 
 
 | 
 
 | 
    March 31, 
    
 | 
 
 | 
 
 | 
    June 30, 
    
 | 
 
 | 
 
 | 
    Sept. 29, 
    
 | 
 
 | 
 
 | 
    Dec. 31, 
    
 | 
 
 | 
| 
 
 | 
 
 | 
    2007
 | 
 
 | 
 
 | 
    2007
 | 
 
 | 
 
 | 
    2007
 | 
 
 | 
 
 | 
    2007
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands, except per share data)
 | 
 
 | 
|  
 | 
| 
 
    Net sales
 
 | 
 
 | 
    $
 | 
    76,374
 | 
 
 | 
 
 | 
    $
 | 
    72,105
 | 
 
 | 
 
 | 
    $
 | 
    50,604
 | 
 
 | 
 
 | 
    $
 | 
    16,751
 | 
 
 | 
| 
 
    Gross profit
 
 | 
 
 | 
 
 | 
    32,782
 | 
 
 | 
 
 | 
 
 | 
    30,827
 | 
 
 | 
 
 | 
 
 | 
    24,615
 | 
 
 | 
 
 | 
 
 | 
    7,819
 | 
 
 | 
| 
 
    Net income (loss)
 
 | 
 
 | 
 
 | 
    9,845
 | 
 
 | 
 
 | 
 
 | 
    11,552
 | 
 
 | 
 
 | 
 
 | 
    8,364
 | 
 
 | 
 
 | 
 
 | 
    (2,416
 | 
    )
 | 
| 
 
    Basic income (loss) per share
 
 | 
 
 | 
    $
 | 
    0.46
 | 
 
 | 
 
 | 
    $
 | 
    0.54
 | 
 
 | 
 
 | 
    $
 | 
    0.39
 | 
 
 | 
 
 | 
    $
 | 
    (0.11
 | 
    )
 | 
| 
 
    Diluted income (loss) per share
 
 | 
 
 | 
 
 | 
    0.44
 | 
 
 | 
 
 | 
 
 | 
    0.52
 | 
 
 | 
 
 | 
 
 | 
    0.38
 | 
 
 | 
 
 | 
 
 | 
    (0.11
 | 
    )
 | 
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    Three Months Ended
 | 
 
 | 
| 
 
 | 
 
 | 
    April 1, 
    
 | 
 
 | 
 
 | 
    July 1, 
    
 | 
 
 | 
 
 | 
    Sept. 30, 
    
 | 
 
 | 
 
 | 
    Dec. 31, 
    
 | 
 
 | 
| 
 
 | 
 
 | 
    2006
 | 
 
 | 
 
 | 
    2006
 | 
 
 | 
 
 | 
    2006
 | 
 
 | 
 
 | 
    2006
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands, except per share data)
 | 
 
 | 
|  
 | 
| 
 
    Net sales
 
 | 
 
 | 
    $
 | 
    49,620
 | 
 
 | 
 
 | 
    $
 | 
    59,542
 | 
 
 | 
 
 | 
    $
 | 
    54,829
 | 
 
 | 
 
 | 
    $
 | 
    95,884
 | 
 
 | 
| 
 
    Gross profit
 
 | 
 
 | 
 
 | 
    17,306
 | 
 
 | 
 
 | 
 
 | 
    21,262
 | 
 
 | 
 
 | 
 
 | 
    23,280
 | 
 
 | 
 
 | 
 
 | 
    39,111
 | 
 
 | 
| 
 
    Net income
 
 | 
 
 | 
 
 | 
    7,011
 | 
 
 | 
 
 | 
 
 | 
    9,333
 | 
 
 | 
 
 | 
 
 | 
    9,013
 | 
 
 | 
 
 | 
 
 | 
    21,341
 | 
 
 | 
| 
 
    Basic income per share
 
 | 
 
 | 
    $
 | 
    0.34
 | 
 
 | 
 
 | 
    $
 | 
    0.44
 | 
 
 | 
 
 | 
    $
 | 
    0.43
 | 
 
 | 
 
 | 
    $
 | 
    1.01
 | 
 
 | 
| 
 
    Diluted income per share
 
 | 
 
 | 
 
 | 
    0.32
 | 
 
 | 
 
 | 
 
 | 
    0.42
 | 
 
 | 
 
 | 
 
 | 
    0.41
 | 
 
 | 
 
 | 
 
 | 
    0.97
 | 
 
 | 
 
 
    Auction
    Rate Securities
 
    At December 31, 2007, we held $81.5 million of Auction
    Rate Securities, valued at fair market value, which was equal to
    cost. Beginning in mid-February, certain of these Auction Rate
    Securities failed auction due to sell orders exceeding buy
    orders. The funds associated with failed auctions will not be
    accessible until a successful auction occurs or a buyer is found
    outside of the auction process. All of our Auction Rate
    Securities are student loan structured issues, where the loans
    have been originated under the Department of Educations
    Federal Family Education Loan Program and the principal and
    interest is 97% reinsured by the U.S. Department of
    Education. At this time, there has been no change in the AAA
    rating of these securities.
 
    The auction failures for the specific type of Auction Rate
    Securities in which we invest are so recent that neither
    valuation models nor secondary markets yet exist. We will
    continue to monitor the market for our Auction Rate Securities
    and will analyze the valuation of these investments each
    reporting period. If the valuation of these investments decline,
    we may be required to record unrealized losses in other
    comprehensive income or impairment charges in 2008.
    
    65
 
 
    INTEVAC,
    INC.
 
    NOTES TO CONSOLIDATED FINANCIAL
    STATEMENTS  (Continued)
 
    We intend and have the ability to hold these Auction Rate
    Securities until the market recovers. We do not anticipate
    having to sell these securities in order to operate our
    business. We believe that the cash generated by our operating
    activities, the scheduled maturities of other investments and
    the establishment of a standby line of credit will be sufficient
    to meet our cash requirements until the market for the Auction
    Rate Securities becomes liquid again.
 
    Standby
    Line of Credit
 
    On March 5, 2008, we entered into an agreement with
    Citigroup Global Markets Inc (Citi). for a secured
    revolving loan facility. This loan facility is secured by our
    Auction Rate Securities held at Citi. Approximately
    $20 million of credit is currently available pursuant to
    the loan facility. The interest rate on the loan facility is
    Prime minus 1.5%, which is equal to, or less than, the interest
    we are earning on the Auction Rate Securities whose auctions
    have failed.
    
    66
 
 
     | 
     | 
    | 
    Item 9.  
 | 
    
    Changes
    In and Disagreements With Accountants on Accounting and
    Financial Disclosure
 | 
 
    None.
 
     | 
     | 
    | 
    Item 9A.  
 | 
    
    Controls
    and Procedures
 | 
 
    Managements
    Report on Assessment of Internal Controls Over Financial
    Reporting
 
    Conclusions
    Regarding Disclosure Controls and Procedures
 
    Our chief executive officer and our chief financial officer have
    concluded, based on the evaluation of the effectiveness of our
    disclosure controls and procedures (as defined in
    Rules 13a-15(e)
    and
    15d-15(e) of
    the Securities Exchange Act of 1934, as amended) by our
    management, with the participation of our chief executive
    officer and our chief financial officer, that our disclosure
    controls and procedures were effective as of December 31,
    2007.
 
    Managements
    Report on Internal Control over Financial
    Reporting
 
    Our management is responsible for establishing and maintaining
    adequate internal control over financial reporting (as defined
    in
    Rules 13a-15(f)
    and
    15d-15(f)
    under the Securities Exchange Act of 1934, as amended). Under
    the supervision and with the participation of our management,
    including our chief executive officer and chief financial
    officer, we conducted an evaluation of the effectiveness of our
    internal control over financial reporting based on the framework
    in Internal Control  Integrated Framework
    issued by the Committee of Sponsoring Organizations of the
    Treadway Commission, or COSO. Based on our evaluation under the
    framework in Internal Control  Integrated
    Framework , our management has concluded that our internal
    control over financial reporting was effective as of
    December 31, 2007.
 
    Changes
    in Internal Control over Financial Reporting
 
    There were no changes in our internal control over financial
    reporting during our fourth fiscal quarter that have materially
    affected, or are reasonably likely to materially affect, our
    internal control over financial reporting.
 
    Limitations
    on the Effectiveness of Controls
 
    Our management, including our chief executive officer and chief
    financial officer, does not expect that our disclosure controls
    and procedures or our internal controls will prevent all errors
    and all fraud. A control system, no matter how well conceived
    and operated, can provide only reasonable, not absolute,
    assurance that the objectives of the control system are met.
    Further, the design of a control system must reflect the fact
    that there are resource constraints, and the benefits of
    controls must be considered relative to their costs. Our
    disclosure controls and procedures and our internal controls
    have been designed to provide reasonable assurance of achieving
    their objectives. Because of the inherent limitations in all
    control systems, no evaluation of controls can provide absolute
    assurance that all control issues and instances of fraud, if
    any, within Intevac have been detected. An evaluation was
    performed under the supervision and with the participation of
    our management, including our chief executive officer and chief
    financial officer, of the effectiveness of the design and
    operation of our disclosure controls and procedures as of
    December 31, 2007. Based on that evaluation, our
    management, including our chief executive officer and chief
    financial officer, concluded that our disclosure controls and
    procedures were effective at the reasonable assurance level.
    
    67
 
    REPORT OF
    INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
 
    Board of Directors and Shareholders
    Intevac, Inc.
 
    We have audited Intevac, Inc. (a Delaware corporation) and
    subsidiaries (collectively, the Company)
    internal control over financial reporting as of
    December 31, 2007, based on criteria established in
    Internal Control  Integrated Framework issued
    by the Committee of Sponsoring Organizations of the Treadway
    Commission (COSO). The Companys management is responsible
    for maintaining effective internal control over financial
    reporting and for its assessment of the effectiveness of
    internal control over financial reporting, included in the
    accompanying Managements Report on Internal Control Over
    Financial Reporting. Our responsibility is to express an opinion
    on the Companys internal control over financial reporting
    based on our audit.
 
    We conducted our audit in accordance with the standards of the
    Public Company Accounting Oversight Board (United States). Those
    standards require that we plan and perform the audit to obtain
    reasonable assurance about whether effective internal control
    over financial reporting was maintained in all material
    respects. Our audit included obtaining an understanding of
    internal control over financial reporting, assessing the risk
    that a material weakness exists, testing and evaluating the
    design and operating effectiveness of internal control based on
    the assessed risk, and performing such other procedures as we
    considered necessary in the circumstances. We believe that our
    audit provides a reasonable basis for our opinion.
 
    A companys internal control over financial reporting is a
    process designed to provide reasonable assurance regarding the
    reliability of financial reporting and the preparation of
    financial statements for external purposes in accordance with
    generally accepted accounting principles. A companys
    internal control over financial reporting includes those
    policies and procedures that (1) pertain to the maintenance
    of records that, in reasonable detail, accurately and fairly
    reflect the transactions and dispositions of the assets of the
    company; (2) provide reasonable assurance that transactions
    are recorded as necessary to permit preparation of financial
    statements in accordance with generally accepted accounting
    principles, and that receipts and expenditures of the company
    are being made only in accordance with authorizations of
    management and directors of the company; and (3) provide
    reasonable assurance regarding prevention or timely detection of
    unauthorized acquisition, use, or disposition of the
    companys assets that could have a material effect on the
    financial statements.
 
    Because of its inherent limitations, internal control over
    financial reporting may not prevent or detect misstatements.
    Also, projections of any evaluation of effectiveness to future
    periods are subject to the risk that controls may become
    inadequate because of changes in conditions, or that the degree
    of compliance with the policies or procedures may deteriorate.
 
    In our opinion, Intevac, Inc. maintained, in all material
    respects, effective internal control over financial reporting as
    of December 31, 2007, based on criteria established in
    Internal Control  Integrated Framework issued
    by COSO.
 
    We also have audited, in accordance with the standards of the
    Public Company Accounting Oversight Board (United States), the
    consolidated balance sheets of Intevac Inc. as of
    December 31, 2007 and 2006, and the related consolidated
    statements of operations and comprehensive income,
    stockholders equity and cash flows for each of the three
    years in the period ended December 31, 2007 and our report
    dated March 14, 2008 expressed unqualified opinion on those
    financial statements.
 
    /s/ GRANT THORNTON LLP
 
    San Jose, California
    March 14, 2008
    
    68
 
     | 
     | 
    | 
    Item 9B.  
 | 
    
    Other
    Information
 | 
 
    On February 14, 2008, our Board of Directors approved an
    updated form of indemnification agreement applicable to our
    directors and certain of our officers. The form was intended to
    update the current form for our reincorporation into Delaware
    and general developments in corporate law since the adoption of
    our original form of indemnification agreement and was done as
    part of our ordinary course of corporate governance matters.
    While we have not yet executed this new form of agreement with
    our directors and officers, we intend to enter into these
    agreements in the first quarter of 2008, and a copy of the form
    of agreement is attached as Exhibit 10.9 to this Report on
    Form 10-K.
 
    PART III
 
     | 
     | 
    | 
    Item 10.  
 | 
    
    Directors,
    Executive Officers and Corporate Governance
 | 
 
    The information required by this item relating to the
    Companys directors and nominees, disclosure relating to
    compliance with Section 16(a) of the Securities Exchange
    Act of 1934, and information regarding our code of ethics, audit
    committee and stockholder recommendations for director nominees
    is included under the captions Election of
    Directors, Nominees, Business Experience
    of Nominees for Election as Directors, Board
    Meetings and Committees, Corporate Governance
    Matters, Section 16(a) Beneficial Ownership
    Reporting Compliance  and Code of Business Conduct
    and Ethics in the Companys Proxy Statement for the
    2008 Annual Meeting of Stockholders and is incorporated herein
    by reference. The information required by this item relating to
    the Companys executive officers and key employees is
    included under the caption Executive Officers under
    Item 4 in Part I of this Annual Report on
    Form 10-K.
 
     | 
     | 
    | 
    Item 11.  
 | 
    
    Executive
    Compensation
 | 
 
    The information required by this item is included under the
    caption Executive Compensation and Related
    Information in the Companys Proxy Statement for the
    2008 Annual Meeting of Stockholders and is incorporated herein
    by reference.
 
     | 
     | 
    | 
    Item 12.  
 | 
    
    Security
    Ownership of Certain Beneficial Owners and Management and
    Related Stockholder Matters
 | 
 
    Securities authorized for issuance under equity compensation
    plans.  The following table summarizes the number
    of outstanding options granted to employees and directors, as
    well as the number of securities remaining available for future
    issuance, under our equity compensation plans at
    December 31, 2007.
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
    (a) 
    
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    (c) 
    
 | 
 
 | 
| 
 
 | 
 
 | 
    Number of Securities 
    
 | 
 
 | 
 
 | 
    (b) 
    
 | 
 
 | 
 
 | 
    Number of Securities 
    
 | 
 
 | 
| 
 
 | 
 
 | 
    to be Issued Upon 
    
 | 
 
 | 
 
 | 
    Weighted-Average 
    
 | 
 
 | 
 
 | 
    Remaining Available 
    
 | 
 
 | 
| 
 
 | 
 
 | 
    Exercise of 
    
 | 
 
 | 
 
 | 
    Exercise Price of 
    
 | 
 
 | 
 
 | 
    for Future Issuance 
    
 | 
 
 | 
| 
 
 | 
 
 | 
    Outstanding Options, 
    
 | 
 
 | 
 
 | 
    Outstanding Options, 
    
 | 
 
 | 
 
 | 
    Under Equity 
    
 | 
 
 | 
| 
 
    Plan Category
 
 | 
 
 | 
    Warrants and Rights
 | 
 
 | 
 
 | 
    Warrants and Rights
 | 
 
 | 
 
 | 
    Compensation Plans(1)
 | 
 
 | 
|  
 | 
| 
 
    Equity compensation plans approved by security holders(2)
 
 | 
 
 | 
 
 | 
    2,587,854
 | 
 
 | 
 
 | 
    $
 | 
    13.37
 | 
 
 | 
 
 | 
 
 | 
    937,772
 | 
 
 | 
| 
 
    Equity compensation plans not approved by security holders
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
 
 | 
 
 | 
    
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Total
 
 | 
 
 | 
 
 | 
    2,587,854
 | 
 
 | 
 
 | 
    $
 | 
    13.37
 | 
 
 | 
 
 | 
 
 | 
    937,772
 | 
 
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 
     | 
     | 
     | 
    | 
    (1)  | 
     | 
    
    Excludes securities reflected in column (a). | 
|   | 
    | 
    (2)  | 
     | 
    
    Included in the column (c) amount are 297,919 shares
    available for future issuance under Intevacs 2003 Employee
    Stock Purchase Plan. | 
 
    The other information required by this item is included under
    the caption Ownership of Securities in the
    Companys Proxy Statement for the 2008 Annual Meeting of
    Stockholders and is incorporated herein by reference.
    
    69
 
 
     | 
     | 
    | 
    Item 13.  
 | 
    
    Certain
    Relationships and Related Transactions, and Director
    Independence
 | 
 
    The information required by this item is included under the
    captions Certain Transactions and Corporate
    Governance Matters in the Companys Proxy Statement
    for the 2008 Annual Meeting of Stockholders and is incorporated
    herein by reference.
 
     | 
     | 
    | 
    Item 14.  
 | 
    
    Principal
    Accountant Fees and Services
 | 
 
    The information required by this item is included under the
    caption Fees Paid To Accountants For Services Rendered
    During 2007 in the Companys Proxy Statement for the
    2008 Annual Meeting of Stockholders and is incorporated herein
    by reference.
 
    PART IV
 
     | 
     | 
    | 
    Item 15.  
 | 
    
    Exhibits
    and Financial Statement Schedules
 | 
 
    (a) List of Documents filed as part of this Annual Report
    on
    Form 10-K.
 
    1. The following consolidated financial statements of
    Intevac, Inc. are filed in Part II, Item 8 of this
    Annual Report on
    Form 10-K:
 
    Report of Grant Thornton LLP, Independent Auditors
 
    Consolidated Balance Sheets as of December 31, 2007 and 2006
 
    Consolidated Statements of Income and Comprehensive Income
    (Loss) for the years ended December 31, 2007, 2006 and 2005
 
    Consolidated Statement of Stockholders Equity for the
    years ended December 31, 2007, 2006 and 2005
 
    Consolidated Statements of Cash Flows for the years ended
    December 31, 2007, 2006 and 2005
 
    Notes to Consolidated Financial Statements for the years ended
    December 31, 2007, 2006 and 2005
 
    2. Financial Statement Schedules.
 
    The following financial statement schedule of Intevac, Inc. is
    filed in Part IV, Item 15(a) of this Annual Report on
    Form 10-K:
 
    Schedule II  Valuation and Qualifying Accounts
 
    All other schedules have been omitted since the required
    information is not present in amounts sufficient to require
    submission of the schedule or because the information required
    is included in the consolidated financial statements or notes
    thereto.
 
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
    Exhibit 
    
 | 
 
 | 
 
 | 
| 
 
    Number
 
 | 
 
 | 
 
    Description
 
 | 
|  
 | 
| 
 
 | 
    3
 | 
    .1(1)
 | 
 
 | 
    Certificate of Incorporation of the Registrant
 | 
| 
 
 | 
    3
 | 
    .2(1)
 | 
 
 | 
    Bylaws of the Registrant
 | 
| 
 
 | 
    10
 | 
    .1+(2)
 | 
 
 | 
    The Registrants 1995 Stock Option/Stock Issuance Plan, as
    amended
 | 
| 
 
 | 
    10
 | 
    .2+(2)
 | 
 
 | 
    The Registrants Employee Stock Purchase Plan, as amended
 | 
| 
 
 | 
    10
 | 
    .3+(3)
 | 
 
 | 
    The Registrants 2004 Equity Incentive Plan
 | 
| 
 
 | 
    10
 | 
    .4(6)
 | 
 
 | 
    Lease, dated February 5, 2001 regarding the space located
    at 3510, 3544, 3560, 3570 and 3580 Bassett Street,
    Santa Clara, California, including the First through Sixth
    Amendments
 | 
| 
 
 | 
    10
 | 
    .5(2)
 | 
 
 | 
    601 California Avenue LLC Limited Liability Operating Agreement,
    dated July 28, 1995
 | 
| 
 
 | 
    10
 | 
    .6+(2)
 | 
 
 | 
    The Registrants 401(k) Profit Sharing Plan
 | 
| 
 
 | 
    10
 | 
    .7+(5)
 | 
 
 | 
    The Registrants Executive Incentive Plan
 | 
    
    70
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
    Exhibit 
    
 | 
 
 | 
 
 | 
| 
 
    Number
 
 | 
 
 | 
 
    Description
 
 | 
|  
 | 
| 
 
 | 
    10
 | 
    .8(7)
 | 
 
 | 
    Loan Facility with Citigroup Global Markets, Inc.
 | 
| 
 
 | 
    10
 | 
    .9
 | 
 
 | 
    Director and Officer Indemnification Agreement
 | 
| 
 
 | 
    21
 | 
    .1
 | 
 
 | 
    Subsidiaries of the Registrant
 | 
| 
 
 | 
    23
 | 
    .1
 | 
 
 | 
    Consent of Independent Registered Public Accounting Firm
 | 
| 
 
 | 
    24
 | 
    .1
 | 
 
 | 
    Power of Attorney (see page 72)
 | 
| 
 
 | 
    31
 | 
    .1
 | 
 
 | 
    Certification of President and Chief Executive Officer Pursuant
    to Section 302 of the Sarbanes-Oxley Act of 2002
 | 
| 
 
 | 
    31
 | 
    .2
 | 
 
 | 
    Certification of Vice-President, Finance and Administration,
    Chief Financial Officer, Treasurer and Secretary Pursuant to
    Section 302 of the Sarbanes-Oxley Act of 2002
 | 
| 
 
 | 
    32
 | 
    .1
 | 
 
 | 
    Certifications Pursuant to U.S.C. 1350, adopted Pursuant to
    Section 906 of the Sarbanes-Oxley Act of 2002
 | 
 
 
     | 
     | 
     | 
    | 
    (1)  | 
     | 
    
    Previously filed as an exhibit to the Companys Report on
    Form 8-K
    filed July 23, 2007 | 
|   | 
    | 
    (2)  | 
     | 
    
    Previously filed as an exhibit to the Registration Statement on
    Form S-1
    (No. 33-97806) | 
|   | 
    | 
    (3)  | 
     | 
    
    Previously filed as an exhibit to the Companys Definitive
    Proxy Statement filed March 31, 2004 | 
|   | 
    | 
    (4)  | 
     | 
    
    Previously filed as an exhibit to the Companys Report on
    Form 8-K
    filed February 7, 2005 | 
|   | 
    | 
    (5)  | 
     | 
    
    Previously filed as an exhibit to the Companys Report on
    Form 8-K
    filed February 7, 2006 | 
|   | 
    | 
    (6)  | 
     | 
    
    Previously filed as an exhibit to the Companys
    Form 10-K
    filed March 16, 2007 | 
|   | 
    | 
    (7)  | 
     | 
    
    Previously filed as an exhibit to the Companys Report on
    Form 8-K
    filed March 6, 2008 | 
|   | 
    | 
    +  | 
     | 
    
    Management compensatory plan or arrangement required to be filed
    as an exhibit pursuant to Item 15(c) of
    Form 10-K | 
    71
 
 
    SIGNATURES
 
    Pursuant to the requirements of Section 13 or 15(d) of the
    Securities Exchange Act of 1934, the registrant has duly caused
    this report to be signed on its behalf by the undersigned,
    thereunto duly authorized, on March 14, 2008.
 
    INTEVAC, INC.
 
    Jeffrey Andreson
    Vice President, Finance and Administration,
    Chief Financial Officer, Treasurer and Secretary
    (Principal Financial and Accounting Officer)
 
    POWER OF
    ATTORNEY
 
    KNOW ALL PERSONS BY THESE PRESENTS, that each person whose
    signature appears below constitutes and appoints Kevin Fairbairn
    and Jeffrey Andreson and each of them, as his true and lawful
    attorneys-in-fact and agents, with full power of substitution
    and resubstitution, for him and in his name, place and stead, in
    any and all capacities, to sign any and all amendments
    (including post-effective amendments) to this Report on
    Form 10-K,
    and to file the same, with all exhibits thereto, and other
    documents in connection therewith, with the Securities and
    Exchange Commission, granting unto said attorneys-in-fact and
    agents, and each of them, full power and authority to do and
    perform each and every act and thing requisite and necessary to
    be done in connection therewith, as fully to all intents and
    purposes as he might or could do in person, hereby ratifying and
    confirming all that said attorneys-in-fact and agents, or any of
    them, or their or his substitute or substitutes, may lawfully do
    or cause to be done by virtue hereof.
 
    Pursuant to the requirements of the Securities Exchange Act of
    1934, this report has been signed below by the following persons
    on behalf of the registrant and in the capacities and on the
    dates indicated.
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
    Signature
 
 | 
 
 | 
 
    Title
 
 | 
 
 | 
 
    Date
 
 | 
|  
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
     /s/  KEVIN
    FAIRBAIRN  
    (Kevin
    Fairbairn)
 | 
 
 | 
    President, Chief Executive Officer and Director (Principal
    Executive Officer)
 | 
 
 | 
    March 14, 2008
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
     /s/  NORMAN
    H. POND  
    (Norman
    H. Pond)
 | 
 
 | 
    Chairman of the Board
 | 
 
 | 
    March 14, 2008
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
     /s/  JEFFREY
    ANDRESON  
    (Jeffrey
    Andreson)
 | 
 
 | 
    Vice President, Finance and Administration, Chief Financial
    Officer Treasurer and Secretary (Principal Financial and
    Accounting Officer)
 | 
 
 | 
    March 14, 2008
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
     /s/  DAVID
    DURY  
    (David
    Dury)
 | 
 
 | 
    Director
 | 
 
 | 
    March 14, 2008
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
     /s/  STANLEY
    J. HILL  
    (Stanley
    J. Hill)
 | 
 
 | 
    Director
 | 
 
 | 
    March 14, 2008
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
     /s/  ROBERT
    LEMOS  
    (Robert
    Lemos)
 | 
 
 | 
    Director
 | 
 
 | 
    March 14, 2008
 | 
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
     /s/  PING
    YANG  
    (Ping
    Yang)
 | 
 
 | 
    Director
 | 
 
 | 
    March 14, 2008
 | 
    
    72
 
 
    SCHEDULE II 
    VALUATION AND QUALIFYING ACCOUNTS
 
    INTEVAC,
    INC.
 
    |   | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
      | 	
| 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    Additions (Reductions)
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
 | 
 
 | 
    Balance at 
    
 | 
 
 | 
 
 | 
    Charged (Credited) 
    
 | 
 
 | 
 
 | 
    Charged (Credited) 
    
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
    Balance at 
    
 | 
 
 | 
| 
 
 | 
 
 | 
    Beginning 
    
 | 
 
 | 
 
 | 
    to Costs and 
    
 | 
 
 | 
 
 | 
    to Other 
    
 | 
 
 | 
 
 | 
    Deductions   
    
 | 
 
 | 
 
 | 
    End 
    
 | 
 
 | 
| 
 
    Description
 
 | 
 
 | 
    of Period
 | 
 
 | 
 
 | 
    Expenses
 | 
 
 | 
 
 | 
    Accounts
 | 
 
 | 
 
 | 
    Describe
 | 
 
 | 
 
 | 
    of Period
 | 
 
 | 
| 
 
 | 
 
 | 
    (In thousands)
 | 
 
 | 
|  
 | 
| 
 
    Year ended December 31, 2005:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Deducted from asset accounts:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Allowance for doubtful accounts
 
 | 
 
 | 
    $
 | 
    217
 | 
 
 | 
 
 | 
    $
 | 
    211
 | 
 
 | 
 
 | 
    $
 | 
    (268
 | 
    )
 | 
 
 | 
    $
 | 
    6
 | 
    (1)
 | 
 
 | 
    $
 | 
    154
 | 
 
 | 
| 
 
    Inventory provisions
 
 | 
 
 | 
 
 | 
    9,863
 | 
 
 | 
 
 | 
 
 | 
    873
 | 
 
 | 
 
 | 
 
 | 
    376
 | 
 
 | 
 
 | 
 
 | 
    124
 | 
    (2)
 | 
 
 | 
 
 | 
    10,988
 | 
 
 | 
| 
 
    Year ended December 31, 2006:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Deducted from asset accounts:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Allowance for doubtful accounts
 
 | 
 
 | 
    $
 | 
    154
 | 
 
 | 
 
 | 
    $
 | 
    (14
 | 
    )
 | 
 
 | 
    $
 | 
    3
 | 
 
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    143
 | 
 
 | 
| 
 
    Inventory provisions
 
 | 
 
 | 
 
 | 
    10,988
 | 
 
 | 
 
 | 
 
 | 
    1,527
 | 
 
 | 
 
 | 
 
 | 
    (32
 | 
    )
 | 
 
 | 
 
 | 
    3,355
 | 
    (2)
 | 
 
 | 
 
 | 
    9,128
 | 
 
 | 
| 
 
    Year ended December 31, 2007:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Deducted from asset accounts:
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
 
 | 
| 
 
    Allowance for doubtful accounts
 
 | 
 
 | 
    $
 | 
    143
 | 
 
 | 
 
 | 
    $
 | 
    (84
 | 
    )
 | 
 
 | 
    $
 | 
    
 | 
 
 | 
 
 | 
    $
 | 
    2
 | 
    (1)
 | 
 
 | 
    $
 | 
    57
 | 
 
 | 
| 
 
    Inventory provisions
 
 | 
 
 | 
 
 | 
    9,128
 | 
 
 | 
 
 | 
 
 | 
    862
 | 
 
 | 
 
 | 
 
 | 
    155
 | 
 
 | 
 
 | 
 
 | 
    2,395
 | 
    (2)
 | 
 
 | 
 
 | 
    7,750
 | 
 
 | 
 
 
     | 
     | 
     | 
    | 
    (1)  | 
     | 
    
    Write-offs of amounts deemed uncollectible. | 
|   | 
    | 
    (2)  | 
     | 
    
    Write-off of inventory having no future use or value to the
    Company | 
    
    73